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INTRODUCTION
Ventral Hernia
History
Ever since human kind is able to stand in a vertical position, abdominal wall hernias 
exist.  The abdominal wall was first described in 1500 BC by the Ebers Papyrus, which 
was found by Professor George Ebers in a tomb in Thebes. Incisional hernias were not 
mentioned, however, epigastric hernias were described. In the passage that was found, 
it is suggested that reduction of the hernia takes place when the patient lies down. 
The importance of closure of the abdominal wall is first described centuries later (first 
century AD), by Aulus Cornelius Celsus. Surgical closure was named ‘gastrorrhaphy’, 
which literally means ‘suturing of the abdomen’. A layered closure of the abdominal wall 
was described to prevent incisional hernia (IH). The abdominal wall was more in detail 
described by Galen, a Roman of Greek origin and one of the most important physicians 
of the Greek-Roman period. Galen was most probably aware of the risk of IHs, since he 
described how to prevent it: by paramedian incisions. The work of Galen form the basis 
of modern surgery (1). 
Anatomy
The abdominal wall is defined by several landmarks: cranially by the xiphoid process 
of the sternum, craniolaterally by the costal margins, inferolaterally by the inguinal 
ligaments and caudally by the iliac crests and pubic bone of the pelvis in the midline. 
The abdominal wall muscles ensure essential movements such as respiration, urination, 
defecation, coughing and giving birth. In addition, the abdominal wall muscles stabilize 
the trunk for walking upright. The abdominal wall exists of a layered structure, with nine 
layers in total: skin, subcuteanous tissue, superficial fascia (of Scarpa), external oblique 
muscle, internal oblique muscle, transversus abdominis muscle, fascia transversalis, 
preperitoneal adipose and areolar tissue and peritoneum. The internal oblique muscle, 
external oblique muscle and transversus abdominis muscle are positioned laterally 
to the abdominal rectus muscle. The linea alba is the preferred location to access 
the abdominal cavity. This structure, which literally means ‘white line’, is an avascular 
fibrous structure composed of collagen and elastin. It derives from the xiphoid process, 
extending to the pubis symphysis. The linea alba is the most important structure, since 
restoration of it remains the goal of abdominal wall reconstruction. It manifests a highly 
complex structure, consisting of three layers of collagen fibers in the same direction 
compared to the three lateral abdominal wall muscles. Closure can be achieved by 
approximating the paired rectus muscles back to the midline. The superior and inferior 
epigastric arteries are responsible for blood supply to the rectus muscles, originating 
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from the internal thoracic artery and external iliac artery. The epigastric arteries are 
situated between the abdominal rectus muscle and the posterior rectus fascia. The 
intercostal nerves innervate the rectus muscles. 
Definition and classification
Incisional hernia is defined as: ‘any abdominal wall gap with or without a bulge in the 
area of a postoperative scar perceptible or palpable by clinical examination or imaging’ 
(2). Primary abdominal wall hernias, or IHs, can be classified in midline and lateral 
abdominal wall hernias. Borders of a midline hernia are: the xyphoid (cranial), the 
pubic bone (caudal) and the lateral margin of the rectal sheath (lateral). Epigastric and 
umbilical hernias can be considered midline hernias. The borders of a lateral hernia are 
as follows: the costal margin (cranial) and the inguinal region (caudal).  Spigelian and 
lumbar hernias are lateral hernias. An umbilical hernia is defined as ‘a midline abdominal 
wall defect from three centimetres above up to three centimetres below the umbilicus’. The 
size of the hernia is described by the length and width of the hernia (3). 
Incisional Hernia 
Incidence, prevalence and risk factors
Incisional hernia is the most frequent postoperative complication after abdominal 
surgery. Approximately 20% of patients undergoing midline laparotomy will develop 
IH. This can increase to more than 35% in ‘high-risk groups’ (4-12). High-risk groups are 
defined as patients with an aneurysm of the abdominal aorta (AAA) and obese patients. 
It is suggested that AAA patients suffer from an underlying connective tissue disorder. 
A dysregulation of collagen type I/III ratio has an important role in the pathogenesis of 
distension of the aorta. In the abdominal wall fascia of patients with IH, a reduced type 
I/III collagen ratio is observed. Patients with a BMI of more or equal than 27 kg/m² have 
more than 30% chance of developing IH after midline laparotomy (13). These patients 
have a higher intra-abdominal pressure, which can cause a high tension on abdominal 
sutures and can thus lead to IH. Besides a high intra-abdominal pressure, there is 
another factor that can contribute to the development of IH. Obesity is associated 
with impaired wound healing, due to decreased vascularity of the tissue. This leads to 
a hypoxic wound, with an impaired synthesis of mature collagen, which results into 
weaker tissue with poor wound healing. Other risk factors for IH include surgical site 
infection, smoking, malignancy, diabetes, pulmonary disease, steroid use, malnutrition 
and collagen disorders like Ehlers Danlos and Marfan diseases (14-18).
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Diagnostic tools
IH is a complication, which should be prevented. However, so far this is not possible. 
Diagnostics and adequate follow up of IH may be underestimated, but are crucial. 
Approximately 80% to 95% of all IHs occur within three years after initial surgery. 
Thus, adequate, reliable long-term follow up is essential in providing high-quality care 
after midline laparotomies. There are several methods of follow up, such as physical 
examination and radiological examination (ultrasound, CT-scan). Until now, IH is a 
clinical diagnosis, which can be made by physical examination alone. Radiological 
examination (i.e., ultrasound or computed tomography) is being applied in case there 
is uncertainty regarding diagnosis. Earlier performed studies have shown that the 
sensitivity of physical examination is 77%, compared with computed tomography 
(CT) (19). Another study by Den Hartog et al. showed that the sensitivity of ultrasound, 
compared with CT, was 70.8%, the specificity being 100%, the positive predictive value 
100% and the negative predictive value 69.6% (20). 
Routinely scheduled outpatient visits to monitor or diagnose IH are time consuming, 
costly and demand devotion of both patient and doctor. Furthermore, it is not always 
necessary to conduct a three year follow up after abdominal surgery and patients will 
not attend a physician if symptoms are absent. Another method of follow-up might 
be the use of questionnaires (21). However, there is little evidence on their reliability. 
Currently, there is no validated questionnaire that can be used as a diagnostic tool. 
Treatment and prevention
Incisional hernia often causes morbidity, such as pain (in patients with symptomatic IH). 
Furthermore, it can have a negative effect on patients’ quality of life and body image 
(22-24). Worst-case scenario, it can lead to obstruction or strangulation of the bowel, 
with possible mortality as a result. Therefore, IH repair is a frequently performed surgical 
procedure. Studies have shown that mesh reinforcement has a 10-year cumulative 
recurrence rate of 23%, compared to 63% for primary suture repair (25, 26). The use 
of mesh in ventral hernia repair is therefore a well-accepted and frequently performed 
technique. However, the ideal location of mesh placement is still a topic of discussion. 
Mesh repair can be achieved by placing the mesh intraperitoneally (IPOM), onlay, 
sublay (retromuscular) or inlay. Currently, there is no level 1-evidence that favours 
one of these techniques. Focus should be on prevention of IH, specifically in high-risk 
groups.  Nowadays conventional laparotomy can frequently be avoided by performing 
laparoscopy or horizontal incisions (27). However, this is not always possible. No 
golden standard is described in literature to prevent IH in patients undergoing 
midline laparotomy. Prevention can be achieved by mesh reinforcement (either onlay 
or sublay) in patients, undergoing midline laparotomy. Patients with a high BMI and 
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patients with AAA might benefit most from prevention. Several prospective studies and 
randomized controlled trials have already been conducted, investigating how IH can 
be prevented (8, 10, 28-30), and which surgical technique should be applied in order 
to lower the incidence of IH. Until recently, there was no level 1-evidence available. The 
European Hernia Society guidelines on the closure of abdominal wall incisions made a 
recommendation in 2015. The Guidelines Development Group stated that prophylactic 
mesh augmentation for an elective midline laparotomy in a high-risk patient is 
suggested, in order to reduce the IH incidence. However, the evidence was weak and 
the authors therefore stated as well that larger trials would be needed to make a strong 
recommendation (2). 
The use of meshes
As stated earlier, use of mesh is proven to be beneficial in ventral hernia repair and has 
become standard practice. The 10-year cumulative recurrence rate of mesh repair of IH 
has been proven to be 23% (25). This percentage rate is 1% for umbilical hernia repair (31, 
32). One of the most important questions that still remain unanswered is: which mesh 
is the ‘ideal’ mesh? This search is still ongoing, and will not be answered in this thesis. 
Currently, there are a wide variety of synthetic, biological and biosynthetic, resorbable/
non-resorbable meshes on the market. Several factors determine which mesh is perfect 
for each specific patient: type of hernia, patient risk factors, type of surgery (clean or 
contaminated setting) and the indication (prevention or treatment). The most commonly 
used mesh in ventral hernia repair (in a clean setting) is the non-resorbable synthetic 
mesh, mostly polypropylene and polyester. These meshes are biocompatible, strong, 
and inexpensive. However, if placed in contact with abdominal viscera, complications 
of adhesion formation, small bowel obstruction, pain and enterocutaneous fistulas can 
occur (33-36). Furthermore, synthetic meshes cannot be easily used in contaminated 
settings. In these cases, biological meshes should be considered as an alternative.  These 
meshes are made of collagen, containing tissues of human or (most often) animal origin 
(37). Biological meshes can be divided in cross-linked en non cross-linked meshes. 
Crosslinking is a chemical process that can be performed to increase the strength and 
to slow down degradation of the mesh. Biological meshes are gradually vascularized 
and remodelled in the host tissue by degradation of the extracellular matrix. The use 
of biological meshes has led to a reduction of foreign body and chronic inflammatory 
response in a contaminated field, since they are more infection resistant than synthetic 
materials (38-40). Unfortunately, high evidence in long-term data of clinical outcome 
and complications is lacking. Another disadvantage is the fact that biological meshes 
are expensive (37). 
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An alternative for abdominal wall repair and soft tissue reinforcement might be the use 
of slowly resorbable synthetic mesh (‘biosynthetic’ mesh). This mesh aims to combine 
advantages of both synthetic (no degradation shortly after implantation) and biological 
(remodelling aspects) meshes. It is also less expensive than a biological mesh. Many 
studies regarding biosynthetic meshes report that there is ‘optimal tissue remodelling’. 
However, the definition of this is unclear, not standardized, and furthermore, there is not 
enough evidence yet that these meshes provide sufficient strength on long-term (41). 
Umbilical Hernia
Approximately 10% of all abdominal wall hernias are umbilical hernias. According to 
the European Hernia Society, an umbilical hernia (UH) is defined as a midline abdominal 
wall defect from three centimetres above up to three centimetres below the umbilicus. 
It can either be present at birth, or it can develop spontaneously throughout life, for 
example by increased intra-abdominal pressure. The prevalence in the adult population 
is 2%. Each year, approximately 4500 umbilical hernias are repaired in the Netherlands. 
Surgical repair of umbilical hernia can be performed by either suture or mesh repair. 
High recurrence rates are reported for suture repair, especially with hernia orifices larger 
than four centimetres. The recurrence rate for mesh repair is very low, with a percentage 
of up to one percent (31) (32).  At this moment, level-1 evidence is lacking regarding 
the umbilical hernia size that should be treated with a mesh. The HUMP trial aims to 
investigate whether mesh repair is superior compared to suture repair in reducing the 
recurrence rate for smaller umbilical hernias (1-4 centimetres). As expected, the results 
of the HUMP trial will be published this year. 
Most of the UHs are repaired under general anesthesia. Nowadays it is becoming more 
common to operate patients with inguinal and UHs under local anesthesia. Many 
studies, investigating local anesthesia for inguinal hernia repair, have been conducted 
until now. It has been shown that local anesthesia is superior for open inguinal hernia 
repair, compared to general or spinal anesthesia (42). Local anesthesia can have several 
advantages, such as less postoperative pain, less micturition problems and early 
mobilisation of patients, which can lead to a shorter duration of hospital stay. Until now, 
there is a lack of evidence regarding local anesthesia for the repair of umbilical hernia. 
A systematic review could not sufficiently show the advantages of local anesthesia, 
due to the heterogeneity amongst included studies. A prospective cohort study, using 
Ropivacaine as a local agent and Remifentanil as a sedative, showed that the use of local 
anesthesia is safe and feasible in umbilical hernia repair.
jairam-layout.indd   15 28/05/2018   21:46
16
Chapter 1
OUTLINE OF THIS THESIS
The first aim of this thesis is the prevention of incisional hernia. The second aim focuses 
on new tools, techniques and meshes in ventral hernia surgery. 
Part I: Prevention of incisional hernia
Chapter 2 presents the European Hernia Society Guidelines on the closure of abdominal 
wall incisions. In this study, a recommendation is made regarding prophylactic mesh 
augmentation in elective midline laparotomies in high-risk patients. 
In Chapter 3, the short-term results of the PRIMA trial are presented. This is a randomized 
controlled trial, investigating the efficacy of mesh reinforcement in high-risk patients 
undergoing midline laparotomy, in order to reduce the incidence of incisional hernia. 
The short-term results focus only on the complications in the first month. 
Chapter 4 presents the long-term results of the PRIMA trial. In this chapter, it is 
investigated whether mesh reinforcement is able to prevent incisional hernia in high-
risk patients undergoing midline laparotomy. 
Chapter 5 presents a meta-analysis of studies describing the results of primary 
suture versus mesh reinforcement after midline laparotomy. In this meta-analysis it is 
investigated whether mesh reinforcement reduces the incidence of incisional hernia. 
Chapter 6 presents a meta-analysis of studies describing the results of primary suture 
versus mesh reinforcement after midline laparotomy, using a biological or (slow) 
resorbable synthetic mesh. 
Part II: New tools, techniques and meshes in ventral hernia surgery
Chapter 7 presents the PROMID pilot study. In this pilot study, the reliability of a 
questionnaire, to assist in diagnosing incisional hernia, is being determined. 
Chapter 8 is a review, in which an overview is given of the characteristics of slowly 
resorbable synthetic meshes, for the treatment and prevention of abdominal wall 
hernias. 
Chapter 9 presents the protocol of a prospective cohort study, in which 85 patients with 
a Ventral Hernia Working Group (VHWG) Grade 3 hernia will be treated with Phasix™ 
mesh (a slowly resorbable synthetic mesh).
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Chapter 10 presents the in-vivo characteristics of both synthetic and biological meshes 
in a validated peritonitis rat model. 
Chapter 11 presents a review on the feasibility of local anesthesia for the surgical 
treatment of umbilical hernia.
Chapter 12 presents a pilot study, in which the safety and feasibility of local anesthesia 
in the treatment of umbilical hernia is being investigated.
In Chapter 13 the findings of this thesis will be discussed. Furthermore, recommendation 
for the future will be provided. 
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ABSTRACT 
Background: The material and the surgical technique used to close an abdominal 
wall incision are important determinants of the risk of developing an incisional hernia. 
Optimizing closure of abdominal wall incisions holds a potential to prevent patients 
suffering from incisional hernias and for important costs savings in health care.  
Methods: The European Hernia Society formed a Guidelines Development Group 
to provide guidelines for all surgical specialists who perform abdominal incisions in 
adult patients on the materials and methods used to close the abdominal wall. The 
guidelines were developed using the GRADE approach (Grading of Recommendations 
Assessment, Development and Evaluation) and methodological guidance was taken 
from SIGN (Scottish Intercollegiate Guidelines Network). The literature search included 
publications up to April 2014. The guidelines were written using the AGREE II instrument. 
An update of these guidelines is planned for 2017.     
Results: For many of the Key Questions that were studied no high quality data was 
detected. Therefore, some strong recommendations could be made but, for many Key 
Questions only weak recommendations or no recommendations could be made due to 
lack of sufficient evidence.
Recommendations: To decrease the incidence of incisional hernias it is strongly 
recommended to utilise a non-midline approach to a laparotomy whenever possible. 
For elective midline incisions, it is strongly recommended to perform a continuous 
suturing technique and to avoid the use of rapidly absorbable sutures. It is suggested 
using a slowly absorbable monofilament suture in a single layer aponeurotic closure 
technique without separate closure of the peritoneum. A small bites technique with 
a suture to wound length (SL/WL) ratio at least 4/1 is the current preferred method of 
fascial closure. Currently, no recommendations can be given on the optimal technique 
to close emergency laparotomy incisions. Prophylactic mesh augmentation appears 
effective and safe and can be suggested in high-risk patients. For laparoscopic surgery 
it is suggested using the smallest trocar size adequate for the procedure and closure 
of the fascial defect if trocars larger or equal to 10 mm are used. For single incision 
laparoscopic surgery we suggest meticulous closure of the fascial incision to avoid an 
increased risk of incisional hernias.
jairam-layout.indd   26 28/05/2018   21:47
27
EHS guidelines on closure of abdominal wall incisions
2
INTRODUCTION
Background
Incisional hernias are a frequent complication of abdominal wall incisions, but a wide 
range of incisional hernia rates are reported (1-6). The weighted mean incisional hernia 
rate at 23.8 months was 12.8 % in a systematic review and meta-regression study(7), but 
incidence rates up to 69 % have been reported in high-risk patients with prospective 
long-term follow-up(8). The reported incidence is determined by several factors: the 
patient population studied, the type of abdominal wall incision, the length of follow-up 
and the method of incisional hernia diagnosis. Risk factors for incisional hernias include 
postoperative surgical site infection, obesity and abdominal aortic aneurysm(9-11). 
Nevertheless, it seems that the suture material and the surgical technique used to 
close an abdominal wall incision, are the most important determinants of the risk of 
developing an incisional hernia(4, 12). The development of an incisional hernia has 
an important impact on the patients’ quality of life and body image(13). Furthermore, 
the repair of incisional hernias still has a high failure rate with long term recurrence 
rates above 30%, even when mesh repair is performed(14-16). Optimising the surgical 
technique to close abdominal wall incisions using evidence based principles, holds 
a potential to prevent patients suffering from incisional hernias and the potential 
sequelae of incisional hernia repairs(17). The mean direct and indirect costs for the repair 
of an average incisional hernia in an average patient in France in 2011 was € 7,089(18). 
Thus, reducing the incisional hernia rate by optimising the closure of abdominal wall 
incisions holds a great potential for costs savings in the use of health care facilities and 
in reducing postoperative disability.
The European Hernia Society (EHS) originated from the “Groupe de la recherche de la 
paroi abdominal” (GREPA), which was founded in 1979 with the aim: “The promotion 
of abdominal wall surgery, the study of anatomic, physiologic and therapeutic 
problems related to the pathology of the abdominal wall, the creation of associated 
groups which will promote research and teaching in this field, and the development of 
interdisciplinary relations”. During the autumn board meeting of the EHS in September 
2013 in Italy it was decided to extend our mission to actively promote the prevention of 
incisional hernias by the Sperlonga statement: “Maybe we should first learn and teach 
how to prevent incisional hernias, rather than how to treat them?”
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Objective
The objective is to provide guidelines for all surgical specialists who perform abdominal 
incisions in adult patients on the optimal materials and methods used to close the 
abdominal wall. The goal is to decrease the occurrence of both burst abdomen and 
incisional hernia. The guidelines refer to patients undergoing any kind of abdominal 
wall incision, including visceral surgery, gynaecological surgery, aortic vascular surgery, 
urological surgery or orthopaedic surgery. Both open and laparoscopic surgeries are 
included in these guidelines.
METHODS
As EHS secretary of Quality, Filip Muysoms, under the auspices of the European 
Hernia Society board, proposed the Guidelines Development Group. The project was 
presented to the EHS board and accepted during the board meeting in Sperlonga, Italy, 
on September 28th 2013. The members of the Guidelines Development Group were 
chosen to recruit key opinion leaders and researchers on the subject from Europe. A 
geographical distribution across European countries was attempted and some younger 
surgeons having performed research on the subject were included in the Guidelines 
Development Group. Many of the members have contributed previously in producing 
guidelines on a national and international level. The Guidelines Development Group 
included abdominal wall surgeons, upper gastro-intestinal surgeons, hepato-biliary 
surgeons, colorectal surgeons and a vascular surgeon.
During a Kick Off meeting of the Guidelines Development Group in the Bonham 
Hotel in Edinburgh on October 28th 2013, the members attended a seminar on 
the methodological aspect of developing guidelines by Robin T Harbour, the Lead 
Methodologist of the Scottish Intercollegiate Guidelines Network (SIGN)(19). The AGREE 
II instrument was used from the start of the project to guide our methodology and 
structure of producing the guidelines(20). AGREE II gives as definition for the Quality of 
a guideline: “The confidence that the potential biases of guideline development have 
been addressed adequately and that the recommendations are both internally and 
externally valid, and are feasible for practice.” During this first meeting Key Questions 
were formulated and translated into 24 patients-intervention-comparison-outcome 
(PICO) formats. For each Key Question at least three Guidelines Development Group 
members were assigned as investigators and specific search terms were formulated. 
jairam-layout.indd   28 28/05/2018   21:47
29
EHS guidelines on closure of abdominal wall incisions
2
On November 11th 2013, a meeting in Glasgow at the SIGN headquarters was held with 
the steering committee of the Guidelines Development Group to discuss the search 
strategy. A clinical librarian working for SIGN performed the primary literature research 
for all Key Questions. This involved a search for systematic reviews and/or meta-analyses 
on the Key Questions in Medline, Embase, NIHR CRD, NICE and The Cochrane library. 
The PRISMA flow diagram is shown in Figure1. The Guidelines Development Group 
members evaluated the systematic reviews for their relevance to the Key Questions 
and a qualitative assessment was done using the SIGN checklist No 1 for systematic 
reviews and meta-analyses(19). Only systematic reviews of High Quality were used as 
basis for the guidelines development. A second search (no filters) on the Key Questions 
was performed for relevant RCT’s published after the end of the search performed for 
the systematic reviews involved. If no High Quality systematic review was identified 
for a Key Question, the working group members performed a separate systematic 
review using the PRISMA statement methodology(21). To avoid lengthening of this 
guidelines manuscript, the results of these systematic reviews will be submitted as a 
separate manuscript on behalf of “The Bonham Group”, which are the members of the 
Guidelines Development Group. The members working together on a Key Question 
provided a Summary of Findings table from the results of the literature search, which 
were presented and discussed during the second group meeting.
The second Guidelines Development Group meeting was held in Edinburgh on April 
25th 2014. For evaluation of evidence, the Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) approach was used(22). For each Key Question, 
a level of evidence was proposed using the GRADE approach and four levels of quality 
of the body of evidence were used: high, moderate, low, very low (Table  1). Based 
on the research evidence, the clinical experience and patient values the Guidelines 
Development Group formulated a recommendation for each Key Question. In the GRADE 
approach only three levels of recommendation are used: strong recommendation, weak 
recommendation and no recommendation.
The results of the guidelines proposed by the Guidelines Development Group were 
presented during the 36th Annual International Congress of the European Hernia 
Society in Edinburgh on May 31st 2014. The manuscript was subsequently written 
by the first author in a uniform manner for all Key Questions and send for review and 
agreement by all co-authors. Prior to submission, the manuscript of the guidelines was 
externally reviewed by experts and evaluated using the AGREE II instrument.
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Table  1. Using the GRADE approach to guideline development(22) the Quality of the body 
of evidence is rated (high/moderate/low/very low) and the recommendations are graded as 
strong or weak
Grading the Quality of the body of evidence for each Key Questions using the GRADE approach
Underlying methodology Quality rating Symbols Definitions
Randomized trials; or double-
upgraded observational studies.
High ■■■■ Further research is very unlikely 
to change our confidence in the 
estimate of effect
Downgraded randomized trials; 
or upgraded observational 
studies.
Moderate ■■■□ Further research is likely to have 
an important impact on our 
confidence in the estimate of effect 
and may change the estimate
Double-downgraded 
randomized trials; or 
observational studies.
Low ■■□□ Further research is very likely to 
have an important impact on our 
confidence in the estimate of effect 
and is likely to change the estimate
Triple-downgraded randomized 
trials; or downgraded 
observational studies; or case 
series/case reports.
Very low ■□□□ Any estimate of effect is very 
uncertain.
Grading of recommendations using the GRADE approach
Strong recommendation Based on the available evidence, if clinicians are very certain that 
benefits do, or do not, outweigh risks and burdens they will make a 
strong recommendation.
Weak recommendation Based on the available evidence, if clinicians believe that benefits and 
risks and burdens are finely balanced, or appreciable uncertainty exists 
about the magnitude of benefits and risks, they must offer a weak 
recommendation.
No recommendation If based on the literature research no evidence could be found, no 
recommendation can be made.  
RESULTS
The results of the searches are shown in the PRISMA flow diagram in Figure  1. From 
the 97 records detected by the SIGN process, 69 records were excluded based on the 
title and abstract as not being relevant to the guidelines. The remaining 28 systematic 
reviews(4, 23-49) were assessed by full text for their relevance to the Key Questions and 
if retained were assessed qualitatively using the SIGN checklist No 1(19). Additional 
searches on PubMed and by checking the references of all manuscripts were performed 
by the members of the Guidelines Development Group assigned to each Key Question. 
Relevant studies published up until April 2014 were included to provide the Summary 
of Evidence tables.
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Prisma	  (low	  diagram	  for	  systematic	  reviews	  
SIGN	  process:	  	  
	  
Records	  iden+fied	  through	  database	  searching	  
n=2819	  
Addi+onal	  records	  
	  iden+fied	  through	  other	  sources	  n=0	  
Records	  a;er	  duplicates	  removed	  
n=2003	  (816	  removed)	  
Records	  screened	  n=97	  
Economic	  =	  6	  
Incidence	  =	  7	  
Socio-­‐economic	  =	  2	  
KQ	  A	  =	  0	  
KQ	  b	  =	  35	  
KQ	  C-­‐K	  =	  15	  
KQ	  L	  =	  7	  
KQ	  M	  =	  16	  
KQ	  Q-­‐P	  =	  0	  
KQ	  Q-­‐T	  =	  12	  
KQ	  U-­‐X	  =	  42	  
Records	  excluded	  n=1906	  
	  
European	  Hernia	  Society	  process:	  
Records	  screened	  by	  +tle	  and	  abstract	  
for	  eligibility	  =97	  
Records	  excluded	  =	  69	  	  
-­‐	  Not	  relevant	  for	  our	  guidelines	  
Studies	  included	  in	  qualita+ve	  
synthesis	  =	  28	  
Full	  text	  ar+cles	  excluded	  =	  20	  
-­‐  Not	  relevant	  for	  our	  guidelines	  
-­‐  Low	  quality	  
Studies	  included	  in	  quan+ta+ve	  
synthesis	  =	  8	  	  
	  
References:	  [1,23,24,26,27,33,43,48]	  
Figure  1. PRISMA flow diagram for the search for systematic reviews and/or meta-analyses 
performed by Scottish Intercollegiate Guidelines Network (SIGN) for the Guidelines 
Development Group of the European Hernia Society guidelines on the closure of abdominal 
wall incisions. The search was performed in November 2013 and included searches in Medline, 
Embase, NIHR CRD, NICE and The Cochrane library
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Which diagnostic modality is the most suitable to detect incisional 
hernias?
No systematic reviews on diagnostic modalities for incisional hernias were found. 
Fifteen records were included in the qualitative analysis(1-3, 6, 50-60). Only four studies 
were retained as High Quality and are listed in the Summary of Findings table (Table 2)
(3, 50, 51, 60).
The quality of most studies investigating the diagnostic accuracy of imaging techniques 
was low to very low. Only some provided a sensitivity analysis. Because no studies 
compared different diagnostic modalities in a similar methodology and with similar 
study arms, no pooling of data was useful or possible. In general, most studies show 
that medical imaging will increase the rate of detection of incisional hernias compared 
to physical examination. In an everyday clinical setting this is usually not important, 
because most asymptomatic hernias do not require treatment and their diagnosis is 
thus not necessary.
CT scan is reliable and reproducible, whereas ultrasound is more operator-dependant. 
However, CT scan will induce a radiation load to the patients and ultrasound is more 
accessible in most health care settings. A good standardisation and dynamic evaluation 
by ultrasound of the abdominal wall is needed, as described by Beck et al.(51) as the 
dynamic abdominal sonography for hernia (DASH) technique.
The difference in accuracy between physical examination and imaging technique is 
most important in the context of comparative studies evaluating incisional hernia rate. 
Next to the method of incisional hernia diagnosis the length of follow-up is important. 
Fink et al.(5) reported in a follow-up study of two prospective trials an increase from 
12.6 % at 12 months to 22.4 % at 36 months (p < 0.001) and concluded that follow-up for 
3 years should be mandatory in any study evaluating the rate of postoperative incisional 
hernia after midline laparotomy.
Statement
It is recommended that prospective studies with incisional hernia 
as a primary outcome integrate medical imaging, either dynamic 
ultrasound or CT-scan, in the follow-up.
■■□□ strong
Statement
It is recommended that studies with incisional hernia as a primary 
outcome include follow-up of at least 24 months (and preferably 36 
months).
■■□□ strong
jairam-layout.indd   32 28/05/2018   21:47
33
EHS guidelines on closure of abdominal wall incisions
2
Ta
bl
e 
2.
 S
um
m
ar
y 
of
 F
in
di
ng
s 
ta
bl
e 
fo
r K
ey
 Q
ue
st
io
n 
A
: w
hi
ch
 d
ia
gn
os
tic
 m
od
al
ity
 is
 th
e 
m
os
t s
ui
ta
bl
e 
to
 d
et
ec
t i
nc
is
io
na
l h
er
ni
as
?
Bi
bl
io
gr
ap
hi
c 
ci
ta
ti
on
St
ud
y 
ty
pe
SI
G
N
 
as
se
ss
m
en
t
N
um
be
r o
f 
pa
ti
en
ts
Pa
ti
en
t c
ha
ra
ct
er
is
ti
cs
In
te
rv
en
ti
on
Co
m
pa
ri
so
n
Le
ng
th
 o
f
fo
llo
w
-u
p
O
ut
co
m
e 
m
ea
su
re
Ba
uc
om
 e
t a
l.
 Jo
ur
na
l o
f t
he
 
A
m
er
ic
an
 C
ol
le
ge
 o
f 
Su
rg
eo
ns
 
20
13
; 2
18
(3
):3
63
-6
.
pr
os
pe
ct
iv
e 
co
ho
rt
 s
tu
dy
H
ig
h 
Q
ua
lit
y
++
18
1
pa
tie
nt
s 
se
en
 a
t a
 g
en
er
al
 
su
rg
er
y 
de
pa
rt
m
en
t w
ho
 h
ad
 a
 
pr
io
r a
bd
om
in
al
 o
pe
ra
tio
n 
 a
nd
 
an
 a
va
ila
bl
e 
C
T 
sc
an
 w
ith
in
 s
ix
 
m
on
th
s 
be
fo
re
 th
e 
vi
si
t
Ph
ys
ic
al
 
ex
am
in
at
io
n 
by
 a
 s
ur
ge
on
C
T 
sc
an
  
re
vi
ew
ed
 b
y 
su
rg
eo
n
no
t 
av
ai
la
bl
e
Ph
ys
ic
al
 e
xa
m
in
at
io
n 
ha
d 
a 
lo
w
 s
en
si
tiv
ity
 (7
7%
)
an
d 
ne
ga
tiv
e 
pr
ed
ic
tiv
e 
va
lu
e 
(7
7%
). 
It 
fa
ils
 to
 
de
te
ct
 2
3%
 o
f h
er
ni
as
 a
nd
 in
 3
2%
 o
f t
he
 p
at
ie
nt
s 
w
ith
 a
 B
M
I ≥
 3
0 
kg
/m
2 . 
G
en
er
al
 c
om
m
en
ts
: A
de
qu
at
e 
de
si
gn
ed
 s
tu
dy
 to
 c
om
pa
re
 p
hy
si
ca
l e
xa
m
in
at
io
n 
to
 C
T 
sc
an
 d
ia
gn
os
is
 o
f i
nc
is
io
na
l h
er
ni
as
. C
T 
sc
an
 w
as
 u
se
d 
a 
"g
ol
d 
st
an
da
rd
" f
or
 th
e 
se
ns
iti
vi
ty
 a
na
ly
si
s. 
 
Be
ck
 e
t a
l. 
Jo
ur
na
l o
f t
he
 
A
m
er
ic
an
 C
ol
le
ge
 
of
 S
ur
ge
on
s 
20
13
;2
16
(3
):4
47
-5
3
pr
os
pe
ct
iv
e 
co
ho
rt
 s
tu
dy
H
ig
h 
Q
ua
lit
y
++
18
1
pa
tie
nt
s 
se
en
 a
t a
 g
en
er
al
 
su
rg
er
y 
de
pa
rt
m
en
t w
ho
 h
ad
 a
 
pr
io
r a
bd
om
in
al
 o
pe
ra
tio
n 
 a
nd
 
an
 a
va
ila
bl
e 
C
T 
sc
an
 w
ith
in
 s
ix
 
m
on
th
s 
be
fo
re
 th
e 
vi
si
t
dy
na
m
ic
 
ab
do
m
in
al
 
ul
tr
as
ou
nd
 b
y 
su
rg
eo
n
C
T 
sc
an
  
re
vi
ew
ed
 b
y 
su
rg
eo
n
no
t 
av
ai
la
bl
e
D
yn
am
ic
 U
ltr
as
ou
nd
 h
as
 a
 h
ig
h 
se
ns
iti
vi
ty
 (9
8%
) 
an
d 
sp
ec
ifi
ci
ty
 (8
8%
). 
It 
ha
s 
a 
po
si
tiv
e 
pr
ed
ic
tiv
e 
va
lu
e 
of
 9
1 
%
 a
nd
 n
eg
at
iv
e 
pr
ed
ic
tiv
e 
va
lu
e 
of
 
97
%
. I
t i
s 
a 
go
od
 a
lte
rn
at
iv
e 
to
 C
T 
sc
an
 d
ia
gn
os
is
. 
G
en
er
al
 c
om
m
en
ts
: P
ap
er
 fr
om
 th
e 
sa
m
e 
gr
ou
p 
as
 B
au
co
m
 e
t a
l. 
Co
nc
er
ns
 th
e 
sa
m
e 
pa
tie
nt
 p
op
ul
at
io
n.
 A
de
qu
at
e 
de
si
gn
ed
 s
tu
dy
 to
 c
om
pa
re
 d
yn
am
ic
 u
ltr
as
ou
nd
 to
 C
T 
sc
an
 d
ia
gn
os
is
 o
f i
nc
is
io
na
l h
er
ni
as
. C
T 
sc
an
 w
as
 u
se
d 
a 
"g
ol
d 
st
an
da
rd
" f
or
 th
e 
se
ns
iti
vi
ty
 a
na
ly
si
s. 
 
de
n 
H
ar
to
g 
et
 a
l. 
H
er
ni
a 
20
09
;1
3(
1)
:4
5-
8
pr
os
pe
ct
iv
e 
 
co
ho
rt
 s
tu
dy
H
ig
h 
Q
ua
lit
y 
++
40
pa
tie
nt
s 
th
at
 h
ad
 a
or
tic
 s
ur
ge
ry
 b
y 
m
id
lin
e 
in
ci
si
on
 a
t l
ea
st
 1
2 
m
on
th
s 
be
fo
re
U
ltr
as
ou
nd
 b
y 
ra
di
ol
og
is
t
C
T 
sc
an
 (b
y 
2 
in
de
pe
nd
en
t 
ra
di
ol
og
is
ts
.
m
ea
n 
3.
4 
ye
ar
s
In
ci
si
on
al
 h
er
ni
a 
pr
ev
al
en
ce
 w
as
 6
0.
0%
 w
ith
 C
T 
sc
an
 a
nd
 4
2.
5%
 w
ith
 u
ltr
as
ou
nd
. T
he
 s
en
si
tiv
ity
 o
f 
U
S 
w
as
 7
0.
8%
 a
nd
 th
e 
sp
ec
ifi
ci
ty
 1
00
%
. U
s 
ha
s 
a 
po
si
tiv
e 
pr
ed
ic
tiv
e 
va
lu
e 
of
 1
00
%
 a
nd
 a
 n
eg
at
iv
e 
pr
ed
ic
tiv
e 
va
lu
e 
of
 6
9.
6%
.
C
T 
sc
an
 d
ia
gn
os
is
 o
f t
he
 in
ci
si
on
al
 h
er
ni
as
 h
as
 a
 
go
od
 in
tr
a-
 a
nd
 in
te
r -
ob
se
rv
er
 re
lia
bi
lit
y.
 
G
en
er
al
 c
om
m
en
ts
: A
de
qu
at
e 
de
si
gn
ed
 s
tu
dy
 to
 c
om
pa
re
 u
ltr
as
ou
nd
 to
 C
T 
sc
an
 d
ia
gn
os
is
 o
f i
nc
is
io
na
l h
er
ni
as
. N
o 
co
m
pa
ris
on
 to
 p
hy
si
ca
l e
xa
m
in
at
io
n.
 L
im
ite
d 
nu
m
be
r o
f p
at
ie
nt
s. 
 C
T 
sc
an
 w
as
 u
se
d 
as
 "g
ol
d 
st
an
da
rd
" f
or
 th
e 
se
ns
iti
vi
ty
 a
na
ly
si
s. 
 
Sc
hr
ei
ne
m
ac
he
r  
et
 a
l. 
A
rc
h 
Su
rg
. 
20
11
;1
46
:9
4-
9
re
tr
os
pe
ct
iv
e 
co
ho
rt
 s
tu
dy
w
ith
 
pr
os
pe
ct
iv
e 
ex
am
in
at
io
n
H
ig
h 
Q
ua
lit
y 
++
11
1
pa
tie
nt
s 
th
at
 h
av
e 
a 
cl
os
ur
e 
of
 a
 
te
m
po
ra
ry
 s
to
m
a 
(4
2%
 il
eo
st
om
ie
s 
an
d 
58
%
 c
ol
os
to
m
ie
s)
.
U
ltr
as
ou
nd
 o
f 
th
e 
ab
do
m
in
al
 
w
al
l b
y 
su
rg
eo
n 
Ph
ys
ic
al
 
ex
am
in
at
io
n 
by
 s
ur
ge
on
m
ed
ia
n 
35
 
m
on
th
s
In
ci
si
on
al
 h
er
ni
a 
pr
ev
al
en
ce
 w
as
 3
2.
4%
 w
ith
 
ul
tr
as
ou
nd
 e
va
lu
at
io
n.
 
Ph
ys
ic
al
 e
xa
m
in
at
io
n 
ha
d 
a 
se
ns
iti
vi
ty
  o
f 5
8.
3%
 
an
d 
a 
sp
ec
ifi
ci
ty
 o
f 9
7.
3%
. T
he
 p
os
iti
ve
 p
re
di
ct
iv
e 
va
lu
e 
w
as
 9
1.
3%
 a
nd
 th
e 
ne
ga
tiv
e 
pr
ed
ic
tiv
e 
va
lu
e 
w
as
 8
3%
. 
G
en
er
al
 c
om
m
en
ts
: B
ot
h 
ex
am
in
at
io
ns
 w
er
e 
pe
rf
or
m
ed
 b
y 
th
e 
sa
m
e 
pe
rs
on
.  
U
ltr
as
ou
nd
 w
as
 u
se
d 
a 
"g
ol
d 
st
an
da
rd
" f
or
 th
e 
se
ns
iti
vi
ty
 a
na
ly
si
s. 
 
jairam-layout.indd   33 28/05/2018   21:47
34
Chapter 2
Does the type of abdominal wall incision influence the incidence of 
incisional hernias or burst abdomen?
Laparotomy incisions can be classified as midline, transverse, oblique or paramedian 
incisions(61). Six systematic reviews have compared midline laparotomies to alternative 
incisions(26, 27, 31, 36, 38, 61), but only two were considered High Quality (26, 27). 
A recent systematic review by Bickenback et al.(26) compared midline, transverse 
(including oblique) and paramedian incisions. This review included all relevant studies 
from previous reviews and no additional RCT’s were detected that were published 
after this review. The literature search of this systematic review(26) identified studies 
published until 2009 and 24 RCT’s directly comparing different laparotomy incisions 
were included in the analysis. The incisional hernia rates after non-midline incisions 
were significantly lower compared to the incisional hernia rates after midline incisions, 
for both transverse incisions (RR = 1.77; 95 % CI:1.09–2.87) and paramedian incisions 
(RR  =  3.41; 95  % CI: 1.02–11.45)(26). However, data on burst abdomen (deep wound 
dehiscence or fascial dehiscence) were not significantly different between the different 
incisions types.
A Cochrane review by Brown et al.(27) published in 2005 and updated in 2011, compared 
transverse versus midline incisions, but excluded studies comparing paramedian 
incisions. A decreased incisional hernia rate after transverse incisions was reported 
compared to midline incisions (OR = 0.49; 95 % CI: 0.30–0.79).
Both reviews concluded that non-midline incisions significantly reduced the risk 
of incisional hernia compared to midline incisions, but did not influence the risk of 
burst abdomen. Interestingly, the Cochrane conclusions were more moderate, due to 
methodological and clinical heterogeneity of the studies and the risk of potential bias.
Statement Non-midline incisions are recommended where possible ■■■□ strong
What is the optimal technique to close a laparotomy incision? 
Ten systematic reviews on the techniques and/or the materials to close abdominal 
wall incisions were identified (4, 32, 34, 37, 38, 42, 43, 48, 62, 63). The data from the 
different systematic reviews are very incoherent and conclusions are often completely 
contradictory. The overall quality of most systematic reviews is low and therefore, 
several should be rejected as evidence to create guidelines. A major problem to identify 
the evidence from the literature is the fact that most prospective studies compared 
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several variables between the study arms. Moreover, the populations studied are often 
very different: midline only or including other incisions, emergency or elective surgery, 
and different operative indications.
The current guidelines on techniques and materials are based on the systematic reviews 
by Diener et al.(4) and van’t Riet et al.(48) which were evaluated as High Quality. Both 
systematic reviews included only studies involving midline laparotomies and the review 
by Diener et al. was the only one to distinguish between elective or emergency surgery. 
The systematic review by Sajid et al.(43) was used for the question on suture materials 
and a recent Cochrane review by Gurusamy et al.(62) was used for the question on 
peritoneal closure.
Using separate PICO’s the shortcoming of many study designs to deliver clear answers 
becomes obvious. Another shortcoming in most studies on closure of laparotomies is 
the failure to monitor the technical details of the suturing technique, like the SL/WL 
ratio and the stitch size. As demonstrated by Israelsson(64) this might be an important 
confounding factor in studies comparing different suture materials. An updated 
systematic review taking into account the mentioned shortcomings of individual studies 
might be performed, but for these guidelines the conclusions are based on the data 
from the currently available systematic reviews. The protocol for an ongoing Cochrane 
review(65) was published in 2006 but the final data have not yet been published.
Statement
It is recommended that prospective randomized studies on the suture 
material to close abdominal wall incisions use the same suturing 
technique in both study groups.   
strong
Statement
It is recommended that prospective randomized studies assessing 
the technique to close abdominal wall incisions use the same suture 
material in both study groups.   
strong
Continuous suturing versus interrupted sutures 
Both meta-analyses concluded that continuous suturing for closure of midline 
laparotomies was beneficial compared to interrupted closure (4, 48). Diener et 
al.(4) found a significant lower incisional hernia rate for continuous suturing (OR 
0.59: p = 0.001) in elective surgery. Most of the included studies were at high risk of bias 
because the interrupted study arm used rapidly absorbable multifilament sutures and 
the continuous arm used either non-absorbable or slowly absorbable monofilament 
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sutures. van’t Riet et al.(48) included studies involving emergency laparotomies and did 
not find any difference in incisional hernia rate between interrupted and continuous 
suturing. Continuous suturing was recommended because it was significantly faster.
Statement
Continuous suturing for closure of midline abdominal wall incisions in 
elective surgery is recommended   
■■□□ strong
Closure versus non-closure of the peritoneum
The Cochrane review by Gurusamy et al.(62) concluded that there was no short-
term or long-term benefit in peritoneal closure. Five studies were included but were 
heterogeneous in type of incision (midline and non-midline) and included both elective 
and emergency laparotomies. In all studies the peritoneum was closed as a separate 
layer in the study arm with peritoneal closure. 
Statement
Closure of the peritoneum as a separate layer during closure of 
laparotomy incisions is NOT recommended
■■□□ weak
Mass closure versus single layer closure
The search for the most appropriate layers to be sutured when closing a laparotomy is 
hampered by the lack of good definitions on what constitutes a mass closure, layered 
closure or single layer closure. No clinical studies directly comparing different closure 
methods were found. 
For future research the Guidelines Development Group proposes the following 
definitions: 
• mass closure: the incision is closed with a suture bite including all layers of the 
abdominal wall except the skin.
• layered closure: the incision is closed with more than one separate layer of fascial 
closure
• single layer aponeurotic closure: the incision is closed by suturing only the abdominal 
fascia in one layer.
 
Statement
For closure of midline abdominal wall incisions in elective surgery, a 
single layer aponeurotic closure is suggested
■□□□ weak
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Suture length to wound length ratio (SL/WL)
The beneficial effect of a high SL/WL ratio on reducing the incidence of incisional 
hernias has been recognised for a long time(66), but evidence from clinical prospective 
studies remains scarce and most of the work addressing the topic comes from the Clinic 
of Sundsvall in Sweden(64, 67, 68). A RCT, performed in Sundsvall, demonstrated the 
importance of the SL/WL ratio in reducing incisional hernia rate. The critical value was 
determined to be at a ratio of 4/1(64). Although a SL/WL ratio ≥4 is often mentioned 
in the protocol of prospective studies, many fail to document that the SL/WL ratio was 
recorded for the individual study patients.
Statement
A suture to wound length ratio (SL/WL) of at least 4/1 for continuous 
closure of midline abdominal wall incisions in elective surgery is 
suggested.
■■□□ weak
Statement
It is recommended that all prospective studies on the closure of 
laparotomy incisions will document the suture to wound length ratio 
(SL/WL) in all patients, as well as the number of stitches.
strong
Small bites versus large bites
Millbourn et al.(69) demonstrated that closure of a midline laparotomy with a "small 
bites" technique resulted in significant less incisional hernias (5.6% vs 18.0 %; p< 0.001) 
and less surgical site infections (SSIs) (5.2% vs 10.2%; p= 0.02). In the small bite technique 
the laparotomy wound is closed with a single layer aponeurotic suturing technique 
taking bites of fascia of 5 - 8 mm and placing stitches every 5 mm. 
Statement
The "small bites technique" for continuous closure of midline incisions 
is suggested. 
■■■□ weak
What is the optimal suture material to close a laparotomy incision? 
Despite significant heterogeneity and confounders in most SRs identified, a study by 
Sajid et al.(43) focused solely on the suture material. Table 3 defines the suture materials 
used in the included studies. 
Rapidly absorbable suture versus non-absorbable or slowly absorbable sutures
Diener et al. (4) reported a significantly lower incisional hernia rate with slowly 
absorbable sutures (OR 0.65: p= 0.009) in elective surgery. Subgroup analysis performed 
by van 't Riet et al.(48) comparing only continuous suturing studies, detected only one 
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RCT by Wissing et al.(70) using continuous suturing in both study arms. This study, which 
included 21% of emergency operations, showed significantly more incisional hernias 
with rapidly absorbable sutures compared to non-absorbable sutures (p= 0.001) and 
compared to slowly absorbable sutures (p = 0.009). 
Statement
The use of rapidly absorbable suture material for closure of midline 
abdominal wall incisions in elective surgery is NOT recommended. 
■■■□ strong
Table 3. List of the most commonly used suture materials to close abdominal wall incisions and 
their characteristics
Suture Producer Material Absorbable
Absorption 
time Filaments
Antibiotics 
impragnated
Prolene Ethicon Polypropylene Non Mono No
Surgipro Covidien Polypropylene Non Mono No
Ethilon Ethicon Nylon Non Mono No
Monosof Covidien Nylon Non Mono No
Ethibond Ethicon Polyethylene Non Multi No
Mersilene Ethicon Polyester Non Multi No
Surgilon Covidien Nylon Non Multi No
Maxon Covidien Polyglyconate Slowly 180 days Mono No
PDS Ethicon Polydioxanone Slowly 183–238 days Mono No
PDS plus Ethicon Polydioxanone + triclosan Slowly 183–238 days Mono Yes
Monoplus B Braun Polydioxanone Slowly 180–201 days Mono No
Monomax B Braun Poly-4-hydroxybutyrate Slowly 390–1080 days Mono No
Vicryl Ethicon Polyglactin Rapidly 56–70 days Multi No
Vicryl plus Ethicon Polyglactin + triclosan Rapidly 56–70 days Multi Yes
Polysorb Covidien Polyglycolic acid Rapidly 60–90 days Multi No
Dexon Covidien Polygglycolic acid Rapidly 60–90 days Multi No
Non-absorbable versus slowly absorbable sutures
No difference in incisional hernia rate for continuous suturing of midline incisions with 
slowly absorbable versus non-absorbable sutures (p= 0.75) was identified(48). However, 
an increased incidence of prolonged wound pain (p< 0.005) and suture sinus formation 
(p= 0.02) with non-absorbable sutures was reported(48). Another MA (which included 
non-midline incisions) identified no difference in incisional hernia rate between slowly-
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absorbable polydioxanone and non-absorbable sutures (OR 1.10: p= 0.43)(43). Once 
again, non-absorbable sutures had a significant higher risk of suture sinus formation 
(OR 0.49: p= 0.01)(43).
Statement
Using slowly-absorbable suture material instead of non-absorbable 
sutures for continuous closure of midline abdominal wall incisions in 
elective surgery is suggested.  
■■□□ weak
Monofilament versus multifilament sutures
Monofilament sutures are believed to be associated with a lower SSI rate than 
multifilament sutures(12). However, none of the SRs commented on this issue specifically. 
If the previous recommendation to use slowly absorbable sutures for closure of elective 
midline laparotomies is followed, this question becomes superfluous because the 
slowly absorbable sutures are all monofilament sutures.
Statement
We suggest using monofilament suture material for continuous closure 
of midline abdominal wall incisions in elective surgery.  
■□□□ weak
Concerning the size of the suture, no studies comparing directly the size of the sutures 
used to close abdominal wall incisions were identified during our searches. For the 
"small bites" technique, Isrealsson et al(12) suggest to use a suture size USP 2/0 (USP = 
United States Pharmacopeia). 
Statement
No recommendation on the size of the sutures for closure of abdominal 
wall incisions can be given due to lack of data.  
■□□□ no
Sutures impregnated with antibiotics
Sutures coated with Triclosan as an antimicrobial agent have been introduced to 
decrease the rate of surgical site infection in surgery. A recent meta-analysis has 
demonstrated a significant beneficial effect in the prevention of surgical site infection 
after all kinds of surgery(71). Surgical site infection is a risk factor for subsequent 
development of incisional hernias and therefore the use of antibiotics impregnated 
sutures to close laparotomies might be beneficial in the prevention of incisional hernias. 
Recently Diener et al.(72) published a large RCT on 1,224 patients undergoing an elective 
midline laparotomy comparing polydioxanone sutures with versus without triclosan 
impregnation. No reduction in the incidence of surgical site infection was reported (OR 
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0.91: CI 0.66–1.25; p = 0.39). Four other RCT’s have compared sutures with or without 
triclosan in laparotomy closure, either with polyglactin sutures (Vicryl)(73, 74) or with 
polydioxanone (PDS)(75, 76). A meta-analysis on all five studies performed by Diener 
et al. showed a significant decrease in surgical site infection (OR 0.67: CI 0.47–0.98). No 
data on incisional hernias are available from these studies.
Statement
Monofilament sutures impregnated with antibiotics for closure of 
elective midline incisions is NOT advised, because of insufficient data 
on their efficiency on prevention of surgical site infections and the lack 
of data on incisional hernias or burst abdomen.
■■■□ weak
Limitations of the statements in these guidelines on suture technique and suture 
materials
The statements are limited by the quality of the data on which they are based. In total, 
61 RCT's have been identified that compared suture materials or techniques to close 
laparotomy incisions. Many studies have more than one variable between study arms 
and therefore analysing them in meta-analyses is difficult. Moreover, many studies 
have flaws in the methodology increasing the risk of bias. We would like to encourage 
researchers that plan studies on abdominal wall closure to improve the methodology 
of their study protocol. Preferably study arms are only different in the variable under 
investigation, either a suture technique or a suture material. Moreover we recommend 
documenting the technical details such as SL/WL ratio, the number of stitches used in 
the patients and to provide a follow up of at least 24 months.    
Although some of the systematic reviews detected included non-midline incisions(43) 
or emergency operations(48), these guidelines are currently limited to elective midline 
laparotomies. For emergency operations and non-midline incisions there is currently 
not enough data available.  
Statement
No recommendation on suture material or suturing technique for use in 
emergency surgery can be given due to lack of sufficient data.
■□□□ no
Statement
No recommendation on suture material or suturing technique for use in 
non-midline incisions can be given due to lack of sufficient data
■□□□ no
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Suture needles and retention sutures
Blunt tip versus sharp needles
Only one SR assessing the type of needle used to close the abdominal wall(23) and one 
RCT comparing blunt needles with sharp needles were identified. The RCT reported no 
difference in SSI rate between blunt and sharp needles(77). 
Statement
No recommendation on the type or the size of needle to close a 
laparotomy can be given due to lack of data.
■□□□ no
Is there a place for retention sutures when closing a laparotomy?
No SR on the use of retention sutures was found. Eight records were screened by full 
text(78-85). Three RCTs on the prevention of burst abdomen by using either retention 
sutures or a reinforced tension line suture in patients with increased risk for wound 
dehiscence and burst abdomen were identified(78, 81, 85). Follow up was too short to 
evaluate incisional hernia rate. The Summary of Evidence is listed in Table 4. Two studies 
showed favourable results(78, 81), but one study reported a high number of adverse 
events when using retention sutures(85). 
Statement
No recommendation on the use of retention sutures in patients with 
multiple risk factors for burst abdomen can be given due to insufficient 
data.
■■□□ no
Postoperative care
Postoperative management and instructions for patients are not supported by high 
quality prospective data, but rely mostly on surgeons' habits, tradition and common 
beliefs (86-88). Long term follow up studies are needed to research the impact on 
the occurrence of incisional hernias of prescribing abdominal binders or restricting 
postoperative activity. The additional searches did not reveal any relevant study on 
long term outcome. Some studies on the short term benefits of abdominal binders were 
found.
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Subcutaneous drains in laparotomy incisions
Prophylactic routine placement of subcutaneous drains after laparotomy is occasionally 
used to decrease wound complications: infection, hematoma, seroma or wound 
dehiscence(88). However, there are several disadvantages to the routine use of 
subcutaneous drains. Namely, they cause patient discomfort and pain at removal, they 
hinder early mobilisation and demand additional nursing care. Therefore their use 
should be driven by a proven benefit.
One systematic review(89) and several RCTs (90-98) on the use of subcutaneous drains 
in abdominal surgery were found. They cover a wide range of operative indications: liver 
surgery, colorectal surgery, cholecystectomy, gynaecological surgery, caesarean section, 
and gastric bypass surgery. With few exceptions, most studies did not show a benefit for 
the use of subcutaneous drains. However, none of these studies had incisional hernias 
or burst abdomen as primary or secondary endpoint. 
Statement
The routine placement of a subcutaneous drain during closure of 
abdominal wall incisions is NOT recommended.  
■■■□ strong
Postoperative binders
One systematic review on the use of abdominal binders was found(86). The review 
included four RCT's (99-102) and a national survey by questionnaire on the use of 
abdominal binders in French surgical practice(86). One additional recent RCT was 
identified(103). The French survey reported that postoperative support of the wound 
with an abdominal binder is common practice after major laparotomies in many 
surgical departments (94% use them in some patients). It is expected to reduce 
postoperative pain and to improve early mobilisation of the patients. Moreover 83% 
of users expect a benefit in the prevention of abdominal wall dehiscence(86). No 
significant improvement for the short term benefits was found by the small RCTs from 
the review(98, 99, 101, 102). The additional study by Clay et al.(100) found a significant 
lower VAS (Visual Analogue Scale) score for pain at the fifth postoperative day and no 
adverse effect on postoperative lung function. No studies were found that had burst 
abdomen or incisional hernias as a primary or secondary endpoints.      
Statement
No recommendation can be given on the use of postoperative 
abdominal binders due to lack of data on their effect on incisional 
hernias or burst abdomen rates.
■□□□ no
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Postoperative restriction of activity
No prospective studies were found on the restriction of physical activity after abdominal 
incisions. Nevertheless, it is advocated by some surgeons in order to decrease the risk 
of incisional hernias, but there is no consensus on the level or the duration of the 
restriction(87). Postoperative restriction might have an adverse impact on the return to 
normal activity and delay the return to work.     
Statement
No recommendation can be given on routine restriction of activity 
after abdominal surgery due to lack of data on the effect on incisional 
hernias or burst abdomen rates.
■□□□ no
Prophylactic mesh augmentation  
Three systematic reviews on the topic were found(24, 39, 104). 
1. Nachappian et al.(39) did not assess of the quality of the individual studies and 
included non published data. Therefore this review did not qualify for inclusion in 
this guideline. 
2. The systematic review by Bhangu et al.(24) is of High Quality and offers a good and 
extensive evaluation of the quality of the individual studies included. However, the 
quality of the non RCTs was usually low and these studies were not be used as 
evidence for these guidelines. 
3. Timmermans et al.(104) published a good meta-analysis on five RCT's using 
polypropylene mesh, including  a RCT published in 2013 by Abo-Ryia et al.(105).
One additional RCT published after the review by Timmermans et al.(106) was identified. 
In this RCT, one hundred and sixty patients were included. This is the first trial on non-
selected elective midline laparotomies (with a majority of oncological patients). All the 
other trials have only included patients deemed at high risk for incisional hernias. In this 
RCT by Caro-Tarrago et al. the mesh augmentation was performed with a light weight 
polypropylene mesh in the onlay position. A significant reduction in incisional hernias 
at 12 months was observed clinically and with CT scan in favour of prophylactic mesh, 
1.5 vs 35.9 % (p < 0.0001). A significantly higher number of postoperative seroma was 
detected in the mesh group, 11.3 vs 28.8 % (p < 0.01). No major complications related to 
the mesh augmentation were reported.
The details of the six published RCT’s using polypropylene mesh including 506 patients 
are listed in Table 5(105-110). Using Review Manager 5.2 software a new meta-analysis 
was performed. The data for this meta-analysis were extracted from the Timmermans et 
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al. meta-analysis and the additional RCT(104, 106). A meta-analysis on the outcomes of 
incisional hernia, seroma and SSI was performed. The pooled analyses data are shown in 
a Forrest plot for each outcome in Figure 2. Prophylactic mesh augmentation is effective 
in the prevention of incisional hernias (RR 0.17: CI 0.08–0.37). An increased incidence of 
postoperative seroma is identified, but the majority of these are from the single study 
by Caro-Tarrago et al.(106) where the mesh was placed in an onlay position, with a 
weight of 45.9 % on the cumulative Risk Ratio for seroma (RR = 1.71; 95 %CI: 1.06–2.76) 
(Figure 2c). 
Although the data are favourable and consistent for prophylactic mesh augmentation, 
the Guidelines Development Group decided that larger trials are needed to make a 
strong recommendation to perform prophylactic mesh augmentation for all patients 
within certain risk groups.
Statement
Prophylactic mesh augmentation for an elective midline laparotomy 
in a high-risk patient in order to reduce the risk of incisional hernia is 
suggested.
■■■□ Weak
Which mesh type, which mesh position and which type of mesh fixation? 
No comparative studies are published between different mesh type, mesh position 
or method of mesh fixation. Pans et al.(111) found no significant protective effect on 
incisional hernia rate by intra-peritoneal augmentation with a polyglactin mesh (Vicryl; 
Ethicon) on incisional hernia rate in a RCT on obesity surgery (n  =  288). Llaguna et 
al.(112) placed a biological mesh (Alloderm; LifeCell) in a retro-muscular position in 
bariatric patients. In this non-randomised comparative study (n = 106 of which 44 with 
mesh) a significantly lower incisional hernia rate was observed in the mesh group, 2.3 vs 
17.7 % (p = 0.014). All other studies published used a polypropylene mesh, most often 
a small pore/heavy weight mesh: Prolene; Ethicon(107), Premilene; B. Braun(109), no 
name mentioned(105, 108, 110). Only Caro-Tarrago et al.(106) used a large pore/light 
weight mesh: Biomesh Light P8; Cousin Biotech.
There is a large variation between the studies on the mesh position for the prophylactic 
mesh augmentation. Onlay, retro-muscular and pre-peritoneal mesh positioning was 
performed in two studies each. No studies on the use of intra-peritoneal augmentation 
with a non absorbable synthetic mesh are reported. Only one study on the use of 
intra-peritoneal augmentation with an absorbable synthetic mesh is reported(111).
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Figure 2. Forrest plots of a meta-analysis performed by the Guidelines Development Group on 
prophylactic mesh augmentation with polypropylene mesh after laparotomy. Analysis on the 
outcomes of incisional hernia, seroma and surgical site infection was performed. 
A: Incisional hernia
B: Wound infection
C: Seroma
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The mesh was in all studies fixed with sutures to the fascia except for the study of Pans 
et al.(111) which used no fixation. No studies on mesh augmentation with glue or a self-
fixating mesh are reported.
Statement
No recommendation on the optimal mesh position for prophylactic 
mesh augmentation can be given due to lack of data.
■□□□ no
Statement
No recommendation on the optimal method of mesh fixation for 
prophylactic mesh augmentation can be given due to lack of data.
■□□□ no
Statement
No recommendation on the type of mesh for prophylactic mesh 
augmentation can be given due to lack of data.
■□□□ no
Trocar wounds for laparoscopic surgery and single port surgery
Trocar size and trocar type 
The first search for systematic reviews resulted in 5 records(33, 40, 41, 46, 49) and 25 
additional records were screened by full text(113-136).  Several studies comment on 
the incidence of trocar-site hernia for various trocar sizes. However the quality of many 
studies is insufficient and challenge the validity of results. Shortcomings of the individual 
studies include retrospective study design, short or unclear length of follow up and 
inappropriate or no information on diagnostic methods to detect incisional hernias. 
Most importantly, available data derive from studies in which the same patient serves 
as case and control; i.e. the incidence of trocar-site hernia is measured for different sizes 
of trocars inserted at different abdominal sites in the same patient. This may impose 
significant bias, related to the strength of the abdominal wall and the wound repair 
mechanisms at varying sites of the abdominal wall, in particular the linea alba to other 
parts of the abdominal wall.
Helgstrand et al.(33) performed a systematic review on the incidence of trocar-site 
hernia. Although they found a risk reduction after sutured closure and a lower hernia 
rate for 5-mm versus larger diameter trocars, no meta-analysis was undertaken. The 
poor quality and design of the majority of the included reports preclude further in-
depth evaluation for supporting evidence. No RCT's have investigated the incidence 
of trocar-site hernia after insertion of blunt versus bladed trocars and no RCT's or case-
control studies have investigated the incidence of trocar-site hernia with reference to 
trocar size or diameter. Available data derive from univariate and multivariate analyses 
of cohort studies, which have investigated the effect of potential risk factors for trocar-
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site hernia. Obesity, age above 60 years diabetes, long duration of surgery, and the need 
for fascia enlargement for specimen extraction were identified as risk factors for the 
development of trocar-site hernia(120, 136).
Statement
For laparoscopic procedures, using the smallest trocar size adequate for 
the procedure is suggested.
■■□□ Weak
Statement
For laparoscopic procedures, suturing the fascial defect, if trocars larger 
than or equal to 10 mm have been used, in the presence of established 
risk factors for incisional hernia formation is suggested.  
■□□□ weak
Closure of trocar incisions
There are no good quality comparative studies investigating different suture materials 
or techniques for closure of trocar fascia defects. Armananzas et al.(113) reported in a 
recently published RCT a benefit for prophylactic intraperitoneal placement of a ventral 
patch at the umbilical site in high-risk patients to reduce the incidence of trocar-site 
hernia from 18.5% to 4.4% (OR 10.1: CI 2.15-47.6; p< 0.001). Larger sample-sized studies 
with a good risk-benefit assessment and longer follow-up are needed to confirm and 
support a stronger recommendation. 
Statement
For laparoscopic procedures a mesh-augmented closure may be 
applied in patients at high risk for trocar-site hernia.
■■■□ weak
Single incision laparoscopic surgery and incisional hernia
The incidence of trocar-site hernia after single port surgery has been mostly investigated 
as a secondary outcome measure in the setting of RCTs and 3 High Quality MAs were 
found(137-139). Two MAs of RCTs have found no difference in the incidence of trocar-
site hernia between single port and multiple port surgery, although a trend in favour 
of multiple port surgery was demonstrated(137, 139). The most recent MA included 19 
RCTs involving 676 patients and found a higher incidence of trocar site hernia following 
single port surgery(138).
Statement
Emerging evidence suggests an increased incidence of trocar-site 
hernia for single-incision surgery as compared to conventional surgery; 
therefore meticulous closure of the incised fascia in single-port surgery 
is recommended.
■■■□ weak
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DISCUSSION
Limitations
Not many strong recommendations could be made due to lack of sufficient evidence 
on many of the PICO questions. It is somewhat confusing to notice that the first strong 
recommendation in these guidelines is to avoid midline laparotomies in favour of 
alternative incisions and that all other recommendations are only valid for elective 
midline incisions. Indeed most research is focused on midline laparotomies. A midline 
laparotomy is still the favoured approach for most surgeons. It allows quick entrance 
to the abdominal cavity and extension of the incision is easy if this is required for 
the operation. Nevertheless, the linea alba is probably the most vulnerable and least 
vascularized part of the abdominal wall. Some refer to incisional hernias as “a midline 
crisis”. Optimising closure of abdominal wall incisions would appear to hold a large 
potential in reducing the incidence of incisional hernias and the subsequent need for 
incisional hernia repair. This has obvious benefits for the individual patient relating to an 
improved quality of life, avoidance of secondary operations and at a macro-economical 
level a significant reduction in costs for health care resources. It is not easy to see the 
impact of each recommendation separately. Therefore, implementation of the optimised 
abdominal wall closure is probably best done by teaching all involved specialists a 
standardised technique described as the “Principles” of abdominal wall closure(17). 
This incorporates all recommendations, although the Guidelines Development Group is 
aware that the level of evidence for the different aspects is sometimes low to very low. 
David Sackett, a pioneer in evidence-based medicine wrote: “…any external guideline 
must be integrated with individual clinical expertise in deciding whether and how it 
matches the patient’s clinical state, predicament, and preferences, and thus whether it 
should be applied”(140). 
Discussions
For most Key Questions on the technique and material to close abdominal wall 
incisions, the grading of the Quality of Evidence and the choice of recommendation 
was straightforward. For several recommendations, while the quality of evidence was 
low, there was good consensus between the members of the Guidelines Development 
Group on the formulated statements. For prophylactic mesh augmentation there was 
disagreement on the strength of recommendation (weak or strong). For this reason, an 
additional meta-analysis was performed (Figure 2). Although the effect size in favour of 
mesh augmentation is large and consistent over the studies, the Guidelines Development 
Group felt that larger trials are needed to support a strong recommendation for 
prophylactic mesh augmentation in high-risk patients. Indeed, the number of patients 
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in the reported studies for each risk group separately (e.g. abdominal aortic aneurysm, 
obesity surgery, oncological surgery) seems too low to recommend prophylactic mesh 
augmentation in all these patient groups. Nevertheless, we are aware that several large 
RCT’s are on-going and this grade of recommendation might be changed in the light of 
future publications.
No recommendations could be made on non-midline incisions due to insufficient 
evidence. Nevertheless, it seems reasonable to promote similar material (slowly 
absorbable suture) and techniques (continuous aponeurotic closure with small bites 
and SL/WL >4/1) for closure of non-midline incisions.
No recommendations could be made on the type or the size of the needle used to close 
abdominal incisions. No studies comparing the size of the sutures were identified in our 
searches.
No recommendation could be made for emergency surgery, which is often a 
contaminated procedure. The Guidelines Development Group consider that the use of 
retention sutures or of reinforced tension line sutures, should be prospectively studied 
in patients at high risk for development of burst abdomen. A risk model and score for 
burst abdomen has been developed by van Ramshorst et al.(141) and could be used as 
basis for including patients in these studies.
No recommendations could be made on the postoperative care after laparotomies. 
Long-term follow-up studies are needed to assess the impact on the occurrence of 
incisional hernias of prescribing abdominal binders or restricting or indeed encouraging 
early postoperative activity.
Applicability
To adopt the guidelines and “evidence based principles” for abdominal wall closure, 
surgeons must be convinced that these are valid recommendations with a large impact 
on the outcome for the patients. These guidelines are an attempt to create awareness 
amongst surgeons about these principles. Adaptation can be done by systematic quality 
control of the suturing technique as described by van Ramshorst et al.(142). The EuraHS, 
European registry for abdominal wall hernias, has developed an online platform for 
registration and outcome measurement of abdominal wall surgery(140). An additional 
route in the database on the closure of abdominal wall incisions and for prophylactic 
mesh augmentation will be provided from 2015 onwards. It is hoped that such a registry 
database will facilitate the data collection for prospective studies.
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Validity of the guidelines
Prior to submission of the manuscript the guidelines were evaluated and scored using 
the AGREE II instrument. Several large multi-centre studies on the closure of abdominal 
wall incisions are currently on-going. High Quality data on the use of the “small bites” 
technique in midline incisions, on the closure of laparotomies in emergency and on 
prophylactic mesh augmentation will be published in the coming years. The Guidelines 
Development Group has decided to update these guidelines in 2017 and present the 
results during the 39th Annual Congress of the European Hernia Society in Vienna in 
May 2017.
CONCLUSIONS
To decrease the incidence of incisional hernias it is recommended to utilize a non-
midline approach to a laparotomy whenever possible. For elective midline incisions, it 
is strongly recommended to perform a continuous suturing technique and to avoid the 
use of rapidly absorbable sutures. It is suggested that the use of a slowly absorbable 
monofilament suture in a single layer aponeurotic closure technique without separate 
closure of the peritoneum and using a small bites technique with a SL/WL ratio at least 4/1 
is the current recommended method of fascial closure. Currently, no recommendations 
can be given on the optimal technique to close emergency laparotomy incisions. 
Prophylactic mesh augmentation appears effective and safe and can be suggested in 
high-risk patients like, aortic aneurysm surgery and obese patients.
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ABSTRACT
Background:  Incisional hernia (IH) is one of the most frequent postoperative 
complications after abdominal surgery. Patients with an abdominal aortic aneurysm 
(AAA) and patients with a BMI of 27 or higher have a risk of more than 30% to develop 
an IH. Primary mesh augmentation (PMA) is a method in which the abdominal wall is 
strengthened to reduce IH incidence. This study focussed on the short-term results of 
the PRIMA trial, a multicentre double blind randomized controlled trial (RCT).
Methods: The RCT was conducted in 11 hospitals in the Netherlands, Germany and 
Austria. Between 2009 and 2012 patients were included if they were either operated via 
midline laparotomy for an AAA or if they had a BMI of 27 or higher. Patients were randomly 
assigned to either receive primary suture (PS), onlay glued mesh augmentation (OMA), 
or sublay glued mesh augmentation (SMA).
Results: A total of 498 patients were selected of which 18 patients were excluded 
preoperatively, leaving 480 randomized patients. Outcomes represent results after 1 
month follow-up. During analysis statistically significant (p = 0.002) more seromas were 
detected after OMA (n = 34, 18.1%) compared to PS (n = 5, 4.7%) and SMA (n = 13, 7%). 
No  differences were discovered in any of the other outcomes such as postoperative 
surgical site infection, hematoma, reintervention or readmission. Multivariable analysis 
revealed an increase in seroma formation after OMA with an odds ratio (OR) of 4.5 (p = 
0.003) compared to PS and an OR of 2.9 (p = 0.003) compared to SMA.
Conclusion: Based on these short-term results, PMA is a save procedure with only an 
increase in seroma formation after OMA , but without an increased risk of surgical site 
infection (SSI). 
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INTRODUCTION
Incisional hernia (IH) is one of the most frequent postoperative complications after 
abdominal surgery. IH incidence ranges between 11% and 20% in the general 
population (1-3). However, risk factors for the development of IH, such as abdominal 
aortic aneurysm (AAA) and obesity, can increase the incidence of IH up to 35% (4-8). In 
AAA patients the connective tissue, especially the ratio between mature and immature 
collagen, is thought to be compromised(9, 10). The formation of collagen of insufficient 
strength plays an important role in the development of the distension of the aorta. 
But this loss of balance is also thought to be of key importance in the formation of IH 
after laparotomy (11, 12). In patients with obesity it is thought that the increase in intra-
abdominal pressure induces stress on the suture line which promotes IH formation (7, 
13).
IH can cause morbidity such as pain, reduced quality of life and poor body image, 
and in some cases can become incarcerated and even lead to mortality (3, 14). In the 
United States around 500.000 IH are surgically repaired annually (15). IH repair with 
mesh reinforcement has shown to produce lower recurrence rates compared with 
primary closure (16). However, recurrence rates for mesh repair are still unacceptably 
high, with a 10 year cumulative incidence rate of 32% (15). Considering the high 
incidence of IH, the unsatisfactory results of IH repair and the high impact on quality 
of life, research should be focusing on prevention rather than on treatment. In 2009 
the PRIMA trial (PRImaryMesh Closure of Abdominal Midline Wounds), an international 
multicenter randomized controlled trial (RCT), was initiated to investigate primary mesh 
augmentation (PMA) as means to reduce IH incidence. This paper will focus on the short-
term results (postoperatively up to 1 month) such as fascial dehiscence, surgical site 
infection (SSI), seroma, hematoma and mesh infection, of this RCT. We hypothesize that 
PMA does not increase postoperative complications compared to primary suture (PS).
METHODS
Study design
The PRIMA trial is a multicenter randomized controlled trial, which included patients 
between 2009 and 2012 in 11 hospitals in the Netherlands, Germany and Austria and 
follow-up is currently being conducted. This trial was initially approved by the local Ethics 
Board in the Erasmus University Medical Center in Rotterdam and was later extended 
to all participating centers. The primary endpoint of this study was IH incidence after 2 
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years, and secondary endpoints were postoperative complications, postoperative pain, 
cost-effectiveness and quality of life. This study was registered in the clinicaltrials.gov 
database and was assigned ID number: NCT00761475.  
Patient population and randomization
Patients were eligible for inclusion in case of: 1. midline laparotomy, 2. presence of an 
AAA and / or body mass index (BMI) equal to or higher than 27. Exclusion criteria were: 
1. Age < 18 years, 2. Inclusion in other trials with interference of the primary endpoint, 3. 
Life expectancy less than 24 months (as estimated by the treating physician), 4. Pregnant 
women, 5. Immune suppression therapy within 2 weeks before surgery, 6. Bovine allergy, 
7. presence of IH. After obtaining informed consent patients were included into the trial 
via the TOP system (Trial Online Process; see http://www.primatrial.nl), where data were 
securely stored. Patients were randomized into 3 groups also via the TOP system by 
means of the minimization method and stratified by centre and operation indication. 
Randomization was performed during the operation, securing optimal allocation 
concealment (17). Patients could be randomized for either primary suture (PS), onlay 
mesh augmentation (OMA) or sublay mesh augmentation (SMA). 
The following data were prospectively gathered and collected: Pre-operative data 
(sex, age, length, weight, BMI, current smoking status, diabetes mellitus (DM), chronic 
obstructive pulmonary disease (COPD), American Society of Anesthesiologists score 
(ASA), previous midline incision, other hernia) intra-operative data (type of operation, 
antibiotics used, length of incision, subcutis suture, wound drain, operation time, blood 
loss, intestinal lesion, bleeding, mesh placement not possible) and postoperative data 
(up until 1 month)(intensive care admission, ventilation, blood transfusion, admission 
days, SSI (CDC definitions of SSI), seroma (a collection of serous fluid in a dead space, 
which can either be in situ or leaking through a wound), hematoma, fascial dehiscence, 
mesh removal, ileus, reinterventions, readmissions, death). The doctors who performed 
the surgery did not perform the follow-up, as this could lead to bias. Patients and the 
research personnel that performed the follow-up-were kept unaware to which group 
patients were randomized, reducing possible bias. 
Surgical Procedures
1. PS
PS consisted out of a running slowly absorbable suture (MonoPlus, USP 1 ,Needle HRT48, 
150 cm loop, B.Braun Surgical Spain, Rubi, Spain) of the  linea alba. A suture length to 
wound length (SL:WL) ratio of 4:1 was routinely applied in all centers, however the ratio 
was not measured in order to reproduce real world surgery.
jairam-layout.indd   68 28/05/2018   21:47
69
Short-term results of the PRIMA trial
3
2. OMA
OMA consisted of creating an anterior plane (between anterior rectus fascia and 
subcutis) and closing the midline with a running slowly absorbable suture (MonoPlus) 
(4:1 ratio recommended). A polypropylene light weight mesh (Optilene Mesh LP 6 x 35 
cm, B. Braun Aesculap AG, Tuttlingen, Germany) was cut to fit the dissected space and 
placed on the anterior rectus fascia with an overlap of 3 cm at each side. The mesh was 
then fixed with fibrin sealant (Tissucol DUO 500 2,0ml; Baxter Healthcare, Deerfield, IL, 
USA). The edges of the mesh were primarily glued, followed by center. The glued mesh 
was smoothed with the back of a forceps to get a good fixation of the mesh on the 
entire surface. In case of an incision larger than 22cm, it was advised to use two vials of 
fibrin sealant. 
3. SMA
SMA consisted of creating a posterior plane (between posterior rectus fascia and rectus 
muscle, and below the arcuate line between the peritoneum and rectus muscle). After 
dissection, the posterior plane (fascia and peritoneum) was closed with running slowly 
absorbable suture (MonoPlus) (4:1 ratio recommended). A polypropylene light weight 
mesh was cut to fit the dissected space and placed on the posterior plane with an 
overlap of 3 cm at each side.. The mesh was then fixed with fibrin sealant (Tissucol DUO 
500 2,0ml; Baxter Healthcare, Deerfield, IL, USA).  The edges of the mesh were primarily 
glued, followed by center. The glued mesh was smoothed with the back of a forceps to 
get a good fixation of the mesh on the entire surface. In case of an incision larger than 
22cm, it was advised to use two vials of fibrin sealant. Afterwards, closure of the midline/
lineaalba was established with running slowly absorbable suture (MonoPlus) (4:1 ratio 
recommended).
Statistical analysis
The sample size calculation was partially based on the data provided by the INSECT trial 
(18). In this study it was discovered that patients with a BMI over 27 have 20% chance of 
developing an IH within one year after the initial operation. Considering that only 50% 
of incisional hernia will be clinically evident in the first 12 months, the total incidence 
is likely to be above 30% after 2 years (2). In addition, patients were also eligible for 
inclusion if an AAA was diagnosed, as AAA patients also have an IH incidence of over 
30%.
For the PRIMA trial, an IH rate of 30% for PS group was expected and of 10% for both 
PMA groups. The 3 comparisons lead to a pair-wise comparison of alpha = 0.017 (0.05/3) 
according to Bonferroni's correction for multiple testing. A superiority model for the 
comparison between PS vs OMA, and PS vs SMA was used with a power of 90%. A 
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non-inferiority model for the comparison of OMA versus SMA was used, with the non-
inferiority margin set at 10%, with a power of 80%. Allowing for some dropouts, 100 
patients were included in the control group and 180 patients in each experimental 
group. A total number of 460 patients were needed to detect a significant difference 
in IH incidence. During the course of the trial it was discovered that a larger number 
then initially anticipated dropped out of the study and thus 20 additional patients were 
included in agreement with the local Medical Ethics committee (19). 
The one-way ANOVA, the Kruskal-Wallis test and the Pearson Chi-Square test were 
used for statistical analysis of demographic data, perioperative and postoperative data. 
Univariate and multivariate logistical regression analyses were conducted to predict 
Odds Ratios (OR) of potential risk factors. Risk factors discovered in this study or known 
in the literature will be added to the multivariate logistic regression analyses. The 
primary analysis was performed on an intention-to-treat principle (patients remained in 
their assigned group even if for instance during the procedure placement of the mesh 
was not possible). All statistical calculations were done using IBM SPSS© 17 Software 
(SPSS, Chicago, Illinois, USA). In accordance with Bonferroni´s correction for multiple 
testing, significance was assumed at P <0.017.
RESULTS
Between March 2009 and December 2012, a total of 498 patients were selected for 
inclusion (Figure 1). Eighteen patients were not randomized due to withdrawal of 
informed consent, no midline incision used for access to the abdominal cavity, or a 
presence of an incisional hernia discovered during the operation. Of the 480 patients, 
107 patients were randomized for PS, 188 patients were randomized for OMA, and 185 
patients were randomized for SMA (Figure 1). Mesh augmentation was not applied in 18 
cases (9.6%) in the OMA group, and 27 cases (14.6%) in the SMA group. 
Patient characteristics
The majority of patients was male (60.8%) and the mean age of the included patients 
was 64.5 years (SD 11.2). No differences were found between groups in preoperative 
data. The majority of patients were operated for either a vascular operation (33.1%) or 
lower gastro-intestinal (GI) operation (33.8%). The median duration of the operation was 
200  (IQR 150-253) minutes. Statistically (p<0.001) more patients received additional 
subcutaneous suturing in the OMA group (n = 70, 37.2%) compared to PS (n = 18, 
16.8%) and SMA (n=34, 18.4%). No other differences were found in intraoperative and 
postoperative data (Table1). 
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Total	#	of	patients	excluded,	n	=	18	
No	midline	incision,	n	=	8	
Withdrew	informed	consent,	n	=	3	
Already	incisional	hernia	present,	n	=	3	
Other,	n	=	4	
Total	number	of	included	patients		
(n	=	498)	
Included	patients,	n	=	480	
AAA,	n	=	150,	
BMI	≥	27,	n	=	330	
	
PS,	n	=	107	
- AAA,	n	=	37	
- BMI	≥	27	=	70	
OMA,	n	=	188	
(No	mesh,	n	=	18)	
- AAA,	n	=	61	
- BMI	≥	27	=	127	
 
 
 
SMA,	n	=	185	
(No	mesh,	n	=	27)	
- AAA,	n	=	52	
- BMI	≥	27	=	133	
 
Figure 1. Study flow diagram
Outcome parameters
All outcomes are presented in Table 2. For all outcomes an intention-to-treat analysis 
was used. A per protocol analysis was also conducted but did not alter results and thus is 
not presented here. A total of 68 SSI (14.2%) were diagnosed postoperatively. According 
to CDC classifications SSIs were divided in to superficial infections (n =27, 5.6%), deep 
infections (n = 22, 4.6%) and intra-abdominal infections (n = 19, 3.9%). After stratifying 
for inclusion criteria, significantly (p = 0.006) more superficial SSIs were detected if a 
patient was included due to BMI ≥ 27 (n = 25, 7.6%) compared to patients included 
for an AAA (n = 2, 1.3%). Stratification with regards to type of operation (vascular, 
upper GI, lower GI, HPB, gynaecology or urology) was not possible due to low number 
of SSI making statistics unreliable. No significant differences were observed between 
intervention groups with regards to SSI.
A total of 52 seromas were observed postoperatively. Significantly (p = 0.002) more 
seromas were diagnosed after OMA (n = 34, 18.1%) compared to PS (n = 5, 4.7%) and 
SMA (n = 13, 7%). No significant difference was observed between PS and SMA.
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 A total of 21 hematomas were observed postoperatively that required a reintervention. 
Of all hematomas, only 1 (0.9%) was observed in the PS group, 11 (5.9%) in the OMA 
group and 9 (4.9%) in the SMA group. No significant differences were observed between 
groups.
A total of 16 fascial dehiscences were observed postoperatively. Of all fascial dehiscences, 
1 (0.9%) was observed in the PS group, 6 in the OMA group (3.2%), and 9 (4.9%)  in the 
SMA group. No differences were observed between groups.
A total of 6 (1.6%) meshes got infected postoperatively and required reintervention. 
In 3 cases the mesh was removed completely. In 3 other cases the surgeons opted to 
perform only a partial mesh removal as only a part of the mesh was infected. In total 
10 meshes were completely removed, 4 were partially removed, and 2 meshes were 
removed and reimplanted during the same operation. Besides before mentioned mesh 
infection, meshes were (partially) removed during reoperation for anastomotic leakage, 
intra-abdominal bleeding and fascial dehiscence. No differences were observed 
between groups. 
A total of 26 (5.4%) postoperative ileus cases were observed. Of all ileus cases, 3 (2.8%) 
were observed in the PS group, 12 (6.4%) in the OMA group, and 11 (5.9%) in the SMA 
group. No differences were observed between groups. With regards to postoperative 
reinterventions, readmissions or death within one month postoperatively, no differences 
were observed between groups. None of the deaths were related to dissection of the 
posterior or anterior plane, or the mesh or glue.
Multivariable analysis
Seroma was the only outcome which was significantly increased. It was opted to 
perform a multivariable analysis to ascertain the OR of seroma after OMA. We adjusted 
for a number of factors (BMI, subcutaneous suture, wound drain, deep SSI) which could 
be of influence on seroma formation. After correction, seroma formation in OMA had 
an OR of 4.5 (p = 0.003) compared with PS, and an OR of 2.9 (p = 0.003) compared with 
SMA.
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DISCUSSION 
This RCT shows that apart from a significant increase in seroma formation, no differences 
were observed for other short-term complications after PMA. OMA increased the odds 
of developing seroma compared to PS and SMA. This increase in seroma and the use 
of prosthetic material did not significantly increase the rate of SSI, mesh infections or 
admission period.
Short term results
Although these results are not the primary outcomes of this RCT, and power calculations 
were not based on these parameters, they are highly relevant. Previously other RCTs and 
even meta-analyses focussing on IH prevention by means of PMA have been published 
(20-23). However, as pointed out in the most recent meta-analysis, the quality of the 
RCT’s was generally low and short term results, such as hematoma, fascial dehiscence, 
mesh infection and mesh removal, were often not described (24). This study is the 
first RCT that carefully documented all short-term results and discovered that solely 
seroma was significantly increased after OMA. In most cases seroma was defined as a 
minor complication and no intervention was necessary. However, seroma can become 
infected but no increase in SSI was detected in this study. The anterior subcutaneous 
space created by dissection during OMA is prone for seroma formation and should 
be minimized if possible. In this trial an attempt was made to reduce this space by 
implementing fibrin glue. Mesh glue fixation is not new and has been in use in inguinal 
hernia repair and laparoscopic IH repair for some time (25). These studies have shown 
that the effectiveness dependent on the mesh/glue combination used, as not all meshes 
adhere well to all glues (26). However, the clinical use of glue for PMA has not yet been 
documented and studies comparing mesh suture fixation with mesh glue fixation are 
not available. Surgeons did like the quickness and technique of fixation of the mesh 
with fibrin glue. A recent meta-analysis focussing on seroma formation preventing by 
means of glue after breast surgery concluded that although data is scarce and not of 
high quality, currently no reduction could be observed (27). In another study by Lau 
et al. that focussed on inguinal hernia repair it was suggested that the timing of glue 
application is also important(28). Once polymerization of the sealant has occurred 
before ventral layer closure, the dissected space will not have been reduced. In the study 
protocol, standard suturing of the subcutis was not implemented, neither was wound 
drainage. These are techniques which may reduce the incidence of seroma formation 
(29). For instance, none of the patients with a wound drain acquired a seroma. Future 
research regarding onlay or OMA should focus on reducing seroma formation. 
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PMA
This is the first trial which compares PS with OMA and SMA. Although in hernia surgery 
the sublay technique is assumed to be superior compared to the onlay technique with 
regards to IH recurrence, evidence is scarce  In addition, prevention of IH is quite different 
compared to reducing recurrence. In this study the anatomical natural structure of the 
abdominal wall was still intact and it was not very difficult to acquire a tensionless closure. 
Furthermore, it was opted to only use 3cm overlap on both sides, even though in hernia 
surgery 5cm is now recommended. We opted for a smaller overlap as the evidence 
for the 5cm overlap in hernia surgery is still insufficient, and further dissection of the 
wound could induce more morbidity and might thus not be necessary. Furthermore, 
prevention of IH is quite different from reducing recurrence, due to the fact that there is 
no fascia defect and the mesh is positioned on a closed midline.
A goal of our study group is to prevent IH from occurring in general, not only in the 
surgical field but also in other specialities, such as gynaecology and urology. However, 
some of the participants were not familiar with hernia techniques at the beginning of 
this trial but were required to perform both PMA techniques nonetheless. The learning 
curve might influence the results and could be bias. However, doctors inexperienced with 
the techniques were supervised by the study coordinator during the initial procedures, 
and both techniques were easily adapted by all doctors. Most of the doctors that were 
not familiar with hernia surgery preferred the OMA technique. A big advantage of OMA 
is that it is far easier to explain and perform and the dissection doesn´t take as long as 
SMA. In this study we did not measure the time of the closure process, but the time for 
the entire operation. It is evident that additional dissection will increase operating time, 
and the results resemble our own experiences. In general, dissection and closure in OMA 
took 15-20 minutes and in SMA took about 25-30 minutes. As in all studies, a number 
of patients did not receive the randomized treatment as was described in the study 
protocol. These cases did stay in their original randomization group as in accordance 
with the intention-to-treat principle. The reason for not applying OMA or SMA varied 
and include extensive blood loss, contaminated abdomen with an increased risk of SSI, 
fascia of insufficient strength to apply augmentation and time constraints.
Conclusion
Based on the short term results of this trial, OMA increased the amount of seroma but 
did not increase SSI or mesh infection. The true effectiveness of OMA will have to be 
evaluated during the long term results of this trial. During that time we will also be 
able to evaluate IH incidence, fistula formation, chronic pain, quality of life and cost-
effectiveness. 
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Prevention of Incisional Hernia with Prophylactic
Onlay and Sublay Mesh Reinforcement versus
Primary Suture only in Midline Laparotomies
(PRIMA): 2-year follow-up of a multicenter,
double-blind randomized controlled trial
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ABSTRACT
Background Incisional hernia is a frequent long-term complication after abdominal 
surgery, with a prevalence greater than 30% in high-risk groups. The aim of the PRIMA 
trial was to evaluate the effectiveness of mesh reinforcement in high-risk patients, to 
prevent incisional hernia. 
Methods We did a multicentre, double-blind, randomised controlled trial at 11 hospitals 
in Austria, Germany, and the Netherlands. We included patients aged 18 years or older 
who were undergoing elective midline laparotomy and had either an abdominal 
aortic aneurysm or a body-mass index (BMI) of 27 kg/m2 or higher. We randomly 
assigned participants using a computer-generated randomisation sequence to one 
of three treatment groups: primary suture; onlay mesh reinforcement; or sublay mesh 
reinforcement. The primary endpoint was incidence of incisional hernia during 2 years 
of follow-up, analysed by intention to treat. Adjusted odds ratios (ORs) were estimated 
by logistic regression. This trial is registered at ClinicalTrials.gov, number NCT00761475. 
Findings Between March, 2009, and December, 2012, 498 patients were enrolled to 
the study, of whom 18 were excluded before randomisation. Therefore, we included 
480 patients in the primary analysis: 107 were assigned primary suture only, 188 were 
allocated onlay mesh reinforcement, and 185 were assigned sublay mesh reinforcement. 
92 patients were identified with an incisional hernia, 33 (30%) who were allocated 
primary suture only, 25 (13%) who were assigned onlay mesh reinforcement, and 34 
(18%) who were assigned sublay mesh reinforcement (onlay mesh reinforcement 
vs primary suture, OR 0·37, 95% CI 0·20–0·69; p=0·0016; sublay mesh reinforcement 
vs primary suture, 0·55, 0·30–1·00; p=0·05). Seromas were more frequent in patients 
allocated onlay mesh reinforcement (34 of 188) than in those assigned primary suture 
(five of 107; p=0·002) or sublay mesh reinforcement (13 of 185; p=0·002). The incidence 
of wound infection did not differ between treatment groups (14 of 107 primary suture; 
25 of 188 onlay mesh reinforcement; and 19 of 185 sublay mesh reinforcement). 
Interpretation A significant reduction in incidence of incisional hernia was achieved 
with onlay mesh reinforcement compared with sublay mesh reinforcement and primary 
suture only. Onlay mesh reinforcement has the potential to become the standard 
treatment for high-risk patients undergoing midline laparotomy. 
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INTRODUCTION 
Incisional hernia is one of the most frequent long-term complications after abdominal 
surgery, with an incidence of 5–20% in the general patient population. However, in 
high-risk patients, the incidence of incisional hernia can increase to more than 30% (1-
3). Obese individuals (ie, those with a body-mass index [BMI] ≥30 kg/m²) and people 
with Abdominal Aortic Aneurysm (AAA) are especially high-risk groups. Patients with 
abdominal aortic aneurysm are at risk because of an underlying connective tissue 
disorder, caused partly by dysregulation of collagen type 1 and 3; this impairment 
probably has an important role in the pathogenesis of distension of the aorta and 
in formation of incisional hernia in patients after median laparotomy (4). Individuals 
with obesity or a BMI equal to or higher than 27 kg/m have a more than 30% chance 
of developing incisional hernia after median laparotomy (5). This group of patients are 
believed to have a higher intra-abdominal pressure, which can cause higher tension 
on abdominal wall sutures. However, this pressure might not be the only contributing 
factor: obesity is also associated with wound-healing complications due to decreased 
vascularity of adipose tissue, leading to local hypoxia. In hypoxic wounds, the synthesis 
of mature collagen is impaired, resulting in weaker tissue and a deficiency in the overall 
healing process. In wound healing, other known risk factors play an important part—
eg, malignant disease, parastomal hernia, wound infection, and smoking (6-10). 
Incisional hernia can cause morbidity (eg, pain) and can have a negative effect on 
patients’ quality of life and body image (11-13). Furthermore, there is a risk of obstruction 
and strangulation of the bowel with perforation and possible mortality as a result. For 
these reasons, repair of incisional hernia is a surgical procedure that is done frequently. 
However, even though repair with mesh reinforcement has lower risk of recurrence 
compared with primary suture, the cumulative 10-year incidence is 32%, which is still 
too high (14, 15). Use of laparoscopic techniques has not yielded better results with 
respect to recurrence of incisional hernia (16-18). Incisional hernia not only has a large 
effect in medicine but also has a great socioeconomic effect. Therefore, prevention of 
incisional hernia is of paramount importance: it will lead to reduction of disease and is, 
thus, cost-effective. 
Many studies have evaluated different types of incision, suture materials, and closure 
techniques to reduce the incidence of incisional hernia (19-21). Horizontal incisions and 
laparoscopy, or endovascular aneurysm repair (EVAR), in patients with abdominal aortic 
aneurysm are well-known surgical techniques that minimise the risk of incisional hernia. 
In each patient undergoing surgery, the best available technique should be considered. 
However, for several individuals, conventional laparotomy is unavoidable. Until now, 
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no adequate method or gold standard to prevent incisional hernia has been reported 
for people undergoing midline laparotomy. Patients at particular high risk of incisional 
hernia, including those with abdominal aortic aneurysm and high BMI, might benefit 
most from prevention (22-25). In 1995, Pans and colleagues did a prospective study to 
compare patients undergoing surgery for morbid obesity with or without intraperitoneal 
polyglactin mesh. No difference in incidence of incisional hernia was noted between 
the two groups (26). Several randomised and non-randomised prospective studies have 
been done to investigate how incisional hernia can be prevented. Currently, no level 1 
evidence is available. The quality of published randomised studies is low and there is no 
consensus about the mesh position in the abdominal wall that should be used (27, 28). 
We initiated the PRIMA trial (PRImary Mesh closure of Abdominal midline wounds) in 
2009 with the aim to investigate prophylactic mesh reinforcement in high-risk groups 
(ie, patients with abdominal aortic aneurysm or a BMI ≥27 kg/m²) (29, 30). We also 
aimed to assess which mesh position in the abdominal wall should be used to prevent 
incisional hernia. The primary aim of the PRIMA trial was to study the effectiveness of 
prophylactic mesh reinforcement to prevent incisional hernia.
METHODS 
Study design and patients 
The PRIMA trial is an international, multicentre, double-blind, randomised controlled 
trial. The study methods and initial (short-term) results of the PRIMA trial have been 
described previously (29), and the trial protocol has been published elsewhere (30). 
The medical ethics committee of the Erasmus University Medical Centre in Rotterdam 
approved the trial; we also obtained approval from the local ethics committees of the 
participating hospitals. 
We selected patients from 11 hospitals in Austria, Germany, and the Netherlands. We 
included adults aged 18 years or older who underwent elective midline laparotomy and 
had either an abdominal aortic aneurysm or a BMI equal to or higher than 27 kg/m². We 
excluded individuals who underwent an emergency procedure, had incisional hernia 
in the medical history, were included in other trials, or had a life expectancy less than 
24 months. Furthermore, we excluded pregnant women, those who received immune 
suppression therapy within 2 weeks before surgery, and people with bovine allergy. All 
participants gave written informed consent. 
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Initially, we included patients with a BMI of 30 kg/m² or greater. However, 9 months after 
the start of the study, Seiler and colleagues (5) on the INSECT trial showed that patients 
with a BMI of 27 kg/m² or greater have a 20% chance of developing an incisional hernia 
within 1 year after the initial operation. Therefore, we reduced the BMI threshold of 30 
kg/m² to 27 kg/m². The medical ethics committee of the Erasmus University Medical 
Centre approved this amendment. 
Randomisation and masking 
After obtaining informed consent we registered patients via the trial’s online process 
system, in which data were stored securely, and every patient received a unique trial 
code. We randomly allocated participants at the end of the elective midline laparotomy 
procedure, before closing the abdomen, securing optimum allocation concealment. 
We used a computer-generated randomisation sequence to allocate patients to one of 
three groups: closure of the abdomen with primary sutures; closure with onlay mesh 
reinforcement; or closure with sublay mesh reinforcement. We stratified randomisation 
by centre and operation indication. 
Trial researchers who followed up participants were unaware of the procedure until the 
endpoint of the trial. To avoid bias, the surgeons who did the laparotomy and closure 
did not follow-up patients. The safety monitoring board had access to all data. 
Procedures 
The trial researcher attended the first operation of each surgeon, urologist, or 
gynaecologist to give instructions if needed. The operating (vascular or gastrointestinal) 
surgeon, urologist, or gynaecologist closed the abdomen, not a specialised abdominal 
wall surgeon. We assessed whether a learning curve occurred by comparing early versus 
later procedures per surgeon. 
For the primary suture procedure, the midline fascia was closed with running, slowly 
absorbable sutures (MonoPlus, suture size USP 1, needle HRT 48, 150 cm loop; B Braun 
Surgical SA, Rubi, Spain), preferably with a loop technique. We advised a suture length-
to-wound length ratio of 4:1 in all centres, which we did not measure. Subcutaneous 
tissue and skin were closed with sutures preferred by the surgeon. 
For onlay mesh reinforcement, the midline fascia was closed with running, slowly 
absorbable sutures (MonoPlus), with a recommended suture length-to-wound length 
ratio of 4:1. An anterior plane with a width of about 8 cm was created between the 
anterior rectus fascia and the subcutis. A lightweight polypropylene mesh (Optilene 
mesh LP, 6 × 35 cm; B Braun Surgical SA) was used and placed on the anterior rectus 
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fascia with an overlap of 3 cm. The mesh size was made particularly for the PRIMA trial 
by cutting an Optilene mesh LP to size. In case of an incision longer than 35 cm, two 
meshes were tied to each other to obtain an overlap of 3 cm. After the mesh was fitted in 
the dissected space it was fixed with 4·0 mL of fibrin sealant (Tisseel; Baxter Healthcare, 
Deerfield, IL, USA), which was done by glueing the edges and the centre of the mesh 
to the tissue and fixing it with the back of a pair of forceps on the entire surface. The 
subcutaneous tissue and skin were closed with sutures preferred by the surgeon. 
For sublay mesh reinforcement, a posterior plane was created between both the 
posterior rectus sheath and the rectus muscle, and caudally to the arcuate line between 
the peritoneum and rectus muscle. The posterior plane (fascia and peritoneum) was 
closed with running, slowly absorbable sutures (MonoPlus), with a recommended suture 
length-to-wound length ratio of 4:1. A lightweight polypropylene mesh (Optilene) 
was used and placed on the posterior rectus fascia, with an overlap of 3 cm. Mesh 
adjustments were made as described for onlay placement, and the mesh was fixed as 
described for onlay mesh reinforcement. The subcutaneous tissue and skin were closed 
with sutures preferred by the surgeon.
Outcomes 
The primary endpoint of the PRIMA study was the presence of incisional hernia during 
2 years of follow-up. We defined incisional hernia as any abdominal wall gap with or 
without bulge in the area of a postoperative scar perceptible or palpable by clinical 
examination or imaging, as determined by the European Hernia Society (28). We 
measured this outcome variable by inviting patients for follow-up at the outpatient 
clinic of the 11 hospitals 1 year and 2 years after the operation. During the visit at the 
outpatient clinic, we undertook a physical examination of the abdomen. Furthermore, 
a radiological examination (ultrasound or CT) was done by an independent radiologist, 
6 months and 2 years after surgery; the radiologist was not aware of the specific 
closure procedure. If disagreement was noted between the observations of the doctor 
who did the clinical examination and the radiologist who undertook the radiological 
examination, we deemed the outcome of the radiological examination decisive. 
Secondary endpoints were postoperative complications (assessed clinically), 
quality of life (self-reported), and postoperative pain (self-reported). Short-term 
postoperative complications (up to 1 month) have been described elsewhere (29). 
Here, we report long-term postoperative complications (up to 2 years). The surgeon 
and trial researcher gathered data for postoperative complications— ie, intensive-
care admission, ventilation, blood transfusion, admission days, surgical site infection, 
seroma, haematoma, fascial dehiscence, mesh removal, ileus, re-interventions, re-
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admissions, and death. We obtained data for short-term and long-term outcomes at 
outpatient clinic visits at 1 month, 1 year, and 2 years after surgery. We defined surgical-
site infection according to guidelines proposed by Mangram (31). The trial researcher 
and surgeon also obtained preoperative data for sex, age, height, weight, BMI, current 
smoking status, diabetes mellitus, chronic obstructive pulmonary disease (COPD), 
American Society of Anaesthesiologists (ASA) score, previous midline incision, and 
other hernia; and intraoperative data for type of operation, use of antibiotics, length 
of incision, subcutis suture, wound drain, operation time, blood loss, intestinal lesion, 
bleeding, and whether mesh placement was not possible. Intraoperative outcomes have 
been reported elsewhere (29). We sent questionnaires to patients at fixed timepoints 
(preoperatively, 1 month after surgery, and at 3 months, 6 months, 1 year, and 2 years 
after surgery) to gather data for quality of life (measured with the 36-item short form 
health survey [SF-36] and EuroQol five dimensions [EQ-5D]) and postoperative pain 
(measured on a visual analogue scale). 
Statistical analysis 
We made three comparisons, leading to a pairwise comparison at an alpha of 0·017 
(0·05/3) according to Bonferroni's correction for multiple testing. We based the sample 
size calculation on the results of the INSECT trial (5), which suggested that patients with 
a BMI of 27 kg/m² or higher have a 20% risk of developing incisional hernia within the 
first year after initial surgery. After taking into account that only 50% of patients with 
incisional hernia will be detectable in the first year after surgery, the total risk will be 
more than 30% after 2 years. Patients with abdominal aortic aneurysm were included 
also, since they have a high risk of developing incisional hernia. 
We assumed the risk of incisional hernia after 2 years was 30% for primary suture and 
10% for both onlay and sublay mesh reinforcement. Primary suture versus onlay or 
sublay mesh reinforcement was a superiority comparison with a power of 90%, whereas 
onlay versus sublay mesh reinforcement was an equivalence comparison with a power 
of 80%. We accounted for 10% dropouts. In total, we needed 100 patients in the primary 
suture group and 180 patients each in the primary mesh reinforcement groups; thus, 
460 patients were needed to detect a significant difference in incidence of incisional 
hernia. However, during the trial, more dropouts occurred than initially expected and, 
therefore, we aimed to recruit an additional 20 patients. 
For the comparison of both experimental groups (onlay and sublay mesh reinforcement) 
with the control group (primary suture), we analysed incisional hernia as a binary 
outcome. We used mixed-effects logistic regression with two group levels to account 
for clustering of patients in hospitals and according to operation type. We did not 
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apply a time-to-event analysis as stated in the protocol, since patients were seen at the 
outpatient clinic at specific timepoints (1 year and 2 years after surgery) and, therefore, 
the exact time to event (incisional hernia) was unclear. However, as a sensitivity 
analysis, we checked if a mixed-effects Cox regression analysis led to different results. 
We adjusted outcomes for the following covariates: age, sex, smoking, BMI, abdominal 
aortic aneurysm, COPD, cardiovascular diseases, ASA classification, and steroids. We 
analysed data according to the intention-to-treat principle. In addition to intention-
to-treat analyses, we also did a per-protocol analysis of the primary outcome for the 
comparison of onlay versus sublay mesh reinforcement.30 We assessed quality of life 
and pain by the intention-to-treat principle. 
For the comparison of the two experimental groups (onlay and sublay mesh 
reinforcement), we calculated a two-sided 98·3% CI for the difference in the probability 
of incisional hernia. Thus, we used an equivalence test for the comparison of onlay 
versus sublay mesh reinforcement instead of a non-inferiority test of onlay versus 
sublay mesh reinforcement (which was incorrectly suggested in the protocol), since 
we postulated that both techniques would have a similar risk of incisional hernia. We 
defined equivalence between the two experimental groups as the absolute difference 
in the probability of incisional hernia being below an equivalence margin of 10%. A 
rejection of the null hypothesis of non-equivalence, the 98·3% CI of the absolute 
difference in the probability of incisional hernia is fully between -10% and 10%, is 
evidence in favour of equivalence. If the evidence in favour of equivalence is not strong 
enough, non-equivalence cannot be ruled out. 
We did not account for dropouts in our analyses: we calculated numbers and 
percentages for all included patients (in that specific treatment group). Therefore, 
we assessed not only the baseline characteristics of all participants but also those of 
remaining participants, since differential loss to follow-up could bias comparisons 
between treatment groups (32). To analyse the effect of potential differences in baseline 
characteristics on the comparisons between treatment groups, we repeated the mixed-
effect regression analysis with adjustment for baseline characteristics. 
We analysed quality of life with multilevel regression models. We judged incisional 
hernia a time-varying covariate, indicating whether the incisional hernia had taken 
place in the period preceding follow-up. We determined the covariance structures with 
the deviance test on the restricted maximum likelihood function. For the difference in 
quality-of-life measurements between treatment groups, we entered dummy variables 
indicating onlay or sublay mesh reinforcement as covariates, with primary suture as the 
reference group. We estimated contrasts at 24 months. We analysed postoperative pain 
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with linear logistic regression. We used mixed modelling for the quality-of-life analysis 
to handle data efficiently with missing and unbalanced timepoints (33). We did the 
statistical analysis with IBM SPSS version 20.0 and R version 3.1.0. This trial is registered 
at ClinicalTrials.gov, number NCT00761475. 
Role of the funding source 
The funders had no role in study design, data collection, data analysis, data interpretation, 
or writing of the report. The corresponding author had full access to all the data in the 
study and had final responsibility for the decision to submit for publication.
RESULTS 
Between March, 2009, and December, 2012, 498 patients were enrolled to the study 
(figure). 18 individuals were excluded because they either withdrew informed consent 
(n=3), did not have midline incision (n=8), had already presented with incisional hernia 
(n=3), or for other reasons (n=4). Of the 480 included patients, 150 (31%) patients had 
an abdominal aortic aneurysm and 330 (69%) individuals had a BMI of 27 kg/m² or 
greater. At randomisation, 107 patients were assigned closure by primary suture, 188 
were allocated closure by onlay mesh reinforcement, and 185 were assigned closure 
by sublay mesh reinforcement. Primary mesh reinforcement was not done in 18 (10%) 
patients assigned onlay mesh reinforcement and in 27 (15%) allocated sublay mesh 
reinforcement (figure 1). Baseline characteristics were similar between groups (table 1). 
Median follow-up was 23 months (IQR 12–25), and 376 (78%) of 480 patients completed 
follow-up. 104 patients were lost to follow-up during the study, 21 who were assigned 
closure by primary suture, 45 allocated onlay mesh reinforcement, and 38 assigned 
sublay mesh reinforcement. The main reasons for loss to follow-up were death and 
patient’s decision to withdraw from the study. Baseline characteristics of remaining 
participants are shown in the appendix.
Besides the physical examinations at 1 year and 2 years, 283 (59%) of 480 patients 
also underwent radiological examinations at 6 months and 2 years, 60 in the primary 
suture group, 115 in the onlay mesh reinforcement group, and 108 in the sublay 
mesh reinforcement group. Of the 376 patients who completed follow-up, 265 (70%) 
underwent radiological examination, 58 in the primary suture group, 105 in the onlay 
mesh reinforcement group, and 102 in the sublay mesh reinforcement group.
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498 patients enrolled
80 randomised
- 150 AAA
- 330 BMI ≥27 kg/m²
188 onlay mesh reinforcement
(18 no mesh)
61 AAA
127 BMI ≥27kg/m²
185 sublay mesh reinforcement
(27 no mesh)
52 AAA
133 BMI ≥27 kg/m²
107 primary suture
37 AAA
70 BMI ≥27kg/m²
18 excluded
- 8 no midline incisions
- 3 withdrew informed consent
- 3 already incisional hernia present
- 4 other*
Figure 1. Trial profile 
AAA= abdominal aortic aneurysm. BMI=body-mass index. *Surgeon’s decision (n=1), laparoscopy done rather than 
laparotomy (n=1), and no operation done (n=2)
92 (19%) of 480 patients developed incisional hernia during the 2 years of follow-
up, 33 (31%) of 107 in the primary suture group, 25 (13%) of 188 in the onlay mesh 
reinforcement group, and 34 (18%) of 185 in the sublay mesh reinforcement group. The 
incidence of incisional hernia differed significantly between onlay mesh reinforcement 
and primary suture (OR 0·37, 95% CI 0·20-0·69; p=0·0016), but did not differ for the 
comparisons of sublay mesh reinforcement versus primary suture (0·55, 0·30-1·00; 
p=0·05) or onlay versus sublay mesh reinforcement (1·39, 0·73-2·65; p=0·31; table 2). The 
98·3% CI for the difference in probability of incisional hernia between sublay and onlay 
mesh reinforcement was -6·8 to 15·2. This confidence interval included the equivalence 
margin of 10%; therefore, non-equivalence of the experimental treatments cannot be 
ruled out. The sensitivity analysis using mixed-effects Cox regression led to very similar 
results, and adjustment for covariates did not had any effect on these findings either. 
Among the subgroup of 150 patients with abdominal aortic aneurysm, incisional hernia 
occurred in 36 (24%), 16 who were assigned closure by primary suture, ten allocated 
onlay mesh reinforcement, and ten assigned sublay mesh reinforcement. Among the 
subgroup of 330 patients with a BMI of 27 kg/m² or higher, incisional hernia occurred 
in 54 (16%), 16 who were allocated closure by primary suture, 15 assigned onlay mesh 
reinforcement, and 23 allocated sublay mesh reinforcement. Subgroup analysis showed 
that treatment effects were consistent in both subgroups (table 2).
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Table 1. Baseline characteristics
Total PS OMR SMR
Total 480 107 188 185
Male, no (%) 292 (60.8) 68 (63.5) 116 (61.7) 108 (58.4)
Age, mean (SD) 64.5 (11.2)* 65.2 (10.5)* 64.2 (12.3)* 64.4 (10.4)
BMI, mean (SD) 30.6 (5.3)* 29.8 (4.4)* 30.8 (5.9)* 30.8 (5.2)
Smoking, no (%) 102 (21.3) 17 (15.9) 41 (21.8) 44 (23.8)
Diabetes mellitus, no (%) 94 (19.6) 19 (17.8) 36 (19.1) 39 (21.1)
COPD, no (%) 52 (10.8) 9 (8.4) 24 (12.8) 19 (10.3)
ASA, no (%)
I
II
III
IV
Unspecified
44 (9.2)
234 (48.8)
150 (31.3)
6 (1.3)
46
10 (9.3)
55 (51.4)
35 (32.7)
1 (0.9)
6
21 (11.2)
90 (47.9)
54 (28.7)
3 (1.6)
20
13 (7.0)
89 (48.1)
61 (33.0)
2 (1.1)
20
Previous midline incision, no (%) 21 (4.4) 3 (2.8) 10 (5.3) 8 (4.3)
Other hernia, no (%) 50 (10.4) 13 (12.1) 19 (10.1) 18 (9.7)
Type operation, no (%)
Vascular
Upper GI
Lower GI
HPB
Gynecology
Urology
159 (33.1)
65 (13.5)
162 (33.8)
21 (4.4)
66 (13.8)
7 (1.5)
39 (36.4)
18 (16.8)
29 (27.1)
3 (2.8)
15 (14)
3 (2.8)
64 (34)
22 (11.7)
67 (35.6)
8 (4.3)
24 (12.8)
3 (1.6)
56 (30.3)
25 (13.5)
66 (35.7)
10 (5.4)
27 (14.6)
1 (0.5)
BMI= body mass index, COPD=chronic obstructive pulmonary disease, ASA=American Society of Anesthesiologists, 
GI=gastrointestinal, HPB=hepatobiliary and pancreatic, SD=standard deviation
Almost a quarter of patients had a postoperative complication after 2 years of follow-up. 
Seromas were seen most frequently in individuals assigned onlay mesh reinforcement 
at 1-month follow-up; however, this outcome had no further adverse outcomes for the 
patient ie, the frequency of surgical-site infections, re-interventions, or re-admissions 
with onlay mesh reinforcement was not different when compared with primary suture 
or sublay mesh reinforcement. With respect to long-term complications at 2-year follow-
up, there were three pulmonary infections (two with onlay mesh reinforcement, one with 
sublay mesh reinforcement), one urinary infection (with primary suture), one seroma 
(with sublay mesh reinforcement), one deep surgical site infection with an abscess 
(with primary suture), seven re-interventions (four with onlay mesh reinforcement, 
three with sublay mesh reinforcement), and six re-admissions (two with primary suture, 
one with onlay mesh reinforcement, three with sublay mesh reinforcement). The risk of 
re-intervention (p=0·343) and re-admission (p=0·508) did not differ between groups. 
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None of the re-interventions or re-admissions was related to the mesh used or the fibrin 
sealant. 73 (15%) of 480 patients died, 15 (14%) of 107 assigned primary suture, 34 (18%) 
of 188 allocated onlay mesh reinforcement, and 24 (13%) of 185 assigned sublay mesh 
reinforcement. The most common cause of death was malignant disease or tumour 
progression. None of the deaths was related to development of an (incarcerated) 
incisional hernia, the mesh used, or the fibrin sealant.
Table 2. Incidence of incisional hernia in all patients with 2-year follow-up and by subgroups
Incidence (%) Odds ratio (95% CI) P value
All patients with follow-up to 2 years (n=480)
Primary mesh reinforcement
vs primary suture*
59/373 (16%)
vs 33/107 (30%)
0·45 (0·27–0·77) 0·003
Onlay mesh reinforcement
vs primary suture*
25/188 (13%)
vs 33/107 (30%)
0·37 (0·20–0·69) 0·0016
Sublay mesh reinforcement
vs primary suture*
34/185(18%)
vs 33/107 (30%)
0·55 (0·30–1·00) 0·05
Onlay mesh reinforcement
vs sublay mesh reinforcement**
25/188 (13%)
vs 34/185 (18%)
1·39 (0·73–2·65) 0·31
Abdominal aortic aneurysm (n=150)
Primary mesh reinforcement
vs primary suture*
20/113 (17%)
vs 16/37 (43%)
0·29 (0·12–0·67) 0·004
Onlay mesh reinforcement
vs primary suture*
10/61 (16%)
vs 16/37 (43%)
0·27 (0·10–0·71) 0·008
Sublay mesh reinforcement
vs primary suture*
10/52 (19%)
vs 16/37 (43%)
0·36 (0·13–0·93) 0·03
Onlay mesh reinforcement
vs sublay mesh reinforcement**
10/61 (16%)
vs 10/52 (19%)
1·04 (0·32–3·39) 0·95
BMI ≥ 27kg/m (n=330)
Primary mesh reinforcement
vs primary suture*
38/260 (15%)
vs 16/70 (23%)
0·58 (0·29–1·19) 0·14
Onlay mesh reinforcement
vs primary suture*
15/127 (12%)
vs 16/70 (23%)
0·47 (0·21–1·06) 0·07
Sublay mesh reinforcement
vs primary suture
23/133 (17%)
vs 16/70 (23%)
0·72 (0·32–1·60) 0·42
Onlay mesh reinforcement
vs sublay mesh reinforcement**
15/127 (12%)
vs 23/133 (17%)
1·62 (0·73–3·63) 0·24
* Intention-to-treat analysis** Per-protocol analysis
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At baseline, 245 (51%) of 480 patients completed SF-36 and 342 (71%) of 480 submitted 
the EQ-5D questionnaire. After 2 years of follow-up, 188 and 333 patients, respectively, 
completed these questionnaires. No differences were recorded between the three 
treatment groups in SF-36 domains or the mental component summary score and 
physical component summary score (table 3). Moreover, no differences were noted 
between treatment groups with respect to EQ-5D scores and postoperative pain 
(measured with the visual analogue scale). Further analysis of the quality-of-life measures 
for patients with and without an incisional hernia showed no differences in scores on 
the SF-36 or EQ-5D questionnaires (table 4). However, patients with an incisional hernia 
had a higher score on the visual analogue scale for postoperative pain (mean estimate 
1·94 [SE 0·39]) compared with patients who did not develop an incisional hernia (0·96 
[0·15]; p=0·01).
DISCUSSION 
The findings of the PRIMA trial show that onlay mesh reinforcement significantly 
reduced the incidence of incisional hernia after midline laparotomy in patients at high 
risk for incisional hernia (ie, those with abdominal aortic aneurysm or a BMI ≥27 kg/
m²). Sublay mesh reinforcement did not have a significant effect on the incidence of 
incisional hernia compared with primary suture. Although the absolute difference in 
incidence of incisional hernia between onlay and sublay mesh reinforcement was less 
than the equivalence margin of 10%, the 98·3% CI for the difference did not provide 
strong evidence in favour of equivalence. 
Postoperative complications were analysed after 1 month (short-term) (29) and after 2 
years. With respect to the short-term complications, only seromas were more frequently 
seen in patients allocated onlay mesh reinforcement, compared with those assigned 
primary suture and sublay mesh reinforcement. However, this increased incidence did 
not have any adverse outcomes for the patient, because the frequency of surgical-site 
infections, mesh infections, re-interventions, or re-admissions did not differ between 
treatment groups. No other differences in short-term postoperative complications were 
seen between the groups and no further postoperative complications were recorded 
after follow-up of 2 years. Furthermore, 15% of the included population died. Most 
deaths were due to malignant disease and no death was associated with either the 
fibrin sealant or the mesh used. Therefore, use of primary mesh reinforcement to reduce 
the incidence of incisional hernia is a safe procedure. 
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Table 4. Quality-of-life scores for patients with and without incisional hernia
No incisional hernia (n=388) Incisional hernia (n=92) p-value
Pain 79·49 (1·68) 77·79 (3·15) 0·60
Physical functioning 65·89 (1·72) 58·98 (3·14) 0·03
Physical health 64·84 (2·85) 58·34 (5·57) 0·26
Emotional problems 75·93 (2·67) 75·35 (5·25) 0·92
Energy / fatigue 61·97 (1·42) 58·17 (2·57) 0·14
Emotional well-being 76·24 (1·15) 77·08 (2·03) 0·67
Social functioning 79·70 (1·67) 78·23 (3·18) 0·65
General health 57·54 (1·27) 57·07 (2·23) 0·83
Mental component score 49·96 (0·71) 51·04 (1·34) 0·42
Physical component score 45·44 (0·70) 43·47 (1·35) 0·14
EQ-5D 0·91 (0·01) 0·91 (0·02)
Postoperative pain * 0·96 (0·15) 1·94 (0·39) 0·01
Data are mean (SE). SF-36 scores range from 0 to 100. EQ-5D scores range from -0.329 to 1.000. EQ-5D=EuroQol five 
dimensions. SF-36=36-item short form health survey.  *Measured on a visual analogue scale (range 0-10). 
Incisional hernia is one of the most common complications after abdominal wall 
surgery. In high-risk groups, the frequency of incisional hernia is 30–40%. Incisional 
hernia can create a social burden for the patient and a financial burden for public 
health. Furthermore, it can lead to worse quality of life. In the PRIMA trial, we noted that 
patients with incisional hernia had a higher pain score compared with those without 
an incisional hernia. Thus, prevention is of paramount importance. Until now, several 
trials have been done to investigate whether primary mesh reinforcement can reduce 
the incidence of incisional hernia. Most study findings showed that use of prophylactic 
mesh in patients with abdominal aortic aneurysm reduced the risk of incisional hernia 
to almost zero. For example, in a study by Muysoms and colleagues (PRIMAAT trial) 
(34), in which patients with abdominal aortic aneurysm were included, the cumulative 
incidence of incisional hernia was 28% in the non-mesh group compared with 0% in the 
mesh group, after follow-up of 2 years. Our data also provide strong evidence that use 
of prophylactic mesh in patients with abdominal aortic aneurysm—and in those with 
a high BMI (≥27 kg/m²)— significantly reduces the incidence of incisional hernia (30% 
incidence with primary suture vs. 13% with onlay mesh reinforcement and 18% with 
sublay mesh reinforcement). 
jairam-layout.indd   99 28/05/2018   21:47
100
Chapter 4
The reasons for the discrepancy in incidence between our study and other studies, 
including the PRIMAAT trial, could be explained by several factors. First, radiological 
examination was done in 59% of patients in our study, which is a more accurate 
procedure to diagnose hernia. In most other studies, radiological examination was not 
done (1, 34, 35), and incisional hernia was diagnosed clinically in the PRIMAAT trial (34). 
Second, follow-up of patients in our trial was for 2 years, whereas follow-up in other 
studies (1, 36, 37) was usually shorter. A higher incidence of incisional hernia is typically 
seen with a longer duration of follow-up (2, 35). In a study by Fink and colleagues (2), the 
incidence of incisional hernia was 12·6% in the first year, which increased significantly 
to 22·4% at 3 years after midline laparotomy, representing a relative increase of 60%. 
Thus, length of follow-up seems to affect the incidence of incisional hernia after midline 
laparotomy. 
Third, different clinician specialties played a part in our study, not solely an abdominal 
closing team, as was the case in the PRIMAAT trial (34) In the PRIMA trial, we included not 
only surgical patients but also those from the departments of urology and gynaecology. 
Thus, general surgeons and those from these different specialties operated on patients. 
This difference is exceptional because—as far as we know—no other study has included 
this variety of surgical specialties, patients, and surgical indications. Even though 
several specialists participated in the PRIMA trial, it is unlikely that this variety might 
have affected the results, considering the few gynaecological and urological patients. 
Finally, we included different groups of high-risk patients in our trial, not only those 
with abdominal aortic aneurysm but also individuals with a BMI of 27 kg/m² or higher. 
Published work is contradictory with respect to primary mesh reinforcement in obese 
patients. For example, findings of a randomised controlled trial in obese individuals (BMI 
≥40 kg/m²) did not show significant results (35); however, this trial used an absorbable 
mesh. Findings of several other trials of a non-absorbable mesh did show a significant 
effect of prophylactic mesh placement in patients with morbid obesity (BMI ≥45 kg/m²) 
(23, 24). In another trial (25), a non-crosslinked biological mesh was placed in patients 
with a BMI greater than 40 kg/m² (or BMI >35 kg/m² with weight-related comorbidity), 
which did not reduce the incidence of incisional hernia substantially. 
Participation of surgeons from different specialties might have led to a learning curve 
in our trial, but this possibility is also a strong advantage of the PRIMA trial: the results 
of our study are applicable to every patient undergoing midline laparotomy, operated 
on by different types of specialists. It is remarkable that placement of a mesh in an 
onlay position led to our significant results, because the sublay technique has always 
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been assumed superior (38). Placement of a mesh in an onlay position is a less complex 
surgical technique, which might have contributed to our results. The participation of 
different specialties might also have been a contributing factor to our findings: urologists 
and gynaecologists were not familiar with both onlay and sublay mesh reinforcement. 
However, sublay mesh reinforcement in particular is a complex technique. This factor 
makes onlay placement of a mesh with glue even more interesting, particularly because 
the onlay position did not lead to complications that had any adverse outcomes for 
patients. 
In the PRIMA trial, we included patients not only with abdominal aortic aneurysm 
but also with a BMI of 27 kg/m² or higher. The possibility exists that these different 
risk factors affect each other in a synergistic way, which might lead to biased results. 
Therefore, we analysed mean BMI in both subgroups; this variable was similar among 
the three treatment groups of both subgroups, and the distribution was not skewed. 
Median BMI in the abdominal aortic aneurysm subgroup was lower than 27 kg/m² (26·6, 
IQR 24·3-29·3), whereas in the high BMI subgroup it was higher than this value (median 
30·9, IQR 28·7-34·1). Thus, abdominal aortic aneurysm and BMI act as independent risk 
factors, and our results are not biased. 
Findings of previous studies have shown that the combination of mesh and sealant 
we used in our study is effective (39, 40). As noted by us previously (29), use of fibrin 
sealant in clinical practice, in combination with prophylactic mesh reinforcement, has 
not been investigated before. In our trial, no great complications or adverse events can 
be attributed with certainty to the sealant or the mesh. Application of the sealant aimed 
to reduce the anterior subcutaneous dissected space during onlay mesh reinforcement, 
which is prone to formation of seromas. Our results for postoperative complications 
did not confirm this expectation. This outcome can be explained by the timing of the 
application of the sealant, which is essential. There will be no reduction of the dissected 
space if polymerisation occurs before the ventral layer is closed (41). Furthermore, other 
techniques that could diminish seroma formation were not applied, such as placement 
of a wound drain and suturing of the subcutaneous tissue plane. Even though the 
expectation of fewer seromas could not be confirmed during this trial, the incidence of 
seroma without glue is unknown in these particular groups of patients. 
We applied Bonferroni correction for multiple testing (α=0·017) in our analysis. Opinions 
on multiple-testing correction for multiarm trials are conflicting (42), because controlling 
the overall probability of a false-positive treatment effect comes at the price of rejecting 
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prematurely potentially effective treatments. In our study, the Bonferroni correction 
affected the interpretation of the difference between sublay mesh reinforcement versus 
primary suture (borderline significance vs non-significant). 
We did not take into account the dropout rate in our statistical analysis. If the frequency of 
dropouts is equal in each arm of a trial, odds ratios should not be affected, assuming that 
the treatment effect in patients with complete follow-up and in those who dropped out 
is equal. In our trial, this assumption was plausible: the frequency of dropouts was very 
similar in the three treatment groups, so dropout of patients probably does not bias the 
odds ratios. Furthermore, we assessed whether differences in baseline characteristics 
between treatment groups were similar in remaining participants (appendix), which 
was the case. To correct for imbalance between the three treatment groups, an adjusted 
analysis for covariates was done, which led to a similar treatment effect. 
One of the main limitations of the PRIMA study is the fact that not all included 
patients underwent radiological examination: 59% had radiological examination, and 
70% of all individuals who completed follow-up underwent imaging. This procedure 
might have led to underestimation of the number of patients with incisional hernia, 
because radiological examination is more sensitive than physical examination alone. 
Therefore, we assessed incidence of incisional hernia in two subgroups: in individuals 
who underwent radiological examination (additional to physical examination); and in 
patients who did not receive radiological examination (data available on request). This 
analysis showed consistent treatment effects in both subgroups. Even though our study 
was not powered on these (small) subgroups, we believe our results are generalisable in 
daily practice. The fact that only 59% of participants had radiological assessment makes 
our study more comparable with daily practice but limits confidence of the study to 
some extent. 
The PRIMA trial provides level one evidence for the prevention of incisional hernia 
after midline laparotomy in patients at risk for incisional hernia. Closure of laparotomy 
with onlay mesh reinforcement has the potential to become the standard treatment in 
high-risk groups, which will reduce the socioeconomic burden of incisional hernia. The 
results of the PRIMA trial also offer future perspectives. The next step will be a trial in 
which onlay mesh reinforcement is combined with the small bites suture technique to 
lower the incidence of incisional hernia even further, because the small bite technique 
has been shown to be superior in closing midline laparotomy.
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Laparotomy with Prophlyactic Mesh Reinforcement:
a meta-analysis and trial sequential analysis
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ABSTRACT
Introduction: Incisional hernia is a frequent complication after abdominal surgery. 
The aim is to assess the efficacy of prophylactic mesh reinforcement after midline 
laparotomy, in order to reduce the incisional hernia incidence.
Method: A meta-analysis was conducted, following the PRISMA guidelines. Primary 
outcome was the incidence of incisional hernia after a follow-up of at least 12 months. 
Secondary outcomes were postoperative complications. Only randomised controlled 
trials were included. A random-effects model was used for the meta-analysis and trial 
sequential analysis was conducted.
Results: Twelve randomized controlled trials were included, encompassing 1815 
patients. The incisional hernia incidence was significantly lower after prophylactic mesh 
reinforcement compared with sutured closure (RR 0.35, 95%CI 0.21-0.57, p<0.0001). 
Both onlay (RR 0.26, 95%CI 0.11-0.67, p= 0.005) and retromuscular (RR 0.28 95%CI 
0.10-0.82, p= 0.02) mesh reinforcement lead to a significant reduction of the incisional 
hernia. The occurrence of seromas was higher in patients who underwent onlay mesh 
reinforcement (RR 2.23, 95%CI 1.10-4.52, p=0.03). Prophylactic mesh reinforcement 
does not result in  an increased rate of surgical site infections. 
Conclusion: Prophylactic mesh reinforcement of a midline laparotomy leads to a 
significant reduction of incisional hernia in high-risk patients for both onlay and 
retromuscular mesh reinforcement. Onlay PMR was associated with a lager size of effect 
than retromuscular PMR. Onlay mesh was associated with significant postoperative 
morbidity, in form of seroma. Further research is needed to define the discriminating 
patient risk factors when prophylactic mesh reinforcement has to be recommended.
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INTRODUCTION
Incisional hernia (IH) is one of the most frequent complications after abdominal surgery, 
with incidences ranging from 11% to 20% in a general surgical population (1-4). The 
incidence of IH can increase up to 40% in high-risk groups, such as patients with an 
Abdominal Aortic Aneurysm (AAA) or morbid obesity (5-12). An IH can be asymptomatic, 
but it can also lead to serious and potentially fatal complications, such as incarceration 
and strangulation of bowel. Furthermore, IH has a high impact on patients’ quality of life 
and body image (13, 14). Moreover, IH treatment represent a financial burden on our 
healthcare system (15). 
The current treatment of IH is mesh repair, which has led to a lower recurrence rate 
compared with the primary suture (PS) technique (16). However, the recurrence rate is 
still high even when a mesh is used. In a Danish nationwide registry study, a cumulative 
recurrence rate after IH repair at 3 years follow-up is reported to be 37% (17). Currently, 
there is no definitive solution for the high recurrence rates and complications related to 
recurrences of IH. It can be concluded that prevention is of paramount importance (18). 
In the past few years, several studies regarding prevention of IH with prophylactic mesh 
reinforcement (PMR) have been conducted. Most randomized controlled trials (RCTs) 
included a limited number of patients. Different surgical techniques of PMR, including 
mesh placement in onlay, retromuscular or intraperitoneal position, have been studied. 
The European Hernia Society guidelines on the closure of abdominal wall incisions 
made a recommendation in 2015 (19). The Guidelines Development Group stated that 
PMR to reduce the IH incidence after elective midline laparotomy in a high-risk patient is 
suggested with a weak recommendation. They also stated that larger trials were needed 
to make a strong recommendation. 
Since the publication of the European Hernia Society guidelines on the closure of 
abdominal wall incisions, three meta-analyses (20, 21, 22) together with the long-
term data of the largest multicentre RCT on IH prevention after midline laparotomy 
comparing PMR with PS (PRIMA trial) (23) have been published. However, in one of these 
meta-analyses, RCTs and observational studies were mixed (20). In the meta-analysis of 
Wang et al., some studies on non-midline incisions were added (21) and in all three 
meta-analysis (20,21,22), long-term data from the PRIMA trial were not included.
This meta-analysis includes only RCTs and long-term data from the recently published 
PRIMA trial (23). Moreover, we performed a Trial Sequential Analysis (TSA) to evaluate 
the strength of the current evidence on PMR after midline laparotomies. 
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The aim of this meta-analysis is to assess the safety and efficacy of PMR in order to 
reduce the IH incidence after elective midline laparotomy. Furthermore, the efficacy of 
both onlay and retromuscular PMR were compared with PS. 
METHODS
Protocol and registration
A meta-analysis was conducted and reported following the PRISMA guidelines (24). 
This meta-analysis was registered prospectively at the Prospero database at the 5th of 
November 2015 (CRD42015027079) with the acronym MARIA review. Our meta-analysis 
was finalized after the publication of the final results of the PRIMA trial on June 19th 
2017.   
Information sources and search terms
A systematic computerized literature search was performed until the first of January 
2017, using 12 databases: EMBASE, Medline, Web-of-Science, SCOPUS, Cochrane, 
CINAHL, Pubmed publisher, Lilacs, Scielo, ScienceDirect, Proquest and Google scholar. 
The Biomedical Information Specialist of the Medical Library (Erasmus University 
Medical Center, Rotterdam, the Netherlands) prepared the search strategy. The syntax 
with search terms is shown in Appendix 1. 
Study selection data extraction and quality assessment
Three reviewers (A.J., M.L.C and F.M.) independently screened all records by title and 
abstract for eligibility. After this first screening, the full text of records was assessed. 
Only eligible RCTs were included. The methodological quality of RCTs was assessed with 
SIGN checklists (Scottish Intercollegiate Guidelines Network). Risk of bias assessment 
was done using the Cochrane Collaboration’s tools, in which the following aspects are 
assessed: random sequence generation, allocation concealment, blinding of patients, 
personnel or outcome assessors, incomplete outcome data and selective reporting (25). 
Assessment of both methodological quality and risk of bias was performed by three 
independent reviewers. Studies were assessed as either low risk of or high risk of bias.
RCTs were included if they met the following inclusion criteria: patients aged ≥ 18 years, 
undergoing midline laparotomy, for all types of indications, with all types of meshes 
and all types of mesh positions. Primary outcome was the incidence of IH. Secondary 
outcomes were postoperative complications: seroma, surgical site infection (SSI), 
hematoma and burst abdomen. Follow-up was determined to be at least 12 months. No 
language restrictions were used. 
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All required data were extracted and collected in a standardized manner by at least 
two authors independently (A.J. and M.L.C.). Any divergences during the data extraction 
phase were resolved through discussion and by consulting a third investigator (F.M.). A 
Summary of Findings table (SoF table) was created, in which the following information 
was collected: study characteristics (title, year of publication, study design, number of 
included patients), indication for midline laparotomy, description of intervention and 
description of the compared intervention (‘control group’), type of mesh that was used, 
mesh placement, length of follow up and outcome measurements. In case a manuscript 
included data for different mesh positions, the data for these different mesh positions 
was described separately per group in the SOE table. For duplicate data reported by the 
same author(s), the article with the longest follow-up period was selected.    
Statistical analysis
A meta-analysis, pooling the results of the retrieved studies, was performed. A sensitivity 
analysis as conducted to reduce the risk of possible bias of primary and secondary 
outcomes was conducted. Meta-analyses that combine other subgroups (mesh position) 
were also performed. A random effects model was used and presented as risk ratios 
(RR) with 95% confidence intervals (CI). Effects were considered statistically significant 
if the 95% CI of the overall effect estimate did not overlap. The I² statistic was used to 
assess heterogeneity. Groups with zero events were adjusted with a constant continuity 
adjustment of 0.5 in each arm (as per the default adjustment in the software used). 
Publication bias was assessed by a funnel plot. Analyses were performed using Review 
Manager software (RevMan version 5.3; The Nordic Cochrane Centre, Copenhagen, 
Denmark). Two sided p-values of <0.05 were considered statistically significant. 
Conducting a meta-analysis can lead to type I errors (false positives) or overestimation 
of treatment effects due to systematic errors (bias) and random errors (play of change). 
In order to avoid this, Trial Sequential Analysis (TSA) was applied. TSA can provide a 
required information size (RIS). The RIS is the required number of patients that needs 
to be included in the meta-analysis to provide firm evidence (26,27). Control Event 
Rate (CER) and Relative Risk Reduction (RRR) were calculated. CER is the proportion 
participants in the control group that have the outcome. RRR can be interpreted as the 
reduction of the relative risk of the specified outcome in the treatment group, compared 
with the control group. Trial Sequential Analysis (TSA) was planned for all retrieved 
studies and for the group of studies with low risk of bias. TSA was performed using the 
TSA software v0.9 (www.uct.dk/tsa/index.html).
jairam-layout.indd   113 28/05/2018   21:47
114
Chapter 5
RESULTS
Study characteristics
Figure 1 shows the PRISMA flow diagram. A total of 1497 records were identified after 
removal of the duplicates. After screening of title and abstract, 39 articles were found 
relevant for full text assessment. After full text assessment, 29 articles were excluded; 
leaving 13 RCTs that fulfilled the inclusion criteria, for the qualitative and quantitative 
assessment (5-11, 23,  28-32). The study of Timmermans et al. (32) was excluded, since only 
the short-term results (postoperative complications in the first month) were discussed. 
The article with the longest follow-up (long-term results, with the primary endpoint IH), 
was selected (23). Thus, 12 RCTs were analyzed. Six studies were considered low risk of 
bias (7, 8, 11, 23, 29, 31) and six studies were considered high risk of bias (5, 6, 9, 10, 28, 
30). Table 1 captures the risk of bias assessment.
The 12 included RCTs comprised 1815 patients in total. Study and patient characteristics 
are presented in the SoF table (Table 2). Inclusion criteria for PMR of the midline 
laparotomy in the individual RCTs were either the presence of an AAA (8, 10, 11, 23), 
morbid obesity (5, 7, 9, 30), colorectal cancer surgery (31) or a mixture of operative 
indications (6, 28, 29). Most studies placed a polypropylene mesh in an onlay 
(6,10,23,29,31) or retromuscular position (7,8,11,23). Two studies used biological meshes 
(10, 30) and one study used a rapid absorbable intra-peritoneal mesh (5).
Outcome measurements
Primary outcome is the incidence of IH after a follow-up of at least 12 months. Twelve 
RCTs were included in the overall quantitative analysis for the primary outcome and 
publication bias was thus evaluated (33). This meta-analysis showed a significant 
reduction of IH in patients with PMR compared with PS patients (RR 0.35, 95%CI 0.21-
0.57, I=69%, p<0.0001) (Figure 2). The funnel plot is slightly asymmetric, indicating a 
possible publication bias of studies that favour mesh prophylaxis (Figure 3). Analysis of 
the primary outcome for the low risk of bias studies (6 RCTs) showed that the occurrence 
of IH is significantly less (RR 0.23, 95%CI 0.10-0.52, I=71%, p= 0.0004) in the PMR group 
compared with the PS group (Figure 2). Both onlay and retromuscular PMR lead to 
a significant reduction of the IH incidence compared with PS, with respectively a RR 
of 0.26 (95%CI 0.11-0.67, I=72%, p=0.005) and a RR of 0.28 (95%CI 0.10-0.82, I=66%, 
p=0.02) (Figure 4).
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Figure 1. PRISMA flow diagram of a systematic review and meta-analysis on the prevention of 
incisional hernia with prophylactic mesh reinforcement. 
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Table 1. Risk of bias assessment on the prevention of incisional hernia with prophylactic mesh 
reinforcement in midline laparotomies
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Figure 2. Forest plots on the incidence of incisional hernias comparing prophylactic mesh 
reinforcement of a midline laparotomy with primary sutures: 
a) overall data from all 12 included studies 
b) separate data for studies with low risk of bias and studies with a high risk of bias  
(a)
(b)
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Figure 3. Funnel plot
Figure 4. Forest plots on the incidence of incisional hernias comparing prophylactic mesh 
reinforcement of a midline laparotomy with primary sutures: 
a) data from studies using onlay mesh reinforcement 
b) data for studies using retromuscular mesh reinforcement   
(a)
(b)
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TSA calculation (for the primary outcome) was performed for all 12 included studies. 
The Control Event Rate (CER) proportion is 28%, the Relative Risk Reduction (RRR) is 
65% and a constant continuity adjustment was set at 0.5 events per group. The accrued 
information size (n=1815) is 273,3% of the estimated RIS (n=664). This means that firm 
evidence is available. In the group of low risk of bias studies (6 RCTs), the CER proportion 
is 31% and RRR is 77%. The accrued information size (n=1015) is 283,5% of the estimated 
RIS (n=358) (Figure 5). 
Figure 5. Trial Sequential Analysis curve for the incidence of IH comparing prophylactic mesh 
reinforcement of a midline laparotomy with primary sutures: 
a) overall data from all 12 included studies 
b) data from studies with low risk of bias  
(a)
(b)
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Secondary outcomes were analysed for the low risk of bias studies only (6 RCTs). 
Patients with an onlay PMR had a higher risk of developing seroma (RR 2.23, 95%CI 
1.10-4.52, I=51%, p=0.03) compared with patients who underwent PS. This finding is 
statistically significant. This is not applicable for the comparison of retromuscular PMR 
with PS: patients who underwent retromuscular PMR did not have a higher chance of 
developing seroma compared with patients who underwent PS (RR 1.67, 95%CI 0.81-
3.47, I=0%, p=0.17) (Figure 6). The occurrence of SSI was not significantly higher in 
onlay PMR compared with PS (RR 0.82, 95%CI 0.55-1.23, I=0%, p=0.33) or in patients 
who underwent retromuscular PMR compared to PS (RR 0.85, 95%CI 0.50-1.45, I=0%, 
p=0.55) (Figure 7). The incidence of hematoma and burst abdomen was not analysed 
because of insufficient data.
Figure 6. Forest plots for postoperative seroma comparing prophylactic mesh reinforcement of 
a midline laparotomy with primary sutures: 
a) data from studies using onlay mesh reinforcement 
b) data for studies using retromuscular mesh reinforcement
(a)
(b)
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Figure 7. Forest plots for surgical site infection comparing prophylactic mesh reinforcement of 
a midline laparotomy with primary sutures: 
a) data from studies using onlay mesh reinforcement 
b) data for studies using retromuscular mesh reinforcement
DISCUSSION
Key results
This meta-analysis shows that the use of PMR in patients undergoing midline laparotomy 
leads to a significantly lower occurrence of IH, compared with PS closure (RR 0.35, 95%CI 
0.21-0.57, p<0.0001). TSA shows that this evidence is firm with an accrued information 
size of 273% of the estimated required information size and an IH reduction of 65%. 
Significant effect was shown both for onlay PMR (RR 0.26, 95%CI 0.11-0.67, p=0.005) and 
for retromuscular PMR (RR 0.28, 95%CI 0.10-0.82, p=0.02). Moreover, this meta-analysis 
shows that PMR is safe with no increase in surgical site infections. Only an increased risk 
of seroma formation for onlay PMR (RR 2.23, 95%CI 1.10-4.52, p=0.03) was found. 
Limitations
A substantial statistical heterogeneity among studies regarding the primary outcome 
is seen (I2=71%). This probably reflects the variability on surgical technique and 
methodological approach across studies, even though they are a priori the same type 
of study (i.e. RCTs). 
(a)
(b)
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Although the technique of PMR in the treatment arm of the RCTs is most often well 
described, there is much less information on the control group with PS. Often the 
protocol describes the use of a suture to wound length ratio (SL/WL) of more than 4/1, 
but the data on the SL/WL ratio is only recorded and reported in a few studies (11), so 
the adherence to the optimal PS technique is unclear in most studies. Moreover, the 
short stitch technique, which is currently known as the best-evidenced technique with 
the lowest incidence of IH (3), was not used in any of the RCTs in this meta-analysis. 
Therefore, one could argue that the treatment effect of PMR is increased because of a 
suboptimal suturing technique in the control groups. 
Of the 12 RCTs included in this meta-analysis, 50% were considered to have a high risk of 
bias. However, due to the use of sensitivity analysis, the treatment effect is maintained 
and shows even a larger treatment effect when only studies with a low risk of bias are 
analyzed (RR 0.23, 95%CI 0.10-0.52, P= 0.0004). 
Only RCTs with a minimum follow-up of 12 months were included. All studies except 
one (29) had a follow-up of at least 24 months. Nevertheless, this is still too short to 
evaluate the long-term efficacy or potential late adverse effects of PMR. 
In most studies physical examination was used to detect the number of patients 
during follow-up. Some studies added selective or systematic medical imaging for the 
evaluation of IH, either ultrasound or CT scan. Added imaging is expected to increase the 
number of patients with IH by detection of subclinical IHs and this might overestimate 
the importance of PMR to provide a clinical benefit for the patients.
Interpretation
It should be taken into account that the results of this meta-analysis are applicable to a 
certain patient group, who are operated under certain circumstances, using a specific 
surgical technique and a specific type of mesh. Most of the 12 included studies used a 
polypropylene mesh in either an onlay or a retromuscular mesh position. Two studies 
used a biological mesh (10, 30) and one study an absorbable synthetic mesh (5). Two of 
these studies did not show PMR to be effective and all 3 were considered at high risk of 
bias. Considering the mesh position, all studies with a low risk of bias had either an onlay 
or a retromuscular mesh position for PMR. Moreover, all included trials were done in an 
elective surgery setting. Thus, there is no evidence on how PMR behaves in emergency 
situations. Therefore, the results of this meta-analysis on PMR can only be considered 
valid for synthetic non-absorbable mesh in either an onlay or a retromuscular mesh 
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position. No evidence is available to support the use PMR with a biological or a synthetic 
absorbable mesh. Also, no evidence is available to support the use of an intra-peritoneal 
mesh position in PMR.   
Another remarkable point was the slightly asymmetric funnel plot for IH, indicating 
possible publication bias towards studies that favour PMR. An overestimation of the 
underlying beneficial effect of the intervention due to selective publication of studies 
might be the reason for this finding. 
As stated earlier, most studies included only patients who are considered as ‘high-risk 
to develop an IH’. It is difficult to identify the individual risk factors that could be applied 
to select patients to benefit from PMR. The guidelines on the closure of abdominal wall 
incisions of the European Hernia Society stated that the evidence is weak for the use 
of PMR in patients at high risk for IH development (19). Such a guideline can only be 
implemented if the guidelines development group also describes the exact criteria that 
would select those patients considered at high risk. From this perspective, the study 
performed by Fischer et al. is quite interesting (18). They stratified patients in four IH risk 
groups (Low, Moderate, High, Extreme), based on characteristics of the patient and the 
surgical procedure. Selection of patients to perform PMR should be based on evidence. 
From this meta-analysis it seems clear that patients undergoing AAA repair and patients 
undergoing bariatric surgery through a midline incision will benefit from PMR. However, 
midline incisions have become rare, since most AAA patients are now treated with 
endovascular procedures and bariatric surgery is performed by laparoscopic access. 
Selection, based on patients’ characteristics, needs cut off values. It can be questioned 
what the cut-off BMI value needs to be in order to advice PMR. The PRIMA trial used BMI 
≥ 27kg/m2 as an inclusion criterion for PMR (23). Further research is needed to identify 
the maximum BMI cut-off point, which can increase the risk to develop IH. Data from 
large clinically oriented prospective registries (34) might be helpful to explore those risk 
factors that would lead to an increased IH risk. Those data are currently not available. 
PMR can be considered safe in elective laparotomies. The only adverse event detected 
in this meta-analysis was an increased rate of seroma formation after onlay PMR. This 
finding is related to the subcutaneous dissection needed for onlay PMR. Even though 
the occurrence of seromas was higher in the onlay PMR group, there were not an 
increased number of surgical site infections. There was not enough data available to 
analyse the number of other adverse events, such as hematoma’s or burst abdomen.
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One of the main strengths of this meta-analysis is the fact that RCTs with low risk of bias 
were analysed separately, to overcome bias affecting meta-analysis (35). Furthermore, 
data of the most recently published RCTs were included (23). TSA shows firm evidence 
in favour of PMR in midline laparotomy for high-risk patients (i.e. morbid obese patients 
and AAA patients). This statement is not only applicable in the overall group, but in 
the low risk of bias studies as well. With TSA, it is suggested that no further trials would 
be needed to address the effects of PMR. However, conducting RCTs in other patient 
populations with another level of risk would be helpful to evaluate the effectiveness of 
a PMR. 
Laparotomies are performed by a variety of surgical specialties, such as vascular 
surgeons, colorectal surgeons, gynaecologists and urologists. Many of those surgeons 
have little experience in treating abdominal wall hernias with meshes, especially 
in retromuscular mesh placement. This meta-analysis shows that an onlay PMR is 
also effective, is definitely easier to perform and probably more acceptable by these 
surgeons. 
CONCLUSION
This meta-analysis provides level-1 evidence in favour of closure of midline laparotomies 
with prophylactic mesh reinforcement in high-risk patients. Thus, in high-risk groups 
(AAA patients and patients with morbid obesity), it should become standard treatment. 
Onlay PMR leads to a significantly lower incidence of IH with a larger size of the 
effect than retromuscular PMR. Seromas occurred more frequently in the onlay mesh 
reinforcement group, however, there were not more surgical site infections seen in this 
group. 
jairam-layout.indd   126 28/05/2018   21:47
127
Prevention of incisional hernia: a meta-analysis
5
REFERENCES
1. Hoer J, Lawong G, Klinge U, Schumpelick V. [Factors influencing the development of 
incisional hernia. A retrospective study of 2,983 laparotomy patients over a period of 10 
years] Einflussfaktoren der Narbenhernienentstehung. Retrospektive Untersuchung an 2.983 
laparotomierten Patienten uber einen Zeitraum von 10 Jahren. Chirurg. 2002;73(5):474-80.
2. Mudge M, Hughes LE. Incisional hernia: a 10 year prospective study of incidence and 
attitudes. Br J Surg. 1985;72(1):70-1.
3. Millbourn D, Cengiz Y, Israelsson LA. Effect of stitch length on wound complications after 
closure of midline incisions: a randomized controlled trial. Arch Surg. 2009;144(11):1056-9.
4. Bosanquet DC, Ansell J, Abdelrahman T, Cornish J, Harries R, Stimpson A, et al. Systematic 
Review and Meta-Regression of Factors Affecting Midline Incisional Hernia Rates: Analysis of 
14,618 Patients. PloS one. 2015;10(9):e0138745.
5. Pans A, Elen P, Dewe W, Desaive C. Long-term results of polyglactin mesh for the prevention 
of incisional hernias in obese patients. World J Surg. 1998;22(5):479-83.
6. Gutierrez de la Pena C, Medina Achirica C, Dominguez-Adame E, Medina Diez J. Primary 
closure of laparotomies with high risk of incisional hernia using prosthetic material: analysis 
of usefulness. Hernia. 2003;7(3):134-6.
7. Strzelczyk JM, Szymanski D, Nowicki ME, Wilczynski W, Gaszynski T, Czupryniak L. 
Randomized clinical trial of postoperative hernia prophylaxis in open bariatric surgery. Br J 
Surg. 2006;93(11):1347-50.
8. Bevis PM, Windhaber RA, Lear PA, Poskitt KR, Earnshaw JJ, Mitchell DC. Randomized clinical 
trial of mesh versus sutured wound closure after open abdominal aortic aneurysm surgery. 
Br J Surg. 2010;97(10):1497-502.
9. Abo-Ryia MH, El-Khadrawy OH, Abd-Allah HS. Prophylactic preperitoneal mesh placement 
in open bariatric surgery: A guard against incisional hernia development. Obes Surg. 
2013;23(10):1571-4.
10. Bali C, Papakostas J, Georgiou G, Kouvelos G, Avgos S, Arnaoutoglou E, et al. A comparative 
study of sutured versus bovine pericardium mesh abdominal closure after open abdominal 
aortic aneurysm repair. Hernia. 2015;19(2):267-71.
11. Muysoms FE, Detry O, Vierendeels T, Huyghe M, Miserez M, Ruppert M, et al. Prevention of 
Incisional Hernias by Prophylactic Mesh-augmented Reinforcement of Midline Laparotomies 
for Abdominal Aortic Aneurysm Treatment: A Randomized Controlled Trial. Ann Surg. 
2016;263(4):638-45.
12. Deerenberg EB, Harlaar JJ, Steyerberg EW, Lont HE, van Doorn HC, Heisterkamp J, et al. Small 
bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, 
multicentre, randomised controlled trial. Lancet. 2015;386(10000):1254-60.
13. van Ramshorst GH, Eker HH, Hop WC, Jeekel J, Lange JF. Impact of incisional hernia on 
health-related quality of life and body image: a prospective cohort study. Am J Surg. 
2012;204(2):144-50.
jairam-layout.indd   127 28/05/2018   21:47
128
Chapter 5
14. van Ramshorst GH, Eker HH, van der Voet JA, Jeekel J, Lange JF. Long-term outcome study 
in patients with abdominal wound dehiscence: a comparative study on quality of life, body 
image, and incisional hernia. J Gastrointest Surg. 2013;17(8):1477-84.
15. Gillion JF, Sanders D, Miserez M, Muysoms F. The economic burden of incisional ventral 
hernia repair: a multicentric cost analysis. Hernia. 2016;20(6):819-30.
16. Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J. Long-term follow-up 
of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg. 
2004;240(4):578-83; discussion 83-5.
17. Helgstrand F, Rosenberg J, Kehlet H, Strandfelt P, Bisgaard T. Reoperation versus clinical 
recurrence rate after ventral hernia repair. Ann Surg. 2012;256(6):955-8.
18. Fischer JP, Basta MN, Mirzabeigi MN, Bauder AR, Fox JP, Drebin JA, et al. A Risk Model and Cost 
Analysis of Incisional Hernia After Elective, Abdominal Surgery Based Upon 12,373 Cases: 
The Case for Targeted Prophylactic Intervention. Ann Surg. 2016;263(5):1010-7.
19. Muysoms FE, Antoniou SA, Bury K, Campanelli G, Conze J, Cuccurullo D, et al. European 
Hernia Society guidelines on the closure of abdominal wall incisions. Hernia. 2015.
20. Borab ZM, Shakir S, Lanni MA, Tecce MG, MacDonald J, Hope WW, et al. Does prophylactic 
mesh placement in elective, midline laparotomy reduce the incidence of incisional hernia? 
A systematic review and meta-analysis. Surgery. 2017;161(4):1149-63.
21. Wang XC, Zhang D, Yang ZX, Gan JX, Yin LN. Mesh reinforcement for the prevention of 
incisional hernia formation: a systematic review and meta-analysis of randomized controlled 
trials. J Surg Res. 2017;209:17-29.
22.  Payne R, Aldwinckle J, Ward S. Meta-analysis of randomised trials comparing the use of 
prophylactic mesh to standard midline closure in the reduction of incisional herniae. Hernia. 
2017;21(6):843-853. 
23. Jairam AP, Timmermans L, Eker HH, Pierik R, van Klaveren D, Steyerberg EW, et al. Prevention 
of incisional hernia with prophylactic onlay and sublay mesh reinforcement versus primary 
suture only in midline laparotomies (PRIMA): 2-year follow-up of a multicentre, double-
blind, randomised controlled trial. Lancet. 2017.
24. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic 
reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
25.  Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing 
risk of bias in randomised trials. BMJ. 2011;343:d5928.
26.  Thorlund K, Imberger G, Walsh M et al (2011) The number of patients and events required to 
limit the risk of overestimation of intervention effects in meta-analysis–a simulation study. 
PLoS One 6:e2549.
27.  Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C (2011) User manual for trial 
sequential analysis (TSA). Copenhagen, Denmark: Copenhagen Trial Unit, Centre for Clinical 
Intervention Research, pp 1–115. http://www.ctu.dk/tsa
28. El-Khadrawy OH, Moussa G, Mansour O, Hashish MS. Prophylactic prosthetic reinforcement 
of midline abdominal incisions in high-risk patients. Hernia. 2009;13(3):267-74.
jairam-layout.indd   128 28/05/2018   21:47
129
Prevention of incisional hernia: a meta-analysis
5
29. Caro-Tarrago A, Olona Casas C, Jimenez Salido A, Duque Guilera E, Moreno Fernandez F, 
Vicente Guillen V. Prevention of incisional hernia in midline laparotomy with an onlay mesh: 
a randomized clinical trial. World J Surg. 2014;38(9):2223-30.
30. Sarr MG, Hutcher NE, Snyder S, Hodde J, Carmody B. A prospective, randomized, multicenter 
trial of Surgisis Gold, a biologic prosthetic, as a sublay reinforcement of the fascial closure 
after open bariatric surgery. Surgery. 2014;156(4):902-8.
31. Garcia-Ureña MA, Lopez-Monclus J, Hernando LA, Montes DM, Valle de Lersundi AR, Pavon 
CC, et al. Randomized controlled trial of the use of a large-pore polypropylene mesh to 
prevent incisional hernia in colorectal surgery. Ann Surg. 2015;261(5):876-81.
32. Timmermans L, Eker HH, Steyerberg EW, Jairam A, de Jong D, Pierik EG, et al. Short-term 
results of a randomized controlled trial comparing primary suture with primary glued mesh 
augmentation to prevent incisional hernia. Ann Surg. 2015;261(2):276-81.
33.  Handbook for grading the quality of evidence and the strength of recommendations 
using the GRADE approach. In: Schünemann H, Brozek J, Guyatt G, Oxman A(eds) (updated 
October 2013).  http://gdt.guidelinedevelopment.org/app/handbook/handbook.html#h.
pq7g5y80zfhj Accessed July 2017
34.  Sedrakyan A, Campbell B, Graves S, Cronenwett JL. Surgical registries for advancing quality 
and device surveillance. Lancet. 2016; 1;388(10052):1358-1360.
35.  Roberts I, Ker K, Edwards P, Beecher D, Manno D, Sydenham E. The knowledge system 
underpinning healthcare is not fit for purpose and must change. BMJ. 2015;350:h2463.
jairam-layout.indd   129 28/05/2018   21:47
A. Jairam
F.E. Muysoms
M. López-Cano
M. Śmietański
G. Woeste
I. Kyle-Leinhase
S.A. Antoniou
F. Köckerling
BioMesh Study Group
Frontiers of Surgery. 2016 Sep 26;3:53
jairam-layout.indd   130 28/05/2018   21:47
C H A P T E R  6
Prevention of Incisional Hernias with Biological mesh:
a systematic review of literature
jairam-layout.indd   131 28/05/2018   21:47
132
Chapter 6
ABSTRACT
Background: Prophylactic mesh augmented reinforcement (MAR) during closure 
of abdominal wall incisions has been proposed in patients with increased risk for 
development of incisional hernias (IHs). As part of the BioMesh consensus project a 
systematic literature review has been performed to detect those studies where MAR 
was performed with a non-permanent absorbable mesh (biological or biosynthetic).  
Methods: A computerized search was performed within 12 databases (Embase, 
Medline, Web-of-Science, Scopus, Cochrane, Cinahl, Pubmed publisher, Lilacs, Scielo, 
ScienceDirect, ProQuest, Google scholar) with appropriate search terms. Qualitative 
evaluation was performed using the MINORS score for cohort studies and the JADAD 
score for randomized clinical trials (RCTs).  
Results: For midline laparotomy incisions and stoma reversal wounds, two RCTs, 
two case control studies and two case series were identified. The studies were very 
heterogeneous in terms of mesh configuration (cross linked versus non-cross linked), 
mesh position (intraperitoneal versus retro-muscular versus onlay), surgical indication 
(gastric bypass versus aortic aneurysm), outcome results (effective versus non effective). 
After qualitative assessment, we have to conclude that the level of evidence on the 
efficacy and safety of biological meshes for prevention of IHs is very low. No comparative 
studies were found comparing biological mesh with synthetic non-absorbable meshes 
for the prevention of IHs.    
Conclusion: There is no evidence supporting the use of non-permanent absorbable 
mesh (biological or biosynthetic) for prevention of IHs when closing a laparotomy 
in high-risk patients or in stoma reversal wounds. There is no evidence that a non-
permanent absorbable mesh should be preferred to synthetic non-absorbable mesh, 
both in clean or clean-contaminated surgery. 
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INTRODUCTION
Prophylactic mesh-augmented reinforcement during closure of abdominal wall 
incisions has been proposed in patients with increased risk for development of incisional 
hernias (IH). Several randomized clinical trials (RCTs) have been published on the use 
of prophylactic mesh in patients undergoing aortic aneurysm surgery (1-4), obesity 
surgery (3,5-7), stoma creation (8-14), in colorectal cancer patients (15-16) or other high-
risk patients (17-18). The recently published guidelines of the European Hernia Society 
have provided the following weak recommendation: “Prophylactic mesh augmentation 
for an elective midline laparotomy in high-risk patients in order to reduce the risk of 
incisional hernias is suggested.”  Due to the lack of sufficient data, no recommendations 
on the type of mesh, the optimal mesh position or the optimal mesh fixation technique 
could be made (19). Although prophylactic mesh-augmented reinforcement has 
been performed safely in clean-contaminated setting, one concern is the potential 
short- or long-term harm by implantation of a permanent mesh (20). Application of a 
non-permanent absorbable for prophylactic mesh-augmented reinforcement might 
therefore hold some benefit if these meshes will be as effective as permanent meshes. 
A systematic literature review has been performed to detect those studies where 
prophylactic mesh-augmented reinforcement was performed with a non-permanent 
absorbable biological or biosynthetic mesh and provide guidance for future research 
on the use of biological or biosynthetic meshes. 
METHODS
Protocol 
The systematic search was part of the BioMesh consensus project. This project, initiated 
by Ferdinand Köckerling, gathered surgical expertise in a working group to provide a 
summary on the use of non-permanent absorbable biological or biosynthetic meshes 
in different indications. During a consensus meeting in Berlin on January 27, 2016, the 
working group decided in consensus on the statements and conclusions derived from 
the level of evidence for each indication. This manuscript reports on the review of the 
use of non-permanent absorbable biological or biosynthetic meshes for the prevention 
of IHs. 
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Eligibility criteria
Inclusion criteria: because of the paucity of available studies on prophylactic mesh-
augmented reinforcement with biological or biosynthetic mesh for the prevention 
of IHs, no limitation to the study design, length of follow-up, or number of included 
patients was used. 
Exclusion criteria: prevention of parastomal hernias were excluded because this was 
part of a separate search within the BioMesh study group (21). 
Information sources
A computerized search was performed within 12 databases (Embase, Medline, Web-
of-Science, Scopus, Cochrane, Cinahl, Pubmed publisher, Lilacs, Scielo, ScienceDirect, 
ProQuest, Google scholar) on June 25, 2015. 
Search
The biomedical librarian of the Erasmus University Medical Centre, Rotterdam, The 
Netherlands, performed the search and the search strategy is provided in Section 
‘Addendum 1’ in Appendix. 
Study selection
From the search, only the studies reporting on the use of a non-permanent absorbable 
biological or biosynthetic mesh were retained. Studies written in English, Dutch, French 
and Spanish were considered. 
Data collection process
Two authors (Filip Etienne Muysoms and An Jairam) independently screened all records 
retrieved upon application of the search strategy by title and abstract. The full text of all 
retained records was screened for eligibility. The references of all review articles found 
were cross-checked for additional eligible records. 
Data items
The following data were extracted by two authors independently and cross-checked: 
type of study, number of patients included patient characteristics, indication for surgery, 
type of biological mesh, position of the mesh, method of mesh fixation, length of 
follow-up and outcome measures (hernias, seroma, wound infections, burst abdomen). 
Primary outcome was IH incidence, and secondary outcomes were postoperative 
seroma, wound infection, and burst abdomen. 
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Quality assessment of individual studies 
Qualitative evaluation was performed using the MINORS score for non-randomized 
studies and the JADAD score for RCTs. Additionally, the quality of evidence across the 
RCTs was done using the GRADE Pro software.  
Statistical Analysis
A meta-analysis of the outcome from the RCTs detected was performed for relevant 
outcomes: IH, seroma, wound infections and burst abdomen. Meta-analysis was 
performed using the Review Manager 5.3 software (Copenhagen: The Nordic Cochrane 
Centre, The Cochrane Collaboration, 2013). Our outcomes were expressed as risk ratios 
(RRs) with 95% confidence intervals (CIs) to estimate the pooled effect size and p-value. 
All tests were two-sided. 
RESULTS
Study selection
The PRISMA flow diagram of our search is illustrated in Figure 1. Six studies were retained 
after the screening and sift for eligibility. Four studies included patients with midline 
laparotomy (2,7,22,23) and two studies investigated the prevention of incisional hernias 
after stoma reversal (24,25).
Study characteristics
Midline laparotomy
Our literature review revealed four studies where a biological mesh was used to prevent 
IHs in high-risk patients. Details of the study characteristics and quality assessment 
(MINORS score, Jadad score) are shown in the summary of evidence table (Table 1). A 
small cohort study on eight patients that underwent a midline laparotomy for cyto-
reductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) described 
short-term outcome, using an intra-peritoneal biological mesh (22). In a prospective 
non-randomized case-control study, obese patients operated for a gastric bypass 
through a midline laparotomy were either treated with an intra-peritoneal biological 
mesh (n=59) or primary suture closure (n=75). A significant reduction in the number 
of IHs by prophylactic mesh was reported (2.3% (90%CI: 2.31-6.86) versus 17.7% 
(90%CI: 7.92-27.52), p=0.014) (25). In a RCT in obese patients undergoing a gastric 
bypass operation through a midline laparotomy, patients were randomized between 
an intraperitoneal biological mesh (n=185) and primary suture closure (n=195).
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Figure 1. PRISMA flow diagram of a systematic review on the use of biological mesh for 
prevention of incisional hernias. 
References: a Boutros 2010, b Llaguna 2011, c Sarr 2014, d Bhangu 2014, e Bali 2015, f Maggiore 2015.
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This adequately powered RCT, did not show any benefit for prophylactic mesh 
concerning the risk for IH at 24 months (17.3% versus 19.5%, p=0.60), but did show a 
significant higher number of wound infections and wound seroma in the mesh group 
(7). In a RCT of aortic aneurysm patients, midline laparotomy closure with an onlay 
biologic mesh (n=20) was compared to primary suture closure (n=20). The study was 
not powered with a sample size calculation, but the follow up was adequate in length 
(36 months) and methodology (systematic CT scan evaluation). A highly significant 
protective effect of the mesh was shown, with no hernias in the mesh group and 32% in 
the non-mesh group (cumulative freedom of incisional hernia at 36 months was 100% 
versus 74.4%, p<0.008) (2). 
Stoma reversal wound
Our literature review revealed two studies in which a biological mesh was used to 
prevent incisional hernias after reversal of a temporary ileostomy. Details of the studies 
are shown in the summary of evidence table (Table 2). In a pilot study with a limited 
patient population (n=7) the feasibility of an intraperitoneal prophylactic mesh was 
investigated in terms of safety in the short term (27). The second report was a matched 
case-control study of 30 patients that received a retro-muscular prophylactic biological 
mesh, compared to 64 matched patients with suture closure of the stoma wound. At 
1-year follow-up with CT scan, the number of patients with IH was significantly lower for 
the mesh group (p = 0.043) (25).
Meta-analysis
The pooled analysis for the outcome IH showed no statistical differences between 
groups (RR 0.38, 95%CI 0.04-3.83; p=0.41). The forest plots of the meta-analysis of the 
two RCTs on prevention of midline laparotomy IHs and the secondary outcomes are 
shown in Figure 2.
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Figure 2. Forest plots and Risk of bias assessment of randomized studies on the prevention of 
incisional hernias by biological mesh reinforcement. 
a) Incisional hernia
b) Seroma
c) Wound infection
d) Burst abdomen
DISCUSSION
Midline laparotomy
Overall, the Level of Evidence on the efficacy of biological mesh to prevent IHs is very low. 
Moreover, the study with the highest level of evidence and lowest risk of bias, did not 
show any advantage in reducing IHs by prophylactic intraperitoneal biological mesh in 
patients undergoing a midline laparotomy for performing gastric bypass surgery (7). On 
the contrary, it did show a higher number of wound complications after the use of the 
prophylactic mesh. Another study regarding gastric bypass patients did show a benefit, 
but this study was non-randomized and had a high risk of bias (25). 
For aortic aneurysm patients, only one RCT is available, which showed a high efficacy 
with 3 years follow-up. However, this study was poorly powered, non-blinded, and 
scored low in the Jadad scale (2). Moreover, no information on sources of funding and 
protocol registration was provided, and therefore, the risk of bias cannot be assessed. 
The currently available evidence is not strong enough to make any statements 
regarding the optimal mesh position (intra-peritoneal, retro-muscular or onlay) in case 
a prophylactic biological mesh is used. Also the different meshes used in the studies 
(non cross-linked human origin; non cross-linked porcine small intestinal submucosa; 
cross-linked bovine pericardium) might have an important impact on the outcome.  
On the contrary, the Level of Evidence on the efficacy of prophylactic synthetic non-
absorbable mesh (all polypropylene) in high-risk patients currently is high, with 8 
published RCTs encompassing 727 patients with a follow-up of at least 12 months (1,4-
6,15-18). Moreover the safety of prophylactic retro-muscular or onlay meshes in clean or 
clean contaminated surgery, is shown in 9 published RCTs encompassing 1207 patients 
(1,3-6,15-18).   
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No comparative studies were found comparing biological mesh with synthetic non-
absorbable meshes for the prevention of incisional hernias. There is a study on-going 
at the Vall d'Hebron Hospital, Universidad Autónoma de Barcelona on prevention of 
incisional hernias from midline laparotomies using an absorbable synthetic mesh 
(Bio-A, WL Gore & Ass, US), PREBIOUS trial (ClinicalTrials.gov NCT02208557). 
4.2. Stoma reversal wound
Overall the Level of Evidence on the efficacy of biological mesh to prevent incisional 
hernias of stoma reversal wounds is very low. Currently, the only study providing evidence 
is a matched case-control study, showing a lower incisional hernia rate at 1-year. This 
study is a pilot study for an RCT that is planned in France, the MEMBO trial (ClinicalTrials.
gov NCT02576184) (27). The small pilot study by Banghu et al. is part of a large project, 
the ROCSS study, which is a properly powered multi-centre RCT from the University of 
Birmingham (ClinicalTrials.gov NCT02238964 & controlled-trials.com ISRCTN46330337) 
(26). This study compares the technique described in the pilot study with sutured 
closure of the stoma wound and has now included 790 patients and the follow-up is 
ongoing. Furthermore, a study from the Vall d'Hebron Hospital (Universidad Autónoma 
de Barcelona), ILEOCLOSE study, (ClinicalTrials.gov NCT02226887) will investigate 
in a RCT the application of prophylactic mesh reinforcement of closure of temporary 
diverting ileostomy with an absorbable synthetic mesh (Bio A) in 120 patients.
4.3. CONCLUSIONS
So far, there is no solid evidence on the effectiveness of prophylactic non-permanent 
absorbable biological or biosynthetic mesh for closure of midline laparotomies or 
reinforcement of a stoma reversal site . There is no evidence that in this setting a non-
permanent absorbable biological or biosynthetic mesh should be preferred to synthetic 
non-absorbable mesh, both in clean or clean-contaminated surgery.
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ADDENDUM
Search strategy used for a systematic literature review on prevention of incisional 
hernias with mesh. A computerized search was performed within 12 databases (Embase, 
Medline, Web-of-Science, Scopus, Cochrane, Cinahl, Pubmed publisher, Lilacs, Scielo, 
ScienceDirect, ProQuest, Google scholar) on June 25th 2015. 
Embase.com  839
('surgical mesh'/exp OR (mesh* OR 4DDOME OR AIGISRx OR AlloDerm OR AlloMax OR 'Bard Composix EX' OR 'BIO-A Tissue 
Reinforcement prosthesis' OR CollaMend OR DermaMatrix OR DualMesh OR 'Evolution P3EM' OR FasLata OR FlexHD OR 
FortaGen OR 'IntePro Lite' OR InteXen OR NEOVEIL OR 'Parietex composite' OR Pelvicol OR Pelvisoft OR Pelvitex OR PerFix OR 
'Peri-Strips Dry' OR PeriGuard OR Permacol OR Physiomesh OR SeamGuard OR Strattice OR Surgisis OR 'TiLoop Bra' OR Timesh 
OR Tutomesh OR Tutopatch OR Ultrapro OR Ventralex OR Veritas OR Vivosorb OR Vypro OR X-Repair OR XenMatrix):ab,ti) 
AND (prevention/exp OR prevention:lnk OR (prevent* OR protect* OR prophyla*):ab,ti) AND ('incisional hernia'/exp OR 
'abdominal wall hernia'/de OR 'abdominal wall defect'/de OR 'abdominal surgery'/de OR 'abdominal wall closure'/de OR 
laparotomy/exp  OR 'abdominal wall'/de OR (((incision* OR cicatri* OR scar* OR ventral*) NEAR/3 (herni*)) OR ((abdominal* 
OR transabdominal*) NEAR/3 (surger* OR clos* OR defect* OR wall*)) OR laparotom* OR (midline NEAR/3 incision*)):ab,ti) NOT 
([animals]/lim NOT [humans]/lim)
Medline (ovid)  490
("surgical mesh"/ OR (mesh* OR 4DDOME OR AIGISRx OR AlloDerm OR AlloMax OR "Bard Composix EX" OR "BIO-A Tissue 
Reinforcement prosthesis" OR CollaMend OR DermaMatrix OR DualMesh OR "Evolution P3EM" OR FasLata OR FlexHD OR 
FortaGen OR "IntePro Lite" OR InteXen OR NEOVEIL OR "Parietex composite" OR Pelvicol OR Pelvisoft OR Pelvitex OR PerFix 
OR "Peri-Strips Dry" OR PeriGuard OR Permacol OR Physiomesh OR SeamGuard OR Strattice OR Surgisis OR "TiLoop Bra" OR 
Timesh OR Tutomesh OR Tutopatch OR Ultrapro OR Ventralex OR Veritas OR Vivosorb OR Vypro OR X-Repair OR XenMatrix).
ab,ti.) AND ("Primary Prevention"/ OR "prevention and control".xs. OR (prevent* OR protect* OR prophyla*).ab,ti.) AND 
("Hernia, Ventral"/ OR "Hernia, Abdominal"/ OR abdomen/su OR laparotomy/  OR "abdominal wall"/ OR (((incision* OR cicatri* 
OR scar* OR ventral*) ADJ3 (herni*)) OR ((abdominal* OR transabdominal*) ADJ3 (surger* OR clos* OR defect* OR wall*)) OR 
laparotom* OR (midline ADJ3 incision*)).ab,ti.) NOT (exp animals/ NOT humans/)
Cochrane   30
((mesh* OR 4DDOME OR AIGISRx OR AlloDerm OR AlloMax OR 'Bard Composix EX' OR 'BIO-A Tissue Reinforcement prosthesis' 
OR CollaMend OR DermaMatrix OR DualMesh OR 'Evolution P3EM' OR FasLata OR FlexHD OR FortaGen OR 'IntePro Lite' OR 
InteXen OR NEOVEIL OR 'Parietex composite' OR Pelvicol OR Pelvisoft OR Pelvitex OR PerFix OR 'Peri-Strips Dry' OR PeriGuard 
OR Permacol OR Physiomesh OR SeamGuard OR Strattice OR Surgisis OR 'TiLoop Bra' OR Timesh OR Tutomesh OR Tutopatch 
OR Ultrapro OR Ventralex OR Veritas OR Vivosorb OR Vypro OR X-Repair OR XenMatrix):ab,ti) AND ((prevent* OR protect* OR 
prophyla*):ab,ti) AND ((((incision* OR cicatri* OR scar* OR ventral*) NEAR/3 (herni*)) OR ((abdominal* OR transabdominal*) 
NEAR/3 (surger* OR clos* OR defect* OR wall*)) OR laparotom* OR (midline NEAR/3 incision*)):ab,ti) 
Web-of-science    474
TS=(((mesh* OR 4DDOME OR AIGISRx OR AlloDerm OR AlloMax OR "Bard Composix EX" OR "BIO-A Tissue Reinforcement 
prosthesis" OR CollaMend OR DermaMatrix OR DualMesh OR "Evolution P3EM" OR FasLata OR FlexHD OR FortaGen OR "IntePro 
Lite" OR InteXen OR NEOVEIL OR "Parietex composite" OR Pelvicol OR Pelvisoft OR Pelvitex OR PerFix OR "Peri-Strips Dry" OR 
PeriGuard OR Permacol OR Physiomesh OR SeamGuard OR Strattice OR Surgisis OR "TiLoop Bra" OR Timesh OR Tutomesh OR 
Tutopatch OR Ultrapro OR Ventralex OR Veritas OR Vivosorb OR Vypro OR X-Repair OR XenMatrix)) AND ((prevent* OR protect* 
OR prophyla*)) AND ((((incision* OR cicatri* OR scar* OR ventral*) NEAR/3 (herni*)) OR ((abdominal* OR transabdominal*) 
NEAR/3 (surger* OR clos* OR defect* OR wall*)) OR laparotom* OR (midline NEAR/3 incision*))) NOT ((animal* OR rat OR rats 
OR mouse OR mice OR murine OR rabbit* OR rodent* OR pig OR sus OR swine* OR porcine OR monkey* OR dog OR sheep OR 
ovine) NOT (human* OR patient*)))
Scopus      697
TITLE-ABS-KEY(((mesh* OR 4DDOME OR AIGISRx OR AlloDerm OR AlloMax OR "Bard Composix EX" OR "BIO-A Tissue 
Reinforcement prosthesis" OR CollaMend OR DermaMatrix OR DualMesh OR "Evolution P3EM" OR FasLata OR FlexHD OR 
FortaGen OR "IntePro Lite" OR InteXen OR NEOVEIL OR "Parietex composite" OR Pelvicol OR Pelvisoft OR Pelvitex OR PerFix 
OR "Peri-Strips Dry" OR PeriGuard OR Permacol OR Physiomesh OR SeamGuard OR Strattice OR Surgisis OR "TiLoop Bra" OR 
Timesh OR Tutomesh OR Tutopatch OR Ultrapro OR Ventralex OR Veritas OR Vivosorb OR Vypro OR X-Repair OR XenMatrix)) 
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AND ((prevent* OR protect* OR prophyla*)) AND ((((incision* OR cicatri* OR scar* OR ventral*) W/3 (herni*)) OR ((abdominal* 
OR transabdominal*) W/3 (surger* OR clos* OR defect* OR wall*)) OR laparotom* OR (midline W/3 incision*))) AND NOT 
((animal* OR rat OR rats OR mouse OR mice OR murine OR rabbit* OR rodent* OR pig OR sus OR swine* OR porcine OR 
monkey* OR dog OR sheep OR ovine) AND NOT (human* OR patient*)))
cinahl (ebsco)  23
(MH "surgical mesh+" OR (mesh* OR 4DDOME OR AIGISRx OR AlloDerm OR AlloMax OR "Bard Composix EX" OR "BIO-A Tissue 
Reinforcement prosthesis" OR CollaMend OR DermaMatrix OR DualMesh OR "Evolution P3EM" OR FasLata OR FlexHD OR 
FortaGen OR "IntePro Lite" OR InteXen OR NEOVEIL OR "Parietex composite" OR Pelvicol OR Pelvisoft OR Pelvitex OR PerFix 
OR "Peri-Strips Dry" OR PeriGuard OR Permacol OR Physiomesh OR SeamGuard OR Strattice OR Surgisis OR "TiLoop Bra" OR 
Timesh OR Tutomesh OR Tutopatch OR Ultrapro OR Ventralex OR Veritas OR Vivosorb OR Vypro OR X-Repair OR XenMatrix)) 
AND (MH "Preventive Health Care" OR MW prevention OR (prevent* OR protect* OR prophyla*)) AND (MH "Hernia, Abdominal" 
OR MH abdomen/su OR MH laparotomy  OR (((incision* OR cicatri* OR scar* OR ventral*) N3 (herni*)) OR ((abdominal* OR 
transabdominal*) N3 (surger* OR clos* OR defect* OR wall*)) OR laparotom* OR (midline N3 incision*))) NOT (MH animals+ 
NOT humans+)
Pubmed publisher  14
("surgical mesh"[mh] OR (mesh*[tiab] OR 4DDOME OR AIGISRx OR AlloDerm OR AlloMax OR "Bard Composix EX" OR "BIO-A 
Tissue Reinforcement prosthesis" OR CollaMend OR DermaMatrix OR DualMesh OR "Evolution P3EM" OR FasLata OR FlexHD 
OR FortaGen OR "IntePro Lite" OR InteXen OR NEOVEIL OR "Parietex composite" OR Pelvicol OR Pelvisoft OR Pelvitex OR PerFix 
OR "Peri-Strips Dry" OR PeriGuard OR Permacol OR Physiomesh OR SeamGuard OR Strattice OR Surgisis OR "TiLoop Bra" OR 
Timesh OR Tutomesh OR Tutopatch OR Ultrapro OR Ventralex OR Veritas OR Vivosorb OR Vypro OR X-Repair OR XenMatrix)) 
AND ("Primary Prevention"[mh] OR "prevention and control"[sh] OR (prevent*[tiab] OR protect*[tiab] OR prophyla*[tiab])) 
AND ("Hernia, Ventral"[mh] OR "Hernia, Abdominal"[mh] OR abdomen/su[mh] OR laparotomy[mh]  OR "abdominal 
wall"[mh] OR (((incision*[tiab] OR cicatri*[tiab] OR scar*[tiab] OR ventral*[tiab]) AND (herni*[tiab])) OR ((abdominal*[tiab] OR 
transabdominal*[tiab]) AND (surger*[tiab] OR clos*[tiab] OR defect*[tiab] OR wall*[tiab])) OR laparotom*[tiab] OR (midline 
AND incision*[tiab]))) NOT (animals[mh] NOT humans[mh]) AND publisher[sb]
Google scholar
Mesh|meshes prevention|preventive|protective|protection|prophylactic|prophylaxis "incisional|cicatrical|scar|ventral  hernia
"|"abdominal|transabdominal  surgery|closure|defect|wall"|laparotomy|"midline  incision"  -animal -animals -rats -mice
Lilacs   18
Scielo   8
 (Mesh*) AND (prevent* OR protect* OR prophyla*) AND ("incisional hernia" OR "cicatrical hernia" OR "scar hernia" OR " ventral 
hernia" OR "abdominal hernia" OR "abdominal surgery" OR "abdominal closure" OR "abdominal defect" OR "abdominal wall" 
OR laparotom* OR "midline  incision") 
ScienceDirect   92
(Mesh*) AND (prevent* OR protect* OR prophyla*) AND ("incisional hernia" OR "cicatrical hernia" OR "scar hernia" OR " ventral 
hernia" OR "abdominal hernia" OR "abdominal surgery" OR "abdominal closure" OR "abdominal defect" OR "abdominal wall" 
OR laparotom* OR "midline  incision")  AND TOPIC (incisional hernia)
ProQuest  9
(ti(Mesh*) OR ab(Mesh*)) AND (ti(prevent* OR protect* OR prophyla*) OR ab(prevent* OR protect* OR prophyla*)) AND 
(ti("incisional hernia" OR "cicatrical hernia" OR "scar hernia" OR " ventral  hernia" OR "abdominal hernia" OR "abdominal 
surgery" OR "abdominal closure" OR "abdominal defect" OR "abdominal wall" OR laparotom* OR "midline  incision") OR 
ab("incisional hernia" OR "cicatrical hernia" OR "scar hernia" OR " ventral  hernia" OR "abdominal hernia" OR "abdominal 
surgery" OR "abdominal closure" OR "abdominal defect" OR "abdominal wall" OR laparotom* OR "midline  incision"))
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ABSTRACT
Background: Incisional hernia (IH) is the most frequent complication after abdominal 
surgery. Long-term follow up is crucial. Patient reported outcome measurements 
(PROMS) are able to monitor patients’ disease progression after treatment. Until now, 
there are no PROMS that assess patients after abdominal surgery or that detects 
patients with IH. We aimed to develop a reliable questionnaire to assist in diagnosing 
IH, called the ‘PROMID questionnaire’: Patient Reported Outcome Measurements in the 
Diagnosis of Incisional Hernias. In this pilot study, the reliability of this questionnaire is 
being determined.  
Methods: Patients diagnosed with IH between 2013 and 2014 were included. A 
questionnaire with seven questions was developed. Patients were asked if they thought 
they had IH, if they felt any pain at the site of the scar and if they saw or felt a lump or a 
bulge. Furthermore, smoking history and patients’ weight and height were taken into 
account. Patients were approached three times by telephone, with an interval of one 
week. Test-retest reliability, internal consistency and sensitivity were measured. 
Results: 43 patients were included. Test-retest reliability was 1.0, and internal 
consistency was 0.56. The question regarding patients’ pain was least consistent with 
other questions. The overall sensitivity of the questionnaire was 95%. 
Conclusion: The PROMID questionnaire is a highly reliable questionnaire, but the 
internal consistency is modest. The clinical relevancy of pain in IH patients is essential. 
Therefore, this question will be kept in the current PROMID questionnaire. It needs 
further validation in a prospective cohort study, in order to use it as a diagnostic tool in 
the future to detect IH. 
Keywords: incisional hernia, PROMs, quality of healthcare, questionnaire
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INTRODUCTION
Incisional hernia (IH) is the most frequent complication after abdominal surgery. The 
incidence varies from 5% to 20% in the general population and rises up to 39% in high 
risk patients, such as AAA patients and patients with obesity [1, 2]. Yearly approximately 
4000 IH operations are performed in the Netherlands [1].  IH can cause morbidity 
and mortality, due to obstruction or strangulation of the bowel, with a potential risk 
of perforation [3]. In addition it might induce back pain by truncal instability and 
psychological complaints by disturbed cosmesis. Thus, treatment of IH is an essential 
surgical challenge [4]. According to the literature, approximately 80 – 95% of all 
incisional hernias occur within three years after initial surgery [5]. Long-term follow up 
is therefore crucial in providing high quality care after abdominal surgery. However, 
the method of follow up remains a challenge. Long-term follow up with physical 
examination and imaging is time consuming and costly and demands devotion and 
dedication of patients and doctors [6]. Furthermore, not all patients will show up if they 
do not have any symptoms [6]. Other methods like postal questionnaires and telephone 
interviews, have been proposed as a method of follow up, but there is very little high-
quality evidence on their reliability [6]. 
For several years now, a tool has developed to collect preoperative and postoperative 
data of patients’ own assessment of their health-related quality of life regarding 
healthcare procedures. These so called ‘Patient Reported Outcome Measurements 
(PROMs)’ are currently being used in different countries, such as Sweden and the United 
Kingdom. The intention of PROMs is to screen patients and help in shared decision 
making. PROMs also intend to improve patient care and patient-doctor communication. 
Furthermore, PROMs can monitor disease progression, stimulate quality of health 
care and it can predict overall wellbeing [7-9]. PROMs can help to make subjective 
findings objective and measurable, like the impact of a treatment on quality of life [7-
9]. In the United Kingdom, PROMs are developed for four surgical conditions; one of 
them is inguinal hernia. At this moment, there is no PROM questionnaire to monitor 
patients after abdominal surgery, even though IH is a frequently observed (long term) 
complication.  
We aimed to develop a reliable questionnaire to assist in diagnosing IH in patients who 
have undergone abdominal surgery. This questionnaire could be used during follow 
up, since not all of these patients are monitored at the outpatient clinic by their doctor 
after many years. In this pilot study, the reliability of the PROMID questionnaire is being 
determined.  
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METHODS
The study was approved by the local ethics committee of the three hospitals that 
participated in this pilot study. Patients were selected from a database in the three 
different hospitals: Havenziekenhuis Rotterdam, IJsselland Ziekenhuis and Sint 
Franciscus Gasthuis. Patients were over 18 years and diagnosed with IH between 
2013 and 2014. The diagnosis ‘incisional hernia’ was a clinical diagnosis, conducted by 
physical examination. Radiological examination was only performed in case there was 
any doubt regarding the diagnosis. All patients were either conservatively treated, or 
they were on the waiting list for surgery. Exclusion criteria were emergency surgery, or 
an insufficient understanding of the Dutch language. 
A telephone questionnaire was developed consisting of seven questions (Table 1). 
Questions were developed in association with the department of Medical Psychology, 
who are well experienced in Quality of Life measurements, and formulating questions 
for these questionnaires. The questions were kept as simple as possible, and are thus 
applicable to the ‘average’ patient. The first four questions regarded symptoms that 
relate to the diagnose IH, and could only be answered with a ‘yes’ or a ‘no’.  The last three 
questions are known risk factors that contribute to the development of IH. Patients were 
called three times with an interval of one week between the phone calls, and the same 
questions were asked to measure the test-retest reliability. The questionnaire was taken 
by telephone by blinded researchers, who did not know what answers patients gave 
between the intervals. Most patients were aware of the diagnosis made by the surgeon, 
so they were not blinded. As stated earlier, only seven questions were asked to the 
patients. In this respect the call did not take much time and varied from 5 to 15 minutes.
Table 1. PROMID questionnaire
1. Do you think you have an incisional hernia? 
2. Do you currently feel any pain at the site of the scar? 
3. Do you feel bulging or a lump at the site of the scar? 
4. Do you see bulging or a swelling at the site of the scar? 
5. What is your weight?
6. What is your length? 
7. Do you currently smoke, or have you ever smoked before in your life on a daily base? 
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Statistical analysis
The aim of this pilot study was to determine the reliability of this questionnaire. This was 
done by measuring the test-retest reliability, the sensitivity, and the internal consistency. 
Data were analyzed using SPSS. Statistical analysis was done by using Spearman’s rank 
correlation coefficient. Furthermore, sensitivity was calculated, and internal consistency 
was measured by Cronbach’s alpha. 
RESULTS 
43 Patients with IH were randomly selected and were phoned between July 2014 and 
February 2015. The majority of patients was male (60%) and the mean age was 64 years 
old (SD: ± 14 years). All patients already visited the surgeon at the moment we called 
them, so they were aware of their diagnose 'incisional hernia'. 70% of patients diagnosed 
with IH was conservatively treated, and 30% were on the waiting list for an operation. 
Patients were called three times with an interval of one week between phone calls. 
Since all included patients were diagnosed with IH, sensitivities could be calculated for 
each of the questions and a sum score of the questions. The first question was if patients 
thought they had IH. 39 Patients answered positively on this question positively, which 
gives a sensitivity of 91%. The second question regarded patients’ pain at the site of 
the scar. Only 24 patients felt any pain at the site of the scar at the moment they were 
interviewed, the sensitivity of this question being 56%. The third question referred to 
whether patients felt a bulge or a lump at the site of the scar. 39 Patients did feel a lump 
or a bulge, which gives a sensitivity of 91%. The fourth question concerned if patients 
saw a lump or a bulge at the site of the scar. There were 38 patients who answered this 
question with a ‘yes’. The sensitivity of this question being 88% (Table 2). The overall 
sensitivity of the questionnaire was 95%. The last three questions concerned risk factors 
for developing IH. The mean BMI was 29, and half of the patient group (47%) smoked or 
had ever smoked in the past. 
The Pearson test-retest correlation coefficients were 1.0, which implied that patients 
repeatedly gave exactly the same answers on the questions on all measurement 
occasions. The internal consistency, measured by Cronbach’s alpha, is 0.56. The question 
that was least consistent with the other questions was the second question; ‘Do you 
currently feel any pain at the site of the scar?’ If this question was deleted, Cronbach’s 
alpha rose to 0.74.
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The question if a patient feels a bulging or a lump at the site of the scar was most 
consistent with other questions.  When leaving this question out of the questionnaire, 
the Cronbach’s alpha dropped to 0.32. 
Table 2. Sensitivity per question
Question Sensitivity
1. Do you think you have an incisional hernia? 91%
2. Do you currently feel any pain at the site of the scar? 56%
3. Do you feel bulging or a lump at the site of the scar? 91%
4. Do you see bulging or a lump at the site of the scar? 88%
DISCUSSION 
This pilot study reveals that the PROMID questionnaire is a highly reliable questionnaire. 
However, the internal consistency of the questions, measured by Cronbach’s alpha, is 
only modest, with the question regarding patients’ pain being least consistent. 
IH is the most common complication after abdominal surgery [3]. Approximately 80% of 
IH develop in the first three years after abdominal surgery, but not all patients attend the 
outpatient clinic for that many years after their first operation [5]. However, long-term 
follow up is essential to monitor patients, in order to diagnose IH in time, and to prevent 
the morbidity and mortality rate [6]. In the current literature, long-term follow up by 
means of a questionnaire is not thoroughly investigated. Therefore, this pilot study is 
relevant. The main purpose of this study was to develop a highly reliable questionnaire. 
Three questions were based on complaints that patients with IH may experience: feeling 
pain at the site of the scar, and seeing or feeling a bulge or a lump. Furthermore, risk 
factors were taken into account, with smoking and obesity as commonly observed risk 
factors.  
The questionnaire has a high test-retest reliability, with a correlation coefficient of 
1.00. This is an excellent result implying that the answers to the questions are reliable. 
However, the internal consistency is only modest, with a Cronbach’s alpha of 0.555. 
This means that this question does not fit the other questions, and it also implies that 
it does not measure the same topic as the other questions: the questions are not a 
closely related set of items. Statistical analysis showed that the low Cronbach’s alpha 
was due to the question regarding patients’ pain, which was least consistent and highly 
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heterogenic. When this question would be removed, the Cronbach’s alpha would 
reach a higher number of 0.741, which is an acceptable scale. The reason for the low 
Cronbach’s alpha rate might be the fact that pain is a general complaint, and is not 
very specific for patients with IH. Furthermore, not all patients with IH experience pain; 
literature shows that 60% of IH patients suffer from pain. Our results are comparable 
with the literature: 56% of patients answered positively to the question if they had pain 
at the site of their scar. Even though the pain question had a modest Cronbach’s alpha, 
and was least consistent, the clinical relevancy of this question should be taken into 
account as well. Pain is an essential symptom of incisional hernia, and can indicate a 
symptomatic incisional hernia, which needs immediate care. Therefore, we decided to 
include this question in the questionnaire.
The most consistent question is if patients feel a lump. The sensitivity of this question 
was 91%. This implies that 91% of patients with IH felt a bulging or a lump at the site of 
the scar, and when this question would be left out, the Cronbach’s alpha would drop to 
an insufficient number of 0.32. Several studies show that 67% of patients with IH might 
have symptoms of bulging. The discordance of these percentage rates might be due to 
the fact that the patients in this study already visited their surgeon and were aware of 
the diagnosis of IH and the complaints related to this.  
In the past, several studies have been performed that validate questionnaires to detect 
recurrence in patients who have undergone groin hernia surgery [10, 11]. Haapaniemie 
et al. validated postal questionnaires as a method of follow up to diagnose patients 
with a recurrence after groin hernia repair. They showed a sensitivity and a specificity of 
their questionnaire of respectively 75% and 73% and still concluded that this is a solid 
basis for quality control. The included questions were if patients had any problems in 
the groin after wound healing, if the lump in the groin has recurred and if patients were 
satisfied with the results of operation [11]. Van den Heuvel et al. validated their PINQ-
PHONE questionnaire, which is a validated method of follow-up after laparoscopic 
inguinal hernia repair. The sensitivity of the PINQ-PHONE has, in contrast to the 
questionnaire of Haapaniemie, an exceptional high number of 100%, which means that 
this questionnaire detected all groin hernia recurrences [10]. The PROMID study would 
be the first study validating a questionnaire to diagnose primary IH. Since IH is the most 
commonly seen complication after abdominal surgery, with a high morbidity as a result, 
it is of paramount importance to develop a validated questionnaire as a method of 
follow up to diagnose IH.
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Essential to take into account is that both postal questionnaires and telephone 
interviews cannot replace physical examination, which is needed to diagnose a hernia 
[6]. Literature showed a high discordance between self-reported outcomes and medical 
chart abstraction to set the diagnosis of a hernia. This low level of agreement is based on 
the complexity of this diagnosis and shows that it cannot be made by patient reported 
outcome measurements alone [12]. 
The PROMID pilot study offers new future perspectives. The aim of this study was only 
to explore the reliability of the questionnaire, and it seems that it is a highly reliable 
questionnaire. The next step will be conducting a prospective cohort study, in order 
to validate the questionnaire. The questionnaire will be submit to patients, who have 
undergone a midline laparotomy in recent years. Furthermore, they will be invited to 
the outpatient clinic as well to perform physical examination. With these data, essential 
metrics such as sensitivity, specificity, positive predictive value and negative predictive 
value can be assessed. 
Limitations
One of the main limitations of this study is non-response, which can introduce bias 
and is a major disadvantage of both postal questionnaires and telephone interviews 
[6, 13]. Telephone interviews are time consuming, in particular when patients have to 
be called repeatedly. This was applicable for this study as well. The advantage of our 
questionnaire is that it is a relatively short one. This might lead to more patients who 
are willing to cooperate and to response, which is also pointed out by Nakash et al.: 
implementing shorter questionnaires improve response rates [6, 14].
Another limitation which can possibly lead to bias, is the fact that 70% of interviewed 
patients were conservatively treated. The main reasons to operate IH are cosmetic 
reasons, (severe) pain or bulging complaints, and a (significant) risk of incarceration 
[4]. This conservatively treated patient group is more frequently asymptomatic, will 
therefore give answers of not having pain or bulging complaints. This can influence 
the sensitivity of the questions. However, only the pain question had a relatively low 
sensitivity, and the bulging questions had high sensitivities. 
CONCLUSION
The PROMID questionnaire is a highly reliable questionnaire. The internal consistency 
on the other hand, is only modest. The question that is least consistent is the question 
regarding patients’ pain. The clinical relevancy of pain in IH patients is essential, 
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and therefore this question will be kept in the current PROMID questionnaire. The 
questionnaire needs further validation in a prospective cohort study, with the aim to 
use it as a method of follow up to diagnose incisional hernia. 
Compliance with ethical standards
The authors declare that they have no conflict of interest. Informed consent was 
obtained from all individual participants included in the study. 
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The Use of Resorbable Synthetic Meshes for
Non-complex Abdominal Wall Hernia in a
Preclinical Setting: a review of literature
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ABSTRACT
Background: Prosthetic materials for the repair of abdominal wall defects have been 
studied extensively to improve outcome. A new approach can be the use of a slowly 
resorbable synthetic mesh, which aims to combine advantages of both synthetic 
and biological meshes. The objective of this review is to give an overview of the 
physicochemical characteristics and biomechanical, histological, and macroscopic 
outcome (recurrence, adhesion formation) of the use of resorbable synthetic meshes, 
for treatment and prevention of abdominal wall hernias, based upon experimental 
studies. 
Methods: A systematic review was conducted according to the PRISMA guidelines. 
Only experimental studies were included. Outcome parameters were resorption, 
degradation, organization of connective tissue, inflammatory response, tensile strength 
and amount of adhesion formation. Surgical characteristics were taken into account as 
well (type of defect, clean vs. contaminated model, position mesh, repair of the defect, 
recurrences). 
Results: In total, eleven articles were included. Three absorbable synthetic meshes 
are currently available: GORE® BIO-A® mesh (Gore), TIGR® Matrix Surgical mesh (Novus 
Scientific) and Phasix™ mesh (Bard). Two studies concluded that, despite an early 
transient inflammatory reaction in the first months, remodelling was good in GORE® 
BIO-A®, 6-12 months after augmentation or suture line reinforcement with only minimal 
to moderate adhesions when used intraperitoneally. The TIGR® Matrix Surgical mesh 
shows only partial remodelling with a persistent foreign body reaction after one year. 
Phasix™ mesh seems to perform well in extraperitoneal implantation after one year in 
two studies, although the defect was also small. Only two studies directly compared 
two resorbable synthetic meshes under the same circumstances. The latter also 
included a number of animals where the meshes were used in a non-hernia model in 
contamination. No hernia recurrences or deaths of animals were described in all studies. 
Conclusion: The use of resorbable synthetic meshes in the prevention or treatment 
of abdominal wall hernias seems safe according to the experimental studies that have 
been performed so far, since no serious complications have occurred. However, there 
is no evidence available that can support the advantages of resorbable synthetic 
meshes over the use of synthetic or biological meshes, mostly due to lack of good data. 
More experimental studies are needed, followed by randomized controlled trials and 
prospective registries in humans with a sufficiently long follow-up period, in order to 
reveal the potential advantages in clinical practice.
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INTRODUCTION
Since a few decades, extensive research in the field of prosthetic materials for the repair 
of abdominal wall defects has been performed. All these materials aim to improve 
the result of simple tissue repair. The traditional synthetic polymeric materials are 
non-resorbable polyester (i.e. polyethylene terephthalate; PET), polypropylene, and 
polytetrafluoroethylene. These non-resorbable meshes were introduced in the late 
1950s in the field of general surgery, urology, and gynaecology for various soft tissue 
reinforcement applications (1-5).
The use of non-resorbable synthetic biomaterials for the reinforcement of soft tissue 
weakness has led to a marked reduction of the hernia recurrence rate compared to 
primary suture (6). However, the use of a non-resorbable mesh is unfavourable in a 
contaminated field because of the risk of post-operative infection of the mesh.  Also, a 
synthetic mesh represents permanent foreign body material, which may lead to (chronic) 
inflammation, excessive fibrosis, and complications of pain and even enterocutaneous 
fistula. Even though most of these meshes show sufficient strength, they can impair 
tissue regeneration (1). 
In order to minimize the risk of complications, biological meshes have been introduced 
gradually (7). They consist of an extracellular matrix (ECM) that is derived from 
collagenous rich tissue, such as dermis, pericardium, or small intestinal submucosa from 
human or animal origin (8). The use of biological meshes may lead to a reduction of 
the foreign body and chronic inflammatory response (9). These implants are resorbable, 
easily colonized with host tissue and blood vessels, and are meant to induce site-
specific remodelling by regenerating newly formed tissue (10). They are more infection 
resistant than synthetic materials. Biological meshes are favourable in case the surgical 
field is contaminated, but high-level evidence in long-term data of clinical outcome and 
complications is lacking. A disadvantage of biological meshes is the excessively high 
cost (8). 
An alternative for abdominal wall repair and soft tissue reinforcement might be the use of 
a slowly resorbable synthetic mesh, which aims to combine advantages of both synthetic 
(no degradation shortly after implantation) and biological meshes (the “remodelling” 
aspects and better tolerance in case of contamination) and which is also less expensive 
than a biological mesh. Resorbable synthetic meshes maintain mechanical strength for 
a certain period. These meshes will gradually resorb, allowing rebuilding of connective 
tissue, although without clear remodelling properties (1, 7, 11, 12). In this way, this new 
generation of materials is different from the available quickly absorbing polyglactin 
jairam-layout.indd   165 28/05/2018   21:47
166
Chapter 8
mesh (Vicryl® mesh; Johnson & Johnson). Experience with resorbable synthetic meshes 
is limited; several experimental studies and a few clinical studies have been performed 
so far. Some studies report “optimal tissue remodelling”, however, the definition of this 
is often very unclear and certainly not standardised. There is not enough evidence yet 
that these meshes provide sufficient strength on the long-term after full resorption (11). 
Furthermore, it is not fully clear if these meshes can be safely used in patients at risk 
of infection. The objective of this review is to give an overview of the physicochemical 
characteristics and biomechanical, histological, and macroscopic outcome (recurrence, 
adhesion formation) of the use of resorbable synthetic meshes, for treatment and 
prevention of abdominal wall hernias, based upon experimental studies. 
METHODS
We conducted a systematic review following the PRISMA guidelines. A systematic 
search was performed in MEDLINE, Embase, Web of Science, Scopus, PubMed Publisher, 
Google Scholar and the Cochrane Library, with a search period until September 2017.
The Biomedical Information Specialist of the Medical Library (Erasmus University 
Medical Center, Rotterdam, the Netherlands) prepared the search strategy. A syntax 
with search terms was designed, which is available at Appendix 1.
Two reviewers (A.J. and G.B.) independently evaluated the identified records. All records 
were screened by title and abstract for eligibility and the full text of eligible records was 
assessed. Studies were included if they met the following inclusion criteria: experimental 
studies, investigating resorbable synthetic meshes, with or without comparison of 
synthetic and/or biological meshes for treatment and prevention of abdominal wall 
hernias. Articles had to be written in Dutch or English. Clinical studies and studies that 
investigated only biological or nonresorbable synthetic meshes were excluded.  
The following outcome measurements were assessed: resorption (= disappearance of a 
substance from its initial place, due to physical or chemical phenomena), degradation (= 
loss of the performance or of the characteristics of substance or device, regardless of the 
mechanism), organization of connective tissue, inflammatory response, tensile strength 
and amount of adhesion formation. Surgical characteristics such as type of defect, clean 
or contaminated model, position of the mesh, repair of defect, and recurrences were 
taken into account. The following baseline study characteristics were extracted from 
all included studies: author, year of publication, animal species, number of included 
animals and follow-up period in months. Data were assembled in a standardized 
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database. This database was set up in Microsoft Office Excel 2010. The data presented 
in this review were directly abstracted from the original articles. No statistical analyses 
were performed.
RESULTS
A total of 570 articles were identified after the removal of duplicates. After screening, 52 
articles were considered relevant and the full text of these articles was evaluated. After 
assessment of the full text versions, 11 articles were suitable for inclusion in this (1, 7, 
11-19). The reasons for exclusion can be found in the PRISMA flow diagram (Figure 1). 
The included resorbable synthetic meshes are the GORE® BIO-A® mesh (Gore), TIGR® 
Surgical Matrix Mesh (Novus Scientific) and the Phasix™ mesh (Bard). Table 1 gives an 
overview of the baseline study characteristics of the included articles. Appendix 2 shows 
per mesh an overview of the type of defect and the surgical, histological, macroscopic 
and biomechanical characteristics. In the following sections the features of each mesh 
(as described by the company) and outcome parameters of the included studies are 
given.
GORE® BIO-A® mesh (Gore)
Features of the mesh
GORE® BIO-A® consists of one type of fiber; a synthetic bioabsorbable 
poly(glycolide:trimethylene carbonate) copolymer. According the Instructions for Use 
(IFU), GORE® BIO-A® is not designed to be a load-bearing prosthesis and is therefore not 
recommended for permanent bridging of fascial defects. Table 2.1 shows the features 
of the GORE® BIO-A® mesh as provided by the company. GORE® BIO-A® does not have 
data to provide on measurements as ball burst strength, strength retention in time and 
mechanical strength. According to the company, strength is not a required function in 
the performance of the product. 
Outcome parameters
In total, eight studies investigated GORE® BIO-A® (7, 11-13, 16-19). The surgical, 
histological and biomechanical characteristics of the GORE® BIO-A® experiments are 
extensively described in Appendix 2.
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Figure 1. Prisma Flow Diagram
Peeters et al. performed a rabbit study. A full thickness midline abdominal wall defect 
(11x4cm) was created and meshes were placed intra-abdominally; afterwards the 
laparotomy was closed (mesh augmentation). At one-year follow-up, the meshes were 
completely degraded and a fibrous rim was present at the edges of the resorbed mesh. 
The connective tissue was dense and well organized and there was no undesirable 
inflammatory response. The tensile strength of the abdominal wall was comparable 
to native tissue. There were moderate intra-abdominal adhesions and no recurrences 
were observed (11). This was also applicable for the group who had undergone primary 
repair (control group). 
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Table 1. Study characteristics
Author
Year of 
publication
Total number of 
animals Type of meshes investigated
Hjort et al. 2012 14 sheep TIGR® Matrix Surgical Mesh, polypropylene
Lopez-Cano et al. 2012 65 rats GORE® BIO-A®
Pascual et al. 2012 72 rabbits GORE® BIO-A®, Strattice®,Tutomesh
Deeken et al. 2013 20 minipigs Phasix™ mesh, P4HB plug
Martin et al. 2013 30 pigs Native abdominal wall
Peeters et al. 2013 46 rabbits GORE® BIO-A®, TIGR® Matrix Surgical Mesh, 
Permacol, Surgisis, polypropylene
Yeo et al. 2014 6 rabbits GORE® BIO-A®
Pascual et al. 2014 9 rabbits GORE® BIO-A®, Strattice®, Tutomesh
Sandor et al. 2014 21 vervets GORE® BIO-A®, Physiomesh
Gruber-Blum et al. 2017 27 rats GORE® BIO-A®, Strattice®, Veritas®
Stoikes et al. 2017 60 rats, 10 rabbits GORE® BIO-A®, Phasix™ mesh
Lopez Cano et al. conducted a rat study: in 65 rats, a full thickness median incision along 
the linea alba was made (4cm length) in which a precut longitudinal GORE® BIO-A® 
prosthesis was inserted as a suture line reinforcement which was held in place with 
slowly resorbable sutures. After a 6 month follow-up the mesh was not fully resorbed. 
Degradation and dense, well-organized connective tissue was visible. A mild degree of 
inflammatory cells was seen at the site of remodelling. There was a significantly (p<0.01) 
increased tensile strength compared with the suture group (polydioxanone 2-0). More 
adhesions were present compared to the suture group, with a low Zülhke score of 1-2. It 
was concluded that GORE® BIO-A® for soft tissue suture line reinforcement GORE® BIO-A® 
is able to initiate constructive synthesis and remodelling of newly organized host tissue 
(13).
Pascual et al. conducted 2 studies: an in vivo study performed in 2012 (7) and a combined 
in vitro and in vivo study, conducted in 2014 (12). Here, we will focus only on the in vivo 
results. GORE® BIO-A® was compared with two different biological meshes: Strattice and 
Tutomesh. In the study from 2012, non-full layer defects of 3x3cm were created in the 
lateral wall of the abdomen of rabbits and were treated with an inlay mesh. After 180 
days, a significant gain in biomechanical strength was seen.  After 6 months of follow-
up, degradation was almost complete and dense connective tissue was seen. The mesh 
was completely resorbed. Macrophage response remained high in GORE® BIO-A® until 
the 180th day. However, at six months follow up, inflammatory cells had disappeared 
(7). The study from 2014 showed that significantly more adhesions were seen in GORE® 
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BIO-A®, as well as the macrophage count (both 90 days after implantation). Thickness of 
neoperitoneum was 90 days after implantation greater for Strattice™ Tissue Mesh (Life 
Cell) and Tutomesh (Taureon) compared with GORE® BIO-A®  (12). 
Table 2.1. Features of GORE® BIO-A® (provided by the company)
Mesh type GORE® BIO-A® Tissue Reinforcement
Material Fiber of synthetic bioabsorbable poly(glycolide: trimethylene carbonate) 
copolymer
Structure Non-woven, porous fibrous structure
Pore size Pore size of between 20-120 micrometers
Ball burst strength Gore does not have data to provide on this measurement. 
Strength retention in time Gore does not have data to provide on this measurement. 
Mechanical strength
(suture retention – parallel/
perpendicular)
Gore does not have data to provide on this measurement. 
Total resorption time 6-7 months
Indications Soft tissue reinforcement: 
- hernia repair as suture-line reinforcement
- muscle flap reinforcement
- general tissue reconstructions
Contraindications Not for reconstruction of cardiovascular defects
Degradation Combination of hydrolytic and enzymatic pathways
Reactions Possible adverse reactions are those typically associated with any 
implantable prosthesis, and may include, but are not limited to, 
contamination, infection, inflammation, adhesion, fistula formation,
seroma formation, hematoma, recurrence
Mesh available sizes 7x10cm, 8x8cm, 9x15cm, 10x30cm, 20x20cm, 20x30cm 
Yeo et al. also investigated GORE® BIO-A® mesh in a clean rabbit model. Meshes were 
inserted in subcutaneous pockets without defect creation on the back of the animal 
(2x2cm fixated with slowly absorbable sutures). After 6 months, almost complete 
resorption/degradation took place. Soft tissue was newly formed with a few giant cells, 
which implies a moderate grade foreign body response (16).  
Sandor et al. created a full thickness defect of 3x7 cm by removal of the fascia, rectus 
muscle, and peritoneum in 21 vervets. The mesh (4x8 cm) was placed intra-abdominally 
in an inlay position and was fixated with continuous 3/0 Prolene sutures. This study 
showed also full resorption and complete degradation of the mesh. After 6 months of 
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follow up, no inflammatory response was detectable and the tensile strength of the 
abdominal wall was lower (but not significantly) compared to the synthetic Physiomesh 
(17).   
Gruber-Blum et al. recently published an experimental study. In this study two lateral 
full muscular defects (diameter 1 centimeter) were created in the abdominal wall of rats. 
The peritoneum was spared. Eleven days after primary surgery, rats were randomized 
to undergo onlay bridged placement of either GORE® BIO-A® mesh, Strattice® mesh or 
Veritas® mesh. Follow up took place after 30 and 60 days. GORE® BIO-A® mesh integrated 
well and was resorbed after 60 days follow up. Tissue integration was significantly higher 
in GORE® BIO-A® mesh compared to Strattice® mesh and Veritas®. After 60 days, a large 
amount of collagen was detected around the mesh fibers. Vascularisation of the mesh 
was superior compared to both Strattice® and Veritas® mesh. GORE® BIO-A® mesh led to a 
moderate foreign body reaction. A higher force of perforation was seen in GORE® BIO-A® 
mesh, when compared to native abdominal wall (18).
Stoikes et al. performed a rat study (non-contaminated), in which parameters such as 
resorption and inflammation were investigated, and a rabbit study (contaminated), in 
which inflammation and tensile strength were tested. In this experimental study, Phasix™ 
mesh and GORE® BIO-A® mesh were investigated and compared. In the rat study, 60 rats 
in total were included: in 30 rats Phasix™ mesh was implanted and in 30 rats GORE® 
BIO-A® mesh was implanted. A defect of 0.5 centimetres was created in the muscle layer. 
A mesh of 2 by 2 centimetres was placed into the subcutaneous plane and was fixated 
over the surgical defect. Follow up was until 24 weeks. It was concluded that Phasix™ 
mesh and GORE® BIO-A® mesh had a similar overall biocompatibility. A significantly 
higher host inflammatory response was seen in GORE® BIO-A® mesh in the first 4 weeks, 
compared to Phasix™ mesh (p<0.01). Furthermore, a greater macrophage infiltration was 
observed in GORE® BIO-A® mesh. Histological assessment showed also that GORE® BIO-A® 
mesh was initially thicker compared to Phasix™ mesh (p<0.0001). GORE® BIO-A® mesh 
has a more rapid resorption profile, compared to Phasix™ mesh. Resorption of GORE® 
BIO-A® mesh was complete after 24 weeks. At week 16, repair thickness transitioned into 
significantly thinner sites, in comparison with Phasix™ mesh.  In the rabbit study, 20 New 
Zealand rabbits were included. In 10 rabbits, Phasix™ mesh was implanted, and in 10 
rabbits, GORE® BIO-A® mesh was implanted. Follow up was until 7 days. In each animal, 
(bilateral) pockets were made subcutaneously along the back. Meshes were implanted 
into this pocket. Each mesh had a diameter of 3.8 centimetres and was inoculated with 
108 CFU of MRSA (methicilline resistant Staphylococcus Aureus). Phasix™ mesh showed 
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significantly lower MRSA bacterial colonization, compared to GORE® BIO-A® mesh 
(p<0.01), 7 days after implantation. Furthermore, a greater ball burst strength was seen 
in Phasix™ mesh, in comparison with GORE® BIO-A® mesh (p<0.001) (19). 
TIGR® Matrix Surgical Mesh (Novus Scientific)
Features of the mesh
TIGR® Matrix Surgical Mesh is a multifilament knitted mesh and consists of two types 
of fiber: a fast-resorbing fiber (40% of weight) and a slow resorbing fiber. According 
to the IFU, TIGR® mesh is marketed for reinforcement (i.e. no bridging) of soft tissue 
where weakness exists, but must always be separated from the abdominal cavity by 
peritoneum. The company explicitly excludes the repair of direct inguinal hernias. Table 
2.2 shows the features of the TIGR® mesh as provided by the company. 
Outcome parameters 
In total, two studies were included which investigated the TIGR® mesh (1, 11). The 
surgical, histological and biomechanical characteristics of the TIGR® mesh are extensively 
described in Appendix 2.
Peeters et al. found in their rabbit study that after one year follow up, the mesh was only 
partially incorporated in the native abdominal wall. Filaments were surrounded with 
less organized collagen depositions. There was an intense foreign body reaction, with 
significantly more macrophages/foreign body giant cells than the GORE® BIO-A® mesh. 
Tensile strength was significantly higher compared with GORE® BIO-A®. There were 
significantly more adhesions than the GORE® BIO-A® group, but similar percentages of 
adhesions compared to the polypropylene mesh group. No recurrences of hernia were 
detected after one-year follow-up, as in the control group (11). 
Hjort et al. performed a sheep study in which a full thickness abdominal wall defect 
(3x3cm) was created. Onlay TIGR® mesh was compared with an onlay polypropylene 
mesh (8x8cm, bridged). After a follow-up of three years, according to the authors, 
‘optimal tissue remodelling’ was seen. The mesh was fully resorbed and degraded 
and replaced by newly formed collagen rich tissue, indicating that continuous tissue 
remodelling has taken place. The inflammatory response remained high in the first 
24 months, which was mainly caused by recruitment of phagocytic cells around and 
between the filaments. Inflammation declined after 24 months and was absent at 36 
months of follow-up. The tensile strength and adhesion percentages were not available 
in this study. No hernia recurrences were seen after 3 years (1). 
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Table 2.2. Features of TIGR® matrix (provided by the company)
Mesh type TIGR®matrix
Material Two types of fiber, consisting of: 
1) fast-resorbing fiber (40 % of weight): copolymer of glycolide, lactide 
and trimethylene carbonate.
2) Slow-resorbing fiber (60 % of weight): copolymer of lactide and 
trimethylene carbonate
Structure Multifilament knitted
Pore size 1 mm (at time of implantation) to 1x2 mm (at 4 months)
Ball burst strength 450 to 500 Newton, using ASTM D3787
Strength retention in time Short term strength retention: 3 weeks (loss of 50% strength)
Long term strength retention: up to 9 months
Mechanical strength
(suture retention – parallel/
perpendicular)
40 Newton
Total resorption time Fast-resorbing fiber 4 months, slow resorbing fiber 3 years 
Indications Soft tissue reinforcement where weakness exist: 
- hernia repair
- abdominal wall defects
- abdominal wall reinforcement
- muscle flap reinforcement
Contra indications - Reconstruction of cardiovascular defects
- TIGR mesh must always be separated from the abdominal cavity by 
peritoneum
- Not for use following planned intraoperative or accidental opening of 
the gastrointestinal tract
- Repair of direct inguinal hernias
Degradation Bulk hydrolysis 
Reactions Infection, inflammation, extrusion, erosion, adhesion, fistula 
formation, seroma formation, hematoma, and recurrence of the 
hernia or tissue defect
Mesh available sizes 10x15cm, 15x20cm, 20x30cm
Phasix™ mesh (Bard)
Features of the mesh
Phasix™ mesh is a monofilament knitted mesh and its fibers are composed of poly-4-
hydroxybutyrate (P4HB). This is a natural polymer from the class of polyhydroxyalkanoates. 
Phasix™ mesh is indicated in patients where weakness exists, to reinforce soft tissue. 
Phasix™ biomaterials should not be used in repairs where permanent wound or organ 
support from the mesh is required. Table 2.3 shows the features of the mesh as provided 
by the company. 
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Table 2.3. Features of Phasix™ mesh (provided by the company)
Mesh type Phasix™Mesh
Material Fiber consisting of poly-4-hydroxybutyrate (P4HB)
Structure Monofilament knitted 
Pore size Minor pore size: 362 microns, major pore size: 700 microns
Ball burst strength 149 Newton, using ASTM D3787
Strength retention in time Loss of 50% strength after 8 weeks 
Mechanical strength 
(suture retention – parallel/
perpendicular)
40 to 45 Newton
Total resorption time 12-18 months 
Indications Soft tissue reinforcement: 
- patients undergoing plastic and reconstructive surgery
- soft tissue repair of ventral or inguinal hernias
- other abdominal fascial defects that require the addition of a 
reinforcing or bridging material to obtain the desired surgical result
Contra indications If permanent wound or organ support from the mesh is required
Degradation Mostly hydrolysis and small amount of enzymatic degradation
Reactions Infection, seroma, pain, mesh migration, wound dehiscence, adhesions, 
hemorrhage, hematoma, inflammation, extrusion and recurrence of the 
hernia or soft tissue defect
Mesh available sizes 10.2x15.2cm, 15.2x20.3cm, 20.3x25.4cm, 25.4x30.5cm
Outcome parameters
Three studies investigated the Phasix™ mesh (14, 15, 19). The surgical, histological 
and biomechanical characteristics of the Phasix™ mesh are extensively described in 
Appendix 2.
Deeken et al. conducted an experimental study with 20 minipigs. Bilateral abdominal 
wall defects of 3 cm were made in the anterior abdominal wall, using a preperitoneal 
bridging technique with a mesh of 10.2cm in diameter. The Phasix™ mesh significantly 
resorbed over time. This was measured by the molecular weight, which progressively 
decreased between measured time points. Collagen scores were consistent over time 
and showed a mixture of both mature and immature collagen, which was seen at all time 
points. There was a mild to moderate inflammatory response, which remained stable 
throughout the complete study. The burst strength of the abdominal wall remained 
also stable over time, but was significantly greater compared to the native abdominal 
wall. There were no recurrences after one year (14). 
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Martin et al. conducted an experimental study with 30 Yucatan pigs. A full fascial 
defect (diameter 2.5 centimetres) in the anterior abdominal wall was made. The mesh 
was placed in a preperitoneal position, and the abdominal wall defect was reinforced 
(augmentation) with a Phasix™ mesh. Evaluation of the functional performance was 
done at 72 weeks. In this study, Phasix™ mesh was investigated in an in vitro and in 
vivo model. In this paper, we focus on the in vivo results. A moderate chronic host 
inflammatory response was found around the mesh knots and monofilaments, and 
contained mainly macrophages, lymphocytes and giant cells. Phasix™ mesh has a higher 
strength in the first 16 weeks compared to the native abdominal wall. At the same time, 
relatively high stiffness occurs in the mesh scaffold, which indicates a natural fibrotic 
response during remodelling. After the 16th week, the ball burst strength decreases, 
as well as the relative stiffness, and the molecular weight decreases while the mesh 
degrades. There is no information regarding the recurrence rate (15).
Stoikes et al. performed a rat study (non-contaminated) and a rabbit study 
(contaminated), as described before. We refer to the Gore Bio-A section and to Appendix 
2 for description of the results. 
DISCUSSION
This review gives an overview of slowly resorbable synthetic meshes that are currently 
available on the market: GORE® BIO-A®, TIGR® Matrix Surgical mesh and Phasix™ mesh. 
Surgical, histological and biomechanical characteristics of these meshes for the 
treatment and prevention of abdominal wall hernias are highlighted. Only experimental 
studies were included. GORE® BIO-A® was more extensively described in literature than 
TIGR® Matrix Surgical mesh and Phasix™ mesh.
The occurrence of incisional hernia after a median laparotomy has an incidence that can 
increase up to 35%. Currently only non-resorbable synthetic meshes are used for hernia 
repair. However, permanent foreign body material can elicit a chronic inflammatory 
response. This response can cause symptoms like chronic postoperative pain, 
discomfort and mesh erosion. Furthermore synthetic meshes are contraindicated for 
hernia repair in a contaminated environment (1, 11, 20, 21). Under these circumstances 
biological meshes are possibly an alternative for the most complex cases, in patients 
at risk for complications of infection. Unfortunately these biological meshes seem to 
provide insufficient strength for adequate repair, especially in large abdominal defects 
with bridging of the defect, as reported by clinical studies (1, 11, 21, 22). In addition the 
costs of this variety of meshes are extremely high. Due to the disadvantages of both 
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synthetic and biological meshes, strategies focussed on the development of new type 
of meshes: slowly resorbable synthetic meshes were gradually introduced. This new 
generation of meshes aims to combine the advantages of both a synthetic mesh (no 
degradation shortly after implantation) and a biological mesh (the “remodelling” aspects 
and the better tolerance in case of contamination). Currently it is unclear in what way 
biological meshes really induce a site-specific remodelling of fascia- and muscle-like 
tissue or whether it is “just” a matured fibrotic scar that remains after full degradation, 
and whether the tensile strength of the new tissue in augmentation techniques has 
an equal strength as with the use of standard synthetic non-resorbable materials. The 
same question holds for the new generation of slowly absorbable synthetic materials 
discussed here in general, and in bridging vs. augmentation in particular (1, 11, 17). 
According to information from the manufacturers, the three commercially available 
materials have a wide range of pore size (0.02-2mm), strength retention (3 weeks – 9 
months), and resorption time, they are resorbed (at least partially) between 4 months 
and 3 years. This is already a first problematic issue, since, apart from weight and pore 
size, there are no clear-cut criteria to describe in a standardised way the biomechanical 
properties of a mesh before implantation. Once this is established, a list of independent 
accredited laboratories with validated measurement tools needs to be installed. These 
materials degrade mainly by hydrolysis and do not seem to be intended to be used 
in case of bridging, although the exact indications and contra-indications based 
on the instructions for use from the manufacturers are ill defined. For TIGR Matrix, 
the contraindication for use in direct inguinal hernia repair is explicitely mentioned. 
However, most of the studies reported here with an acute defect used a bridging model 
(1, 7, 14, 17-19). The data presented in this review show the various aspects of resorbable 
synthetic meshes. 
Essential parameters of resorbable synthetic meshes are remodelling, tensile strength, 
inflammation, adhesions and recurrence. No firm conclusion can be made based upon 
these experimental studies regarding remodelling. Different parameters influencing 
optimal remodelling of a resorbable synthetic mesh have to be taken into account: (1) 
the type and size of defect, (2) the level of contamination, (3) the surgical technique to 
repair the defect that has been applied (augmentation, bridging, inlay), (4) the specific 
characteristics of the mesh studied (resorption time and strength retention in time), 
and (5) the duration of follow up. Two studies concluded that, despite an early transient 
inflammatory reaction in the first months, remodelling was good in GORE® BIO-A® 6-12 
months after augmentation or suture line reinforcement with only minimal to moderate 
adhesions when used intraperitoneally (11, 13). The latter study is the only one in this 
review reporting on hernia prevention. Interestingly it also seems to provide a sufficient 
support in an onlay bridging model up to 2 months (20), but this needs to be confirmed 
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with longer follow-up.  The TIGR® Matrix Surgical mesh shows only partial remodelling 
with a persistent foreign body reaction after one year (1, 11). This finding might also be 
attributed to the fact that TIGR ® Matrix Surgical mesh consists of two distinct fibers. A 
strong repair with absent inflammatory response was seen in another onlay bridging 
model after 3 years, although the defect was small (3x3cm in sheep model) (1). This 
mesh cannot be used intraperitoneally because of the risk for adhesions, as stated in 
the IFU of the manufacturer. According to the manufacturer, also Phasix™ mesh cannot 
be used intraperitoneally, unless covered by an anti-adhesive barrier. Here again the 
mesh seems to perform well in extraperitoneal implantation after one year, although 
the defect was also small in both studies (3cm in minipig model (bridging) and 2.5 cm 
in Yucatan swine model (augmentation). These models may not reflect the performance 
of the mesh, in real clinical setting.
Only two studies directly compared two resorbable synthetic meshes under the same 
circumstances (11, 19).  Only one of these included a macroscopic, histological and 
biomechanical analysis after one year (11). The other one is the only available study 
that included also a number of animals where the meshes were used in a contaminated 
setting, but only with an evaluation after 7 days, and in a non-hernia model (19). It is clear 
that these data need to be confirmed before sound conclusions can be drawn. Overall 
it can be stated that after implantation indeed at least some degree of remodelling 
occurs, but whether this can lead to strong fascial tissue of good quality in the long 
term remains completely unclear. This can only truly be assessed in bridging models. 
Also it is unclear what the clinical impact is of the degree of inflammation during or after 
remodelling, although in none of the studies it was seen that a (higher) inflammatory 
response led to short or long-term complications. In conclusion so far, the use of these 
materials seems safe, although it should be clear they have not been marketed to be 
used in contaminated settings, even though they are intended to be clinically used in 
these settings mainly.
This review paper has several limitations, inherent to the heterogeneity and quality of 
the selected publications. Apart from defect size and type, surgical techniques used 
were extremely variable. For instance, we know that inlay repair of incisional hernias 
with synthetic non-resorbable mesh in a clinical setting is prone to failure, yet this 
technique was used in two studies (7, 17). In addition, many different animal models 
were used and meshes were always placed in a clean environment, except in one study. 
Last but not least, outcome parameters were not standardised and only four studies 
had a follow-up of one year or longer (1, 8, 11, 15). This all makes it extremely difficult 
to extrapolate these results to humans. In order to overcome these limitations, a longer 
follow-up (at least longer than full resorption of the material) in a chronic standardized 
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validated large hernia model with an accepted surgical technique, adequate comparison 
groups and a fixed set of clearly defined and relevant outcome parameters is needed, 
before any statements can be made (23, 24). 
Ideally, each experimental study has to stick to such a set of fixed independent and 
dependent parameters. In order to achieve this, we have set up a table with our own 
suggested parameters (Table 3). Research groups from different countries should work 
together in this, along with the industry. All these studies should be registered in order 
to avoid publication bias.
Table 3. Format fixed set of parameters 
Surgical characteristics
Physicochemical, Macroscopic, Histological, and 
Biomechanical outcome parameters
Defect: acute / chronic
Setting: clean / clean-contaminated/contaminated
Position mesh: inlay / onlay / sublay / IPOM
Repair of defect: augmentation / bridging
Resorption
Degradation
Connective tissue
Inflammatory response
Tensile strength 
Adhesion
Recurrences
Experimental studies should be followed by clinical studies. At this moment several 
prospective clinical cohort studies regarding GORE® BIO-A® and TIGR® Matrix Surgical 
mesh have been published, with positive short-term results  (25-27). No clinical study 
for the Phasix™ mesh has been published yet; several studies are currently being 
conducted and results will follow soon. Ideally, resorbable synthetic meshes should 
be compared with either synthetic meshes (in a clean setting) or biological meshes 
(in a contaminated setting). Unfortunately no randomized controlled trials have been 
conducted yet. Concurrently, we urge all surgeons to register their patient data in well-
designed prospective registries, especially when new meshes are launched in order 
to detect as soon as possible (rare) potential adverse effects related to the safety of a 
specific material. 
CONCLUSION
The use of resorbable synthetic meshes in the prevention or treatment of abdominal 
wall hernias seems safe according to the experimental studies that have been performed 
so far. Although a certain degree of remodelling occurs, it remains completely unclear 
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whether this can lead to strong fascial tissue of good quality in the long term. Currently, 
there is no clear experimental evidence available that can support the advantages of 
resorbable synthetic meshes over the use of synthetic or biological meshes in human 
settings, mostly due to lack of good data. More experimental studies are needed, using 
standardized models and parameters, followed by randomized controlled trials and 
prospective registries in humans with a sufficiently long follow-up period, in order to 
reveal the potential advantages in clinical practice.
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APPENDIX
Appendix 1: Syntax with search terms
Embase.com  284
(hernioplasty/exp OR herniorrhaphy/exp OR hernia/de  OR 'abdominal wall hernia'/exp OR 'abdominal wall defect'/de OR 
'incisional hernia'/exp OR (hernia* OR hernio* OR ('abdominal wall' NEXT/1 defect*)):ab,ti) AND ('synthetic biology'/exp OR 
((biomaterial/exp OR 'biodegradable implant'/exp) AND ('synthetic fiber'/exp OR polymer/de)) OR (((synth* OR polymer*) 
NEAR/3 (bio*)) OR biosynth* OR 'bio a' OR tigr OR tephaflex OR phasix OR (slow* NEAR/3 (resor* OR absor*))):ab,ti)
 MEDLINE (OvidSP) 209
(Herniorrhaphy/ OR hernia/  OR Hernia, Abdominal/ OR exp Hernia, Ventral/ OR (hernia* OR hernio* OR (abdominal wall ADJ 
defect*)).ab,ti.) AND (Synthetic Biology/ OR ((exp Biocompatible Materials/ OR Absorbable Implants/) AND (polymers/)) OR 
(((synth* OR polymer*) ADJ3 (bio*)) OR biosynth* OR bio a OR tigr OR tephaflex OR phasix OR (slow* ADJ3 (resor* OR absor*))).
ab,ti.)
Cochrane  Library 18
((hernia* OR hernio* OR ('abdominal wall' NEXT/1 defect*)):ab,ti) AND ((((synth* OR polymer*) NEAR/3 (bio*)) OR biosynth* OR 
'bio a' OR tigr OR tephaflex OR phasix OR (slow* NEAR/3 (resor* OR absor*))):ab,ti)
Web-of-science   209
TS=(((hernia* OR hernio* OR ("abdominal wall" NEAR/1 defect*))) AND ((((synth* OR polymer*) NEAR/3 (bio*)) OR biosynth* 
OR "bio a" OR tigr OR tephaflex OR phasix OR (slow* NEAR/3 (resor* OR absor*)))))
Scopus   294
TITLE-ABS-KEY(((hernia* OR hernio* OR ("abdominal wall" W/1 defect*))) AND ((((synth* OR polymer*) W/3 (bio*)) OR biosynth* 
OR "bio a" OR tigr OR tephaflex OR phasix OR (slow* W/3 (resor* OR absor*))))) AND doctype(ar)
PubMed Publisher 5
(Herniorrhaphy[mh] OR hernia[mh]  OR Hernia, Abdominal[mh] OR Hernia, Ventral[mh] OR (hernia*[tiab] OR hernio*[tiab] OR 
abdominal wall defect*[tiab])) AND (Synthetic Biology[mh] OR ((Biocompatible Materials[mh] OR Absorbable Implants[mh]) 
AND (polymers[mh])) OR (((synth*[tiab] OR polymer*[tiab]) AND (bio*[tiab])) OR biosynth*[tiab] OR bio a OR tigr OR tephaflex 
OR phasix OR (slow*[tiab] AND (resor*[tiab] OR absor*[tiab])))) AND publisher[sb]
Google Scholar
hernia|hernioplasty|herniorrhaphy|"abdominal wall defect" biosynthetic|"bio synthetic"|"bio a"|tigr|tephaflex|phasix|"slowly 
resorbable|absorbable"
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A Post-Market, Prospective, Multi-Center, Single-
Arm Clinical Investigation of Phasix™ Mesh for
VHWG Grade 3 Midline Incisional Hernia Repair
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ABSTRACT
Background Incisional hernia is a frequent complication of midline laparotomy. The 
use of mesh in hernia repair has been reported to lead to fewer recurrences compared 
to primary repair. However, in Ventral Hernia Working Group (VHWG) Grade 3 hernia 
patients, whose hernia is potentially contaminated, synthetic mesh is prone to infection. 
There is a strong preference for resorbable biological mesh in contaminated fields, since 
it is more able to resist infection, and because it is fully resorbed, the chance of a foreign 
body reaction is reduced. However, when not crosslinked, biological resorbable mesh 
products tend to degrade too quickly to facilitate native cellular ingrowth. Phasix™ Mesh 
is a biosynthetic mesh with both the biocompatibility and resorbability of a biological 
mesh and the mechanical strength of a synthetic mesh. This multi-center single-arm 
study aims to collect data on safety and performance of Phasix™ Mesh in Grade 3 hernia 
patients. 
Methods A total of 85 VHWG Grade 3 hernia patients will be treated with Phasix™ 
Mesh in 15 sites across Europe. The primary outcome is Surgical Site Occurrence (SSO) 
including hematoma, seroma, infection, dehiscence and fistula formation (requiring 
intervention) through 3 months. Secondary outcomes include recurrence, infection and 
quality of life related outcomes after 24 months. Follow-up visits will be at drain removal 
(if drains were not placed, then on discharge or staple removal instead) and in the 1st, 3rd, 
6th, 12th, 18th and 24th month after surgery. 
Conclusion Based on evidence from this clinical study, Phasix™ Mesh may become a 
preferred treatment option in VHWG Grade 3 patients. 
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BACKGROUND
Incisional hernia (IH) is one of the most frequent complications after midline laparotomy, 
with incidences varying from 10% to 20%, and even higher percentages occur in high-
risk groups [1, 2]. IH can lead to a high morbidity and reduces quality of life [3, 4]. Due 
to the high IH incidence rates, hernia repair surgery is one of the most frequently 
performed surgical procedures [5]. The aim of hernia surgery is to relieve symptoms, to 
prevent complications or to resolve acute complications. 
There are several options for hernia repair, including primary suture repair, synthetic 
or biologic material placement, repair with relaxing incisions, component separation 
and use of musculofascial flaps, utilizing both open and laparoscopic approaches [6-8]. 
Synthetic mesh repair procedures, either open or laparoscopic, lead to fewer recurrences 
compared to primary repair; recurrences after mesh are 7.7% compared to 23.8% after 
primary closure [1, 3, 9, 10]. Improved outcomes are believed to be related to reduced 
tension on the fascial edges and sutures when mesh is used in hernia repair procedures. 
Despite reducing hernia recurrence rates, the use of synthetic mesh has been associated 
with complications in approximately 17% of patients. These complications include 
infection, pain, adhesions, fistulae and foreign body reactions including increased 
inflammation and/or connective tissue deposition [3, 11]. Especially complex and large 
abdominal wall defects continue to pose a challenge to surgeons, which are associated 
with recurrence rates of up to nearly 40% [12].
It can be stated that synthetic mesh is more prone to infection than primary closure, 
and this poses a problem in potentially contaminated hernias like Ventral Hernia 
Working Group (VHWG) Grade 3 hernias [13] (Figure 1). The success of the mesh repair 
is jeopardized by potential contamination due to complicating factors like previous 
wound infection, the presence of a stoma or violation of the gastro-intestinal tract. 
The use of a biological tissue matrix has been advocated in (potentially) contaminated 
hernias, because of their ability to resist infection, milder inflammatory response and 
more orderly collagen deposition than non-resorbable, synthetic meshes [14-16]. 
Most often, biological meshes are derived from human, porcine or bovine dermis, and 
these materials have been processed to acellular sheets of collagen and elastin. The 
development of resorbable mesh products has faced challenges related to the rate of 
absorption with complications arising when the mesh product is resorbed too quickly. 
Rapid resorption does not support sufficient healing if structural reinforcement is 
diminished during the tissue repair period. 
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Figure 1. Ventral Hernia Working Group Grading System
Therefore, some meshes contain chemicals to induce additional crosslinking in 
the graft. This slows down the degradation process, causing the mesh to retain its 
strength for a longer period of time[17]. However, crosslinking in the mesh reduces its 
biocompatibility; causing delayed cellular infiltration and neovascularization [17-19]. 
Ideally, a resorbable mesh should have a high ability to resist infections and retain its 
functional strength for a sufficient period of time to allow native cellular ingrowth tissue 
remodeling, maturation of collagen and gradual shift of mechanical load. 
Phasix™ Mesh is a commercially available biosynthetic mesh. It is a slowly resorbable mesh 
prepared from poly-4-hydroxybutrate which has been studied for use as a biomaterial 
for different medical applications due its strength and flexibility, biocompatibility and 
desirable degradation times [20-22]. Phasix™ Mesh is comparable in performance to 
traditional polypropylene mesh when using standard measures of mechanical strength 
(suture pullout, tear and ball burst strength) [23, 24]. Preclinical implantation studies 
indicate that Phasix™ Mesh retains approximately 70% of its original strength at 12 
weeks [23]. Absorption of the mesh material will be essentially complete in 12-18 
months [24]. Given the long-term strength retention observed in preclinical studies, it is 
anticipated that Phasix™ Mesh may result in low recurrence and complication rates with 
minimal pain and discomfort when used for hernia repair. 
Rationale
From a general perspective, the current literature still is rather void of evidence-based 
guidelines regarding optimal choice of mesh. Simple, uncontaminated hernias are 
usually treated with synthetic mesh; biologic meshes are mostly used in potentially 
contaminated hernias, since post-operative mesh infection is anticipated. 
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Until now, the use of Phasix™ Mesh was studied primarily in patients up to VHWG Grade 
2 [25]. Based on the data gained from this clinical study, additional evidence may be 
provided with a view to optimal selection of hernia repair material in a population of 
higher risk. Based on the combination of the features of the Phasix™ Mesh proven in 
previous clinical and non-clinical investigations, and based on evidence from the clinical 
study as described in this protocol, Phasix™ Mesh may become a preferred treatment 
option in VHWG Grade 3 patients. 
METHODS
Objectives
The objective of this study is to collect additional data on safety and performance of 
Phasix™ Mesh in subjects requiring VHWG Grade 3 midline incisional hernia repair. 
Among others, Surgical Site Occurrence (SSO), hernia recurrence, pain, infection, 
reoperation and adverse events will be collected for subjects with a VHWG Grade 3 
hernia meeting the study inclusion and exclusion criteria.
Design
The study has been designed as a post-market, prospective, single arm, multi-center, 
open-label study to collect data on performance and safety of Phasix™ Mesh in subjects 
with a VHWG Grade 3 midline hernia. This study will be conducted in 15 hospitals across 
Europe. 
Participants
Subjects with a VHWG Grade 3 incisional hernia scheduled for hernia repair are eligible 
for this study and will be asked for informed consent at the outpatient clinic. 
Inclusion criteria
All subjects who meet the following criteria listed below can be enrolled in the study:
• Age 18 years or older
• Diagnosis of an incisional midline hernia
• VHWG Grade 3 hernia
• Size of hernia >10 cm2, measured intraoperatively
• Elective retro-rectus hernia repair
• Signed informed consent
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Exclusion criteria
All subjects who meet the following criteria must be excluded from study enrolment:
Regarding the subject:
• Body Mass Index (BMI) > 35 kg/m2
• Peritonitis
• Use or suspected future use of chemotherapeutic medication during any part of 
the study
• Known human immunodeficiency virus (HIV) infection
• Cirrhosis of the liver and/or ascites
• Pregnancy, plans to become pregnant during the study period or current 
breastfeeding
• Alcohol/substance abuse problem or a relapse within 12 months of the screening 
visit
• Involvement in another interventional clinical study in the last 30 days prior to 
informed consent signature
• Life expectancy of less than 2 years at the time of enrollment
• Known sensitivity to Phasix™ Mesh or component materials (subjects with known 
allergies to tetracycline hydrochloride or kanamycin sulfate)
• Any condition that, in the opinion of the investigator, would preclude the use of the 
study device or preclude the subject from completing the follow-up requirements
Regarding ventral hernia:
• More than 4 previous repairs of the hernia under observation
• The hernia repair requires more than a single piece of mesh
• Intact permanent mesh adjacent to the current hernia to be repaired
Regarding surgery:
• American Society of Anesthesiology class 4 or 5
• Surgical technique requires surgical bridge repair 
• Complete removal of existing mesh from a prior hernia repair (in the same affected 
area) is not possible
• The hernia repair requires intraabdominal mesh placement
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Study procedures
Screening
Subjects with a diagnosis of incisional midline hernia requiring surgical repair to close 
the defect who are presenting at the study site will be considered potential subjects for 
inclusion in this clinical study and should be pre-screened for study eligibility. If inclusion 
criteria are potentially met and no exclusion criteria are anticipated to be present at the 
time of pre-screening, the Investigator will invite the subject to participate in the study.
Informed Consent
Subjects will be asked to sign a written informed consent form. A copy of the informed 
consent will be provided to the subject. 
Eligibility
Final eligibility will be determined intraoperatively. Subjects who fail to meet eligibility 
criteria should be considered screen failures and will be treated per hospital standard of 
care. Reason for screen failure will be documented. 
Intervention
All subjects will undergo an open ventral repair of the hernia. All intraoperative inclusion 
and exclusion criteria will be verified. 
Subjects will be administered perioperative antibiotics according to hospital protocol. 
Subjects will be prepared to undergo hernia repair with Phasix™ Mesh. The general 
instructions for the use of Phasix™ Mesh are supplied by the manufacturer. 
Surgical technique
The surgical technique will require retro-rectus placement (onlay is allowed as an 
exception when retro-rectus placement cannot be achieved), using slowly resorbable 
sutures, with or without Component Separation Technique (CST). The peritoneum should 
remain posterior to the mesh upon completion of mesh placement. The mesh may be 
cut to shape or size desired for each specific application. The mesh is to be positioned so 
its edges extend beyond the margins of the defect by at least 5 cm. It is recommended 
that the mesh is fixated at approximately 5-6 cm intervals (6-12 absorbable sutures) 
around the periphery of the mesh. Defect closure must be confirmed. All skin incisions 
will be closed with staples/sutures and wounds will be dressed with sterile occlusive 
dressings. 
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Outcome parameters
Primary outcome
Primary outcome will be Surgical Site Occurrence (SSO) up to and including, the 3-month 
follow-up assessment. SSOs will be assessed by physical examination at each study visit 
through 3 months. SSO is defined as hematoma, seroma, surgical site infection, wound 
dehiscence, skin necrosis and fistula, all of which require intervention. 
Secondary outcome
Secondary outcomes will be:
• Surgical Site Occurrence (SSO) after the 3-month follow-up assessment
• Surgical Site Infection (SSI)[26], is included in SSOs, but will also be analysed 
separately
• Hernia Recurrence rate (via physical exam, if uncertain via ultrasonography, CT or 
MRI)
• Pain at every follow-up point, measured with the Visual Analogue Scale (VAS) 
• Device related adverse event incidence
• Rate of reoperation due to the index hernia repair
• Quality of Life assessments (Carolinas Comfort Scale™[27]a and EuroQol-5D (EQ-5D)
[28])
• Surgical procedure time as measured from incision to closure (skin to skin)
• Return to work
• Length of hospital stay (day of index surgery until day of discharge, LOS)
To measure these outcomes, the following data will be gathered at different points in 
time, and saved in an electronic case report form:
Pre-operative data
• Demographic data (age, sex, race, ethnicity) and medical history
• Information regarding the inclusion and exclusion criteria
• Height and weight (calculated to a BMI)
• Length and width of hernia
• Wound assessment 
- signs of infection
- status and location of potential previous mesh
- signs of necrosis
• Pain medication usage
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• Pain (measured with VAS), discomfort (measured with Carolinas Comfort Scale™) 
and quality of life (measured with EQ-5D)
Peri-operative data
• Information regarding the inclusion and exclusion criteria
• Intra-operative evaluation of wound and abdomen
• Intra-operative assessment and description of hernia
• Intra-operative assessment of complications, e.g. enterotomy
• Surgical procedure
• Mesh details
• Fixation details
• Wound closure
Post-operative data
The following data will be collected at fixed follow-up visits, namely at drain removal (if 
applicable, otherwise at discharge or at staple removal), 1 month, 3 months, 6 months, 
12 months, 18 months and 24 months (Table 1): 
• Wound assessment
- signs of infection 
- status and location of potential previous mesh
- signs of necrosis
• Hernia recurrence (diagnosed with physical exam, if uncertain via ultrasonography, 
or via CT/MRI)
• Adverse events
• Device failure/malfunction/defects
• Pain (measured with VAS)
• Discomfort (measured with Carolinas Comfort Scale™)
• Quality of life (measured with EQ-5D)
In addition, pain medication usage will be collected at 12 and 24 months follow-up. 
Withdrawal/Early Termination
A subject is considered an Early Termination if discontinuation occurs after study 
treatment and before 24 months follow-up. The site will attempt to bring the subject 
back to the hospital to complete all Early Termination visit study procedures: Physical 
examination, Pain measured with VAS, Carolinas Comfort Scale™, EQ-5D and collect 
adverse events. Reason for subject discontinuation will be documented when possible. 
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Sample size consideration
The expected rate of SSO at 3 months is 37% based on historical data (ranging from 
21-53%)[29-32]. With 75 subjects, the accuracy of the estimated SSO will be ± 11% (i.e. 
half of the width of the 95% confidence interval of the estimated rate of SSO is 11%). 
The study plans to enroll 85 subjects for follow-up. Anticipating on an attrition rate of 
about 10%, 75 subjects will be evaluable to assess the primary endpoint of Surgical Site 
Occurrence (SSO) at 3 months.
Table 1. Summary of procedures performed per visit. 
Study Procedure Sc
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Describe study to potential subject X
Obtain informed consent X
Collect demographics and medical history X
Verify eligibility criteria X X
Physical examination X X X X X
Placement of device X
Pain Scale (VAS) X X X X X
Carolinas Comfort ScaleTM X X X X
EQ-5D X X X X
Collect Adverse Events X X X X X
Collect pain medications X X
Statistical analysis
There will be a modified intention-to-treat population (mITT), which consists of the 
subjects in whom Phasix™ Mesh has been implanted. The screen failures were not 
implanted, and therefore not used in the analysis. A per-protocol (PP) population may 
be created if there are subjects who have any major protocol deviations. However, all 
analyses will be primarily based on the mITT population. 
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Demographics and baseline characteristics will be summarized using the mITT 
population. Summary statistics for categorical variables will include frequency counts 
and percentages, and for continuous variables mean, standard deviation, minimum, 
median and maximum. 
The primary endpoint is the SSO rate up to (including) 3 months (± 14 days) post device 
placement based on the mITT population. A 95% confidence interval will be reported 
for the SSO rate. 
The SSO rate after 3 months, the hernia recurrence rates and surgical site infection 
rates until 1, 3, 6, 12, 18 and 24 months post device placement will be reported per visit 
along with their 95% confidence intervals based on the mITT population as secondary 
endpoints. Additionally, Kaplan-Meier analyses for the time from surgery to hernia 
recurrence and for the time from surgery to surgical site infection may be performed. 
The secondary endpoints of VAS pain scale, Carolinas Comfort Scale™ and EQ-5D will be 
summarized based on the mITT population with mean, standard deviation, minimum, 
median and maximum presented by visit. 
Device related adverse events will be tabulated by system organ class and preferred 
term. The number of subjects with a post procedure reoperation due to the index hernia 
repair will be presented by time intervals (until 1, 3, 6, 12, 18 and 24 months post device 
placement), surgical procedure duration of the index procedure (calculated as time of 
skin closure complete minus time of first incision) and length of hospital stay will be 
summarized descriptively. The time to return to work will be tabulated using summary 
statistics as well. 
Safety parameters, such as adverse events, device deficiencies (mechanical failure, 
malfunction or defects), physical examination and pain medication, will be summarized 
using the mITT population. 
Subgroup analyses will be performed by sex, sites (sites with few treated subjects can 
be combined) and other factors of interest. 
No missing value imputation methods will be applied in any of the aforementioned 
analyses. 
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Safety
In this study, Adverse Events (AE) are defined as any undesirable clinical event occurring 
in the abdominal wall or the abdominal space, as well as any other undesirable clinical 
events judged to be related to the study device or surgical procedure regardless of 
anatomical region, from time of implantation to end of study participation. Abnormal 
laboratory results are also to be considered as AEs if the results are accompanied by 
clinical signs or symptoms. The investigator will assess the relationship of an AE to the 
study device or procedure and categorize them as ‘definitely’, ‘possibly’ or ‘not related’. 
An adverse device effect (ADE) is an AE related to the use of the mesh product implanted 
(e.g. insufficient or inadequate implantation, installation, operation or malfunction of 
the Phasix™ Mesh). 
Serious adverse events (SAE) are the events that meet the definition of serious in the 
ISO 14155:2011. 
All events will be followed to satisfactory resolution or stabilization. 
The investigator is responsible for the detection and documentation of events meeting 
the criteria and definition of AE, ADE or SAE. All SAEs and investigator-judged device 
related AEs that occur, must be reported to the sponsor within 24 hours of becoming 
aware of the event. 
An independent safety monitoring committee will reassess safety of the study protocol 
and decide about potential adaptations if one of the following criteria are met:
• More than 4 device related SAEs within 3 months of Phasix™ Mesh implantation
• More than 1 device related recurrence within 3 months of Phasix™ Mesh 
implantation
The enrolment and treatment of new subjects are suspended until the impact of the 
study parameters (e.g. surgical technique, hernia size, mesh size, AE time-course) on the 
results is assessed. The follow-up for the subjects already treated continues. 
Monitoring for accuracy and timely submission of data forms and compliance with the 
study protocol, meeting enrolment commitments and applicable regulations will take 
place by monitoring personnel.
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Ethics
This study will be conducted in accordance with the principles of the Declaration of 
Helsinki and Good Clinical Practice guidelines. The Medical Ethical Committee of the 
Erasmus Medical Center and the Institutional Review Board of every participating 
hospital have approved the protocol. Written informed consent will be obtained from all 
subjects. All study data will be recorded in electronic Case Report Forms provided to the 
investigational site. Site and subject numbers will be used to track subject information 
throughout the study. 
The sponsor of the study has taken out an insurance policy for all participants of the 
study, in the case of any negative consequences experienced due to the study or the 
medical device. 
The results of the study will be published in a peer-reviewed journal and on clinicaltrials.
gov, which is accessible for the public.
DISCUSSION
A major challenge in all hernia studies is the formulation of a clear definition on the 
severity or grade of the hernia. The difference between grade 3 and 4 hernias is not 
always clear, since the classification is more gradual than it seems. The definition for 
Grade 3 hernias used in this study is the same as the one of the Ventral Hernia Working 
Group in 2010, which excludes presence of infected mesh[13]. 
A discussion topic in this study is the absence of a control group. Because no standard 
treatment is recorded for VHWG Grade 3 hernias, comparing Phasix™ Mesh with 
synthetic mesh has been considered to be unethical, since the potential contamination 
of the hernia could cause complications when using a synthetic mesh . Comparing 
Phasix™ Mesh with just sutures (primary closure) would not be ethical either, due to the 
high recurrence rates associated with primary closure. 
It was considered to compare Phasix™ Mesh with the treating surgeon’s standard of 
care for VHWG Grade 3 hernias in each participating hospital. However, due to the lack 
of consensus on what standard of care for VHWG Grade 3 hernias is, this would lead to a 
very heterogenous control group. This justifies the single-arm design of the study.
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CONCLUSION
This multicenter trial will collect additional data on safety and performance of Phasix™ 
Mesh in subjects with a VHWG Grade 3 midline hernia requiring surgical repair. Based 
on evidence from this clinical study, Phasix™ Mesh may become a preferred treatment 
option in VHWG Grade 3 patients. 
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a The CAROLINAS COMFORT SCALE™ questionnaire was created by and is licensed from the 
Division of Gastrointestinal and Minimally Invasive Surgery of Carolinas Medical Center, 
North Carolina
b Reprinted from Surgery, 148(3), The Ventral Hernia Working Group, Incisional ventral hernias: 
Review of the literature and recommendations regarding the grading and technique of 
repair, 544-558, Copyright (2010), with permission from Elsevier.
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Characteristics of Different Mesh Types for
Abdominal Wall Hernia Repair in an
Experimental Model of Peritonitis
jairam-layout.indd   205 28/05/2018   21:47
206
Chapter 10
ABSTRACT
Background: The use of synthetic mesh to repair a potentially contaminated incisional 
hernia may lead to higher failure rates. A biological mesh might be considered, but 
little is known about long-term results. Both biological and synthetic meshes were 
investigated in an experimental model of peritonitis to assess their characteristics in 
vivo.
Methods: Male Wistar rats were randomized into five groups and peritonitis was induced. 
A mesh was implanted after 24 h. Five meshes were investigated: PermacolTM (cross-
linked collagen), StratticeTM (non-cross-linked collagen), XCMTM Biologic (non-cross-
linked collagen), Omyra® Mesh (condensed polytetrafluoroethylene) and ParieteneTM 
(polypropylene). The rats were killed after either 30, 90 or 180 days. Incorporation and 
shrinkage of the mesh, adhesion coverage, strength of adhesions and histology were 
analysed.
Results: Of 135 rats randomized, 18 died from peritonitis. Some 180 days after 
implantation, both XCMTM Biologic and PermacolTM had significantly better incorporation 
than StratticeTM (P = 0.003 and P = 0.009 respectively). StratticeTM had significantly fewer 
adhesions than XCMTM Biologic (P = 0.001) and PermacolTM (P = 0.020). Thirty days after 
implantation, PermacolTM had significantly stronger adhesions than StratticeTM (P < 
0.001). Shrinkage was most prominent in XCMTM Biologic, but no significant difference 
was found compared with other meshes. Histological analysis revealed marked 
differences in foreign body response among all meshes.
Conclusion: This experimental study suggested that XCMTM Biologic was superior in 
terms of incorporation, macroscopic mesh infection, and histological parameters such 
as collagen deposition and neovascularization. There must be sufficient overlap of mesh 
during placement, as XCMTM Biologic showed a high rate of shrinkage.
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Surgical relevance 
The use of synthetic mesh to repair a potentially contaminated incisional hernia 
is not supported unequivocally, and may lead to a higher failure rate. A biological 
mesh might be considered as an alternative. There are few long-term studies, as 
these meshes are expensive and rarely used.
This study evaluated the use of biological mesh in a contaminated environment, 
and investigated whether there is an ideal mesh for this environment. A new non-
cross-linked biological mesh (XCMTM Biologic) was evaluated in this experiment.
The new non-cross-linked biological mesh XCMTM Biologic performed best and 
may be useful in patients with a potentially contaminated incisional hernia.
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INTRODUCTION
Incisional hernia is a common postoperative complication, with an incidence ranging 
from 11 to 20 per cent1,2. Currently, incisional hernias are most often repaired with mesh 
material3. The use of mesh significantly decreases 10-year recurrence rates4. There are 
various mesh types available; polypropylene mesh is the most widely used5,6.
The use of synthetic meshes to repair potentially contaminated or contaminated 
incisional hernias is not supported unequivocally and may lead to complications (wound 
healing problems, adhesions and fistula formation) and even death6,7. A biological 
mesh might be considered as an alternative8. These meshes are made from collagen-
containing tissues of human or animal origin9. They are composed of tissue such as 
intestine, heart valves or skin, and are processed to remove cells, cell components and 
hair (if present) as well as other antigens present in the tissue10,11. After decellularization 
and degradation of these tissues, a three-dimensional structure of collagen and some 
protein remnants remains. Additional chemical cross-linking of the mesh can be done 
to increase its strength and to slow down its degradation10,12,13. Degradation takes 
places after implantation of the mesh. During this phase, there is incorporation of host 
fibroblasts and collagen replacement occurs. This so-called xenograft remodelling 
begins within a few hours after implantation and continues for several months to years. 
Two experimental studies14,15 have assessed the efficacy of biological meshes in the 
short term. There are few long-term studies16,17, as these meshes are expensive and 
rarely used. 
In this study, both biological and synthetic meshes were investigated in an experimental 
peritonitis model. They were all compared in several aspects: incorporation, shrinkage, 
adhesion formation and abscess formation 30, 90 and 180 days after implantation. 
The aim of this study was to evaluate the feasibility of using a biological mesh in a 
contaminated environment, and to investigate whether there is an ideal mesh. The 
working hypothesis for this study was that biological meshes would be better than 
synthetic mesh in a contaminated field.
METHODS
Some 135 male Wistar rats were obtained from a licensed breeder (Harlan Laboratories, 
Boxmeer, The Netherlands). They were bred under specific pathogen-free conditions 
and were kept under standard laboratory conditions. This included a temperature of 
20-24°C, a relative humidity of 50-60 per cent, and 12-h light-dark cycles. The rats were 
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housed in pairs in individually ventilated cages, and fed freely with standard rat chow 
and water throughout the experiment. On arrival, the animals weighed 250-325 g and 
were acclimatized for at least 7 days before the experiment. The study protocol was 
approved by the Ethical Committee on Animal Experimentation of Erasmus University 
(Rotterdam, The Netherlands).
Peritonitis model
The rats were divided randomly into five groups of 27 animals each before the start of 
the experiment. All rats were anaesthetized with a mixture of isoflurane and oxygen, 
and received a single preoperative dose of 0.05 mg/kg buprenorphine analgesia 
subcutaneously. Before operation, all animals were weighed, the abdomen was shaved, 
and the skin disinfected with 70 per cent ethanol. The abdominal cavity was opened 
via a 3-cm midline incision. To induce peritonitis, the caecum ligation puncture model 
(CLP) was used18. The caecum was ligated just distal to the ileocaecal valve (maintaining 
bowel continuity) and punctured beyond the ligature with an 18-G needle. The fascia 
and skin were closed separately with a running absorbable suture of polyglycolic acid 
(5/0 Safil®; B. Braun, Melsungen, Germany). All animals received 5 ml sodium chlorine 0.9 
per cent and were placed under a heating lamp to recover from anaesthesia.
After 24 h, all rats were again anaesthetized with a mixture of isoflurane and oxygen. 
They received a single dose of buprenorphine (0.05 mg/kg subcutaneously). The skin 
was desinfected with 70 per cent ethanol, the abdomen was reopened, and a bacterial 
culture swab taken to confirm faecal peritonitis. The necrotic or ischaemic part of the 
caecum was removed. The abdominal cavity was rinsed with 20 ml warmed phosphate 
buffer and gentamicin was administered (6 mg/kg intramuscularly). A sterile mesh of 
2.5 × 3 cm was implanted intraperitoneally and fixed transmuscularly with six non-
absorbable nylon sutures (5/0 Ethilon®; Ethicon, Somerville, New Jersey, USA). The fascia 
and skin were closed separately with a running absorbable suture of polyglycolic acid 
(5/0 Safil®). All animals received 5 ml sodium chlorine 0.9 per cent and were placed under 
a heating lamp to recover from anaesthesia.
Mesh material
Five different meshes were analysed in this experiment. Two non-cross-linked collagen 
matrices of porcine dermis (StratticeTM, LifeCell Corporation, Branchburg, New Jersey, 
USA; XCMTM Biologic, Kensey Nash Corporation, Exton, Pennsylvania, USA, distributed 
by DePuy Synthes, Oberdorf, Switzerland), one cross-linked collagen matrix of porcine 
dermis (PermacolTM; Sofradim, Trévoux, France, part of Covidien-Medtronic, New Haven, 
Connecticut, USA), one mesh of condensed polytetrafluoroethylene (Omyra® Mesh; B. 
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Braun), and one polypropylene mesh (ParieteneTM; Sofradim). In a sterile environment, 
all meshes were cut to 2.5 × 3 cm. Each mesh was handled according to the instructions 
for use provided by the manufacturer.
Wellness and survival 
All animals were weighed on a daily basis in the first week after surgery and weekly 
thereafter. Maximum weight loss within the first 7 days was expressed as a percentage of 
the weight at the start of the experiment. Wellness and behaviour were assessed using 
a 12-point wellness scoring system19. Animals were killed if they reached the humane 
endpoint (at least 20 per cent weight loss or a wellness score less than 5 points). All 
animals that died underwent autopsy.
Macroscopic assessment of mesh-specific parameters
Animals were killed 30 days, 90 or 180 days after mesh placement. They were 
anaesthetized with a mixture of isoflurane and oxygen, the abdomen was shaved, and 
the skin desinfected with 70 per cent ethanol. The abdominal wall was opened via a 
U-shaped incision in the ventral abdominal wall. A photograph was taken of the inner 
abdominal wall and mesh site (Fig. 1). Incorporation and shrinkage of the mesh, adhesion 
coverage and strength of adhesions were assessed. All parameters were evaluated by 
two independent investigators. Discrepancies were discussed and resolved. The rat was 
killed by cardiac cut.
Incorporation of mesh
First, the remaining mesh was measured using a calliper and the perimeter calculated. 
Second, the incorporation of the mesh was assessed by lifting its edges; if the mesh could 
be lifted from the abdominal wall without adhering tissue, it had not been incorporated. 
The percentage incorporation was calculated as the length of incorporated mesh as a 
percentage of the perimeter of remaining mesh. Full incorporation was represented by 
incorporation of all sides, taking any shrinkage of the mesh into account.
Shrinkage of mesh
Shrinkage of the mesh was assessed by measurement of the surface of the remaining 
mesh using a calliper. The mesh surface at the time of death was expressed as a 
percentage of the standard implant size (7.5 cm2).
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Figure 1. Photograph taken during sacrifice: Inner abdominal wall and the mesh site (cross-
linked biological mesh)
Adhesions 
Adhesions were evaluated in two ways. First, a qualitative analysis was done to assess 
strength and tenacity of adhesions using the Zühlke score (Table S1, supporting 
information)20. Second, the quantity of adhesions was assessed and expressed as a 
percentage of adhesions on the mesh surface. 
Abscesses 
Abscesses were regarded as an expression of an ongoing intra-abdominal infection. 
The presence of abscesses was assessed by visual inspection and examination of the 
abdominal cavity. The size of all abscesses was scored using an abscess scoring system 
(Table S1, supporting information)21.
Histological evaluation
Full-thickness abdominal wall samples were harvested from each animal. This sample 
measured 1.0 × 0.5 cm, was taken from one of the long sides in between the sutures, 
and contained both abdominal wall and mesh (Fig. S1, supporting information). The 
jairam-layout.indd   211 28/05/2018   21:47
212
Chapter 10
samples were fixed for 24 h in 4 per cent formalin and subsequently embedded in 
paraffin. Two 4-µm sections were cut and stained with either haematoxylin and eosin 
or sirius red, according to standard diagnostic procedure in the pathology department.
All slides were analysed blind by an experienced pathologist. Haematoxylin and eosin-
stained slides were evaluated by means of a scoring system described by Peeters and 
colleagues22. All cells were assessed under the microscope and the number of cells 
per high-power field (40 × magnification) was counted. No additional stains were 
performed. Sirius red-stained slides were assessed using an adapted scoring system 
described by Deeken and Matthews23. Histological analysis of the biological meshes 
focused on the periprosthetic area, whereas analysis of ParieteneTM and Omyra® Mesh 
focused on both the perifilamentary areas and the pores. Both areas were assessed and 
a grade was given for the overall number of cells per sample. In addition, the extent of 
fibrous encapsulation around each mesh was assessed. The histological scoring systems 
used are described in Tables S3–S5 (supporting information).
Statistical analysis
A power calculation was done before the experiment. The calculation was based on an 
expected difference of 25–30 per cent in amount of adhesions between the meshes. 
The expected mortality of the CLP model was 25 per cent. Aiming for a power of 80 per 
cent and P < 0.050, the number of animals needed was 27 per group. All meshes were 
included in the experiment as equal study groups. None of the study groups served as 
a control group only.
Continuous variables are expressed as median (i.q.r.). As the data did not show a normal 
distribution for incorporation and shrinkage of the mesh, quantity and tenacity of 
adhesions, abscess formation and histological scores, statistical analyses were done 
using non-parametric Kruskal–Wallis tests for independent samples. If the overall test 
showed significant differences, pairwise tests were carried out to determine which 
groups caused these. P values were adjusted for multiple testing using Dunn’s post-test. 
P < 0.050 was considered statistically significant. All statistical analyses were undertaken 
in SPSS® version 21.0 (IBM, Armonk, New York, USA). 
RESULTS
All 135 rats survived the initial operation to induce peritonitis, but five died within 
24 hour after induction of peritonitis and another 13 died in the next 24 hours after 
implantation of the mesh (overall mortality rate 13.3 per cent). There were no significant 
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differences between the groups. None of the rats reached the humane endpoint. 
Autopsy in all animals showed that the cause of early death was abdominal sepsis 
secondary to faecal peritonitis. In addition, one rat in the XCMTM Biologic group died 14 
days after implantation from bowel obstruction caused either by intestinal adhesions 
or volvulus (adhesion between caecum and mesentery; no adhesions between bowel 
and mesh). The remaining 117 rats survived and could be analysed at the intended 
endpoint. The distribution of the surviving animals per study group is shown in Table 1.
Peritonitis model
The bacterial culture swab on day one confirmed intraperitoneal bacterial contamination 
with Gram-positive (Enterococcus, Staphylococcus) and Gram-negative (Escherichia coli) 
microorganisms in all rats. All animals suffered from symptoms of sepsis, including 
apathetic behaviour, piloerection, ocular exudates, abnormal posture, shivering, 
diarrhoea and weight loss. Mean weight loss varied from 9.0 to 11.2 per cent, and was 
significantly greater in the Omyra® Mesh group than in the XCMTM Biologic group (P = 
0.005) and the PermacolTM group (P = 0.013). There were no differences in wellness score 
among the five groups. The removed part of the caecum was macroscopically ischaemic 
in 89 per cent of the animals, necrotic in 4 per cent, and both ischaemic and necrotic in 
7 per cent of the animals.
Table 1. Overview of experimental groups 
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Weight (g/m2) 78 n.a. n.a. n.a. 90
Pore size (mm) 1.0–1.6 n.a. n.a. n.a. 2.4
No. of animals 27 27 27 27 27
Postoperative 
deaths
3 2 2 3* 9
No. analysed
30 days 8 9 9 10 6
90 days 9 8 9 7 6
180 days 7 8 7 7 6
* One rat died from bowel obstruction on day 14; results for this animal were not used for analysis. n.a., not applicable.
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Incorporation of mesh
 The percentage incorporation varied greatly between the mesh groups (Table 2 and Fig. 
2). At 180 days after implantation, it was highest for XCMTM Biologic (88(72-100) per cent), 
followed by PermacolTM (62(58-67) per cent), ParieteneTM (57(32-87) per cent), Omyra® 
Mesh (54(40-66) per cent) and lowest for StratticeTM (21(10-30) per cent). Both XCMTM 
Biologic and PermacolTM showed significantly better incorporation than StratticeTM 180 
days after implantation (P = 0.003 and P = 0.009). There were no significant differences 
in incorporation between the synthetic and biological meshes.
Shrinkage of mesh 
All meshes shrank; however, the amount of shrinkage varied widely from 12 to 51 per 
cent at different time points for different meshes (Table 2 and Fig. 3). Shrinkage was 
most evident in XCMTM Biologic: 21(4-36) per cent at 30 days, 43(38-66) per cent at 90 
days and 36(34-51) per cent at 180 days. ParieteneTM showed the least shrinkage at 30 
days after implantation (8(1-257) per cent ). StratticeTM and Omyra® Mesh showed the 
least shrinkage 90 days after implantation (15 (13-20) per cent and 15 (9-20)per cent 
respectively). StratticeTM showed the least shrinkage 180 days after implantation (13(5-
17) per cent). Although there were considerable differences in shrinkage between the 
various groups, no significant difference was found.
Adhesions 
The percentage of adhesions was relatively high in all mesh groups, except StratticeTM 
(Table 2). The percentage of adhesions increased over time in the XCMTM Biologic and 
Omyra® Mesh groups. The percentage of adhesions 180 days after implantation was 
highest in XCMTM Biologic (100(70-100) per cent), followed by PermacolTM (7363-83) 
per cent), ParieteneTM (70(60-80) per cent) and Omyra® Mesh (63(60-70) per cent), and 
lowest in StratticeTM (0(0-0) per cent). StratticeTM had a significantly lower percentage 
of adhesions than PermacolTM at all time points (P = 0.007, P = 0.002 and P = 0.020, 
respectively). The quantity of adhesions in StratticeTM was also significantly lower than in 
XCMTM Biologic 90 and 180 days after implantation (P = 0.009 and P = 0.001 respectively).
The tenacity of adhesions was strong to very strong at all time points in all mesh 
groups, except for StratticeTM. In the StratticeTM group, there was variation in median 
tenacity: no adhesions 30 days after implantation, strong adhesions at 90 days, and 
again no adhesions 180 days after implantation. PermacolTM was the only mesh that had 
significantly stronger adhesions than StratticeTM 30 days after implantation (P < 0.001). 
All other comparisons between the groups were not significant.
jairam-layout.indd   214 28/05/2018   21:47
215
Mesh types for hernia repair in an experimental model
10
Ta
bl
e 
2.
 R
es
ul
ts
 fo
r m
ac
ro
sc
op
ic
 m
es
h-
sp
ec
ifi
c 
pa
ra
m
et
er
s 
n
In
co
rp
or
at
io
n 
of
 m
es
h 
(%
)
Sh
ri
nk
ag
e 
of
 
m
es
h 
(%
)
A
dh
es
io
ns
 o
n 
m
es
h 
(%
)
Te
na
ci
ty
 o
f 
ad
he
si
on
s
N
o.
 o
f a
ni
m
al
s 
w
it
h 
ab
sc
es
s 
To
ta
l n
o.
 o
f 
ab
sc
es
se
s
A
bs
ce
ss
 s
co
re
 
(h
ig
he
st
)
Pa
ri
et
en
e™
30
 d
ay
s 
8
52
 (4
0-
60
)
8 
(1
-2
5)
63
 (5
0-
75
)
3 
(3
–3
)
0
0
n.
a.
90
 d
ay
s 
9
55
 3
0-
71
)
19
 (8
-2
9)
58
 (4
8-
70
)
3 
(3
–4
)
1
2
4
18
0 
da
ys
 
7
57
 (3
2-
87
)
14
 (5
-2
0)
70
 (6
0-
80
)
3 
(3
–3
)
0
0
n.
a.
Pe
rm
ac
ol
™
30
 d
ay
s 
9
57
 (5
0-
60
)*
22
 (7
-2
6)
70
 (5
5-
85
)*
3 
(3
–4
)*
0
0
n.
a.
90
 d
ay
s 
8
47
 (4
3-
54
)
23
 (1
9-
28
)
83
 (7
0-
93
)†
3 
(3
–4
)
1
1
0.
5
18
0 
da
ys
 
8
62
 (5
8-
67
)‡
20
 (1
7-
24
)
73
 (6
3-
83
)‡
3 
(3
–3
)
0
0
n.
a.
St
ra
tt
ic
e™
30
 d
ay
s 
9
16
 (1
2-
22
)
18
 (1
2-
25
)
0 
(0
-5
)
0 
(0
–2
)
0
0
n.
a.
90
 d
ay
s 
9
18
 (1
3-
27
)
15
 (1
3-
20
)
0 
(0
-5
)
3 
(2
–3
)
0
0
n.
a.
18
0 
da
ys
 
7
21
 (1
0-
30
)
13
 (5
-1
7)
0 
(0
-0
)
0 
(0
–3
)
0
0
n.
a.
XC
M
™
 B
io
lo
gi
c
30
 d
ay
s 
10
38
 (3
4-
44
)
21
 (4
-3
6)
25
 (5
-7
0)
3 
(3
–3
)
0
0
n.
a.
90
 d
ay
s 
7
46
 (4
2-
75
)
43
 (3
8-
66
)
95
 (5
0-
10
0)
†
3 
(3
–3
)
0
0
n.
a.
18
0 
da
ys
 
7
88
 (7
2-
10
0)
‡
36
 (3
4-
51
)
10
0 
(7
0-
10
0)
‡
3 
(3
–3
)
0
0
n.
a.
O
m
yr
a®
 M
es
h
30
 d
ay
s 
6
59
 (4
3-
73
)
14
 (1
2-
16
)
38
 (2
0-
55
)
3 
(3
–3
)
0
0
n.
a.
90
 d
ay
s 
6
40
 (2
5-
62
)
15
 (9
-2
0)
48
 (3
0-
60
)
3 
(3
–3
)
0
0
n.
a.
18
0 
da
ys
 
6
54
 (4
0-
66
)
27
 (3
-3
3)
63
 (6
0-
70
)
3 
(3
–3
)
0
0
n.
a.
Va
lu
es
 a
re
 m
ed
ia
n 
(i.
q.
r.)
. n
.a
., 
N
ot
 a
pp
lic
ab
le
. *
P 
< 
0.
05
0 
ve
rs
us
 S
tr
at
tic
e™
 a
t 3
0 
da
ys
, †
P 
< 
0.
05
0 
ve
rs
us
 S
tr
at
tic
e™
 a
t 9
0 
da
ys
, ‡
P 
< 
0.
05
0 
ve
rs
us
 S
tr
at
tic
e™
 a
t 1
80
 d
ay
s 
(K
ru
sk
al
–W
al
lis
 te
st
 
w
ith
 D
un
n’
s 
po
st
-t
es
t)
. 
jairam-layout.indd   215 28/05/2018   21:47
216
Chapter 10
Figure 2. Median percentage incorporation of each mesh at 30, 90 and 180 days
Figure 3. Median percentage shrinkage of each mesh at 30, 90 and 180 days
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Abscesses
Abscess formation was rare; only two animals developed abscesses (Table 2). Both 
animals were killed after 90 days: one in the ParieteneTM and the other in the PermacolTM 
group. The animal in the ParieteneTM group had a small abscess on the bowel (not in 
proximity to the caecal ligation site) and a large macroscopic abscess alongside the 
mesh. The animal in the PermacolTM group had a very small macroscopic abscess 
alongside the mesh.
Histological evaluation
Four slides from the XCMTM Biologic group did not contain mesh material and could not 
therefore be analysed. One of these incomplete samples was harvested 30 days after 
implantation, two samples were harvested 90 days after implantation and the fourth 
180 days after implantation.
In general, the haematoxylin and eosin staining revealed no significant differences 
in the total count of inflammatory cells, mononuclear cells and extracellular matrix 
deposition between the different mesh groups (Tables S6 and S7, Figs S2–S5, supporting 
information, online available). The histological findings of all meshes are discussed 
individually as follows.
ParieteneTM 
ParieteneTM mesh had a large number of macrophages, foreign body giant cells, 
eosinophils and neutrophils at all time points. The number of macrophages and foreign 
body giant cells was significantly higher after 180 days in ParieteneTM than in StratticeTM (P 
= 0.022). Numbers of eosinophils and neutrophils, on the other hand, were significantly 
higher in ParieteneTM mesh than in the non-cross-linked biological mesh at 30 and 90 
days. Sirius red staining revealed significantly greater collagen deposition in ParieteneTM 
compared with StratticeTM 30 and 180 days after implantation.
PermacolTM 
Slides of the PermacolTM meshes showed a moderate amount of macrophages, but only 
scanty eosinophils and neutrophils. There were no significant differences compared with 
other mesh groups. There was a significantly greater amount of collagen encapsulation 
in the PermacolTM group than in the StratticeTM group at 30 days (P = 0.029) and 180 days 
(P = 0.031) after implantation. 
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Evaluation of mesh-specific histological parameters revealed moderate to pronounced 
scaffold degradation, pronounced fibrous encapsulation, and peripheral cellular 
infiltration and neovascularization. There were no significant differences between 
PermacolTM and other mesh groups.
StratticeTM 
Compared with ParieteneTM mesh, StratticeTM had significantly fewer neutrophils and 
eosinophils 30 and 90 days after implantation, and significantly fewer macrophages 
180 days after implantation. In addition, StratticeTM had significantly less collagen 
encapsulation than ParieteneTM and PermacolTM 30 and 180 days after implantation.
Assessment of the mesh-specific histological parameters revealed a significantly 
increased amount of scaffold degradation in Strattice™ than in ParieteneTM and Omyra® 
Mesh 90 days after implantation.
XCMTM Biologic
XCMTM Biologic had large numbers of macrophages and foreign body giant cells present 
30 and 90 days after implantation (more than 10 cells per high-power field). In contrast, 
eosinophils and neutrophils were almost absent, and their numbers were therefore 
significantly lower than in ParieteneTM at 90 days (P = 0.029). XCMTM Biologic had 
significantly more collagen encapsulation than StratticeTM 30 days after implantation. 
There were no significant differences at other time points.
Analysis of mesh-specific histological parameters revealed an increased amount of 
scaffold degradation at all time points compared with other meshes, but this difference 
was only significant compared with ParieteneTM at 30 days after implantation (P = 0.025).
Omyra® Mesh 
Omyra® Mesh had large numbers of macrophages and foreign body giant cells at all time 
points (more than 10 cells per high-power field). Thirty days after implantation, there 
was a large number of eosinophils and neutrophils, but these were absent at 90 and 
180 days. At 90 days after implantation, collagen encapsulation was significantly more 
prominent around the Omyra® Mesh than around StratticeTM (P = 0.002).
Assessment of mesh-specific histological parameters revealed the absence of scaffold 
degradation with an increased amount of fibrous encapsulation at all time points.
jairam-layout.indd   218 28/05/2018   21:47
219
Mesh types for hernia repair in an experimental model
10
DISCUSSION
This experimental study in a peritonitis model revealed that the use of biological mesh 
is feasible in a contaminated environment. Overall, XCMTM Biologic appeared superior in 
this model; however, adhesions and shrinkage of the mesh were evident.
Regarding the individual meshes, StratticeTM had inferior incorporation, whereas the 
other meshes incorporated well. This agrees with previous studies14,24 using StratticeTM 
mesh. Even 180 days after implantation, there was little incorporation of this mesh 
into the abdominal wall. In addition, it was found that collagen deposition was less in 
StratticeTM than in the other meshes.
Overall, there was a large, but non-significant variation in shrinkage, ranging from 8 to 
43 per cent at various time points. XCMTM Biologic shrank excessively, by 21–43 per cent. 
Structural resistance might be influential with regard to mesh shrinkage. Resistance 
is a function of the volume of the material used in the mesh. Large-pore, low-weight 
meshes show less resistance, and thus less shrinkage. No previous studies of XCMTM 
Biologic have assessed shrinkage rates in an experimental model. The other meshes 
studied shrank between 8 and 27 per cent at various time points. This finding highlights 
the importance of implanting mesh materials with sufficient overlap around a hernia 
defect.
All meshes, except for StratticeTM, formed strong adhesions; those formed by PermacolTM 
were significantly stronger than those on all other meshes. The tenacity of adhesions is 
linked to the percentage adhesion on the surface of the mesh.
Although all meshes were assessed in a peritonitis model, active inflammation with 
abscess formation was found in only two animals at the time of death. Previous 
studies14,24 revealed abscesses in 42–62 per cent of animals at the time of death. 
Both Deerenberg and colleagues14 and the present study group studied StratticeTM, 
ParieteneTM and Omyra® Mesh. In the study of Deerenberg et al.14, these three meshes 
showed little abscess formation. There were significantly larger numbers of abscesses 
surrounding the mesh in C-QurTM (omega-3-fatty acid-coated polypropylene; Atrium, 
Hudson, New York, USA), and DualMesh® (expanded polytetrafluoroethylene; Gore, 
Flagstaff, Arizona, USA). Mulder and colleagues24 reported abscesses on more than 50 
per cent of PermacolTM meshes. Many abscesses were also found in Surgisis® (non-cross-
linked porcine submucosa; Cook Medical, Bloomington, Indiana, USA) and CollaMendTM 
FM (cross-linked porcine dermis; C.R. Bard (Davol), Warwick, Rhode Island, USA), meshes 
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that were not investigated here. Aside from the mesh materials, another reason for the 
lack of abscesses could be the fact that the substrain of Wistar rats used in the present 
study is more resistant to infection.
In this study, the synthetic meshes ParieteneTM and Omyra® Mesh and the biological 
cross-linked mesh PermacolTM incorporated well and had only moderate shrinkage. 
Although the three meshes arepoly of different materials, their in vivo response was 
similar. Interestingly, PermacolTM is the only biological mesh in this study that mimicked 
the behaviour of the synthetic meshes. PermacolTM is of porcine origin and is additionally 
cross-linked with hexamethylene di-isocyanate25. These additional cross-links give a 
more synthetic-like behaviour to the biological mesh compared with the non-cross-
linked biological meshes. The foreign body reaction against PermacolTM may therefore 
be comparable to that of the synthetic meshes, but not to that of the non-cross-linked 
biological meshes.
Two distinct patterns were identified when the histological mesh-specific parameters 
were evaluated. First, the synthetic meshes ParieteneTM and Omyra® Mesh, and the cross-
linked biological mesh PermacolTM, showed almost no scaffold degradation, a large 
amount of fibrous encapsulation, and little or no cellular infiltration, neovascularization 
and extracellular matrix deposition. Second, the non-cross-linked meshes StratticeTM 
and XCMTM Biologic showed a large amount of scaffold degradation, little to no 
fibrous encapsulation, and considerable cellular infiltration, neovascularization and 
extracellular matrix deposition. These two patterns could be explained by the respective 
mesh materials. If high biocompatibility is desirable, a non-cross-linked biological mesh 
is optimal. However, slower mesh incorporation and quicker mesh degradation should 
be taken into account.
There are several limitations to this study that do not allow direct translation to a clinical 
setting. There are three differences between the human situation and this experimental 
study. First, there is a difference in the treatment of abdominal sepsis. The rats received 
a single dose of antibiotics and one abdominal cavity rinse, whereas humans receive 
long-term intravenous antibiotics and undergo extensive debridement with or without 
open abdomen treatment. Second, there are differences in the dimension of the mesh. 
The mesh is proportionally much thicker in rats than in humans, in comparison with the 
thickness of the abdominal wall. This could lead to decreased incorporation of the mesh 
in the rat model. Third, all meshes were placed intraperitoneally in this study. This includes 
non-coated or non-composite synthetic meshes, whereas previous studies14,24,26–28 
showed high cellular reactivity and adhesion formation after intraperitoneal placement 
of these meshes compared with extraperitoneal placement. The same applies to the 
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cross-linked mesh PermacolTM, which was placed intraperitoneally in the rat model, 
whereas in humans results of placement in the intraperitoneal plane have been 
variable10,29,30. However, closure of the peritoneum is not always possible in patients, 
and contact between the viscera and mesh could be occurring. Therefore, it is important 
to assess mesh behaviour of synthetic and cross-linked meshes in an intra-abdominal 
environment in vivo.
In this experimental study, XCMTM Biologic appeared superior, in terms of incorporation, 
macroscopic mesh infection, and histological parameters such as collagen deposition 
and neovascularization. It is important, however, that there is a sufficient overlap of the 
mesh during placement, as XCMTM Biologic showed a high rate of shrinkage. 
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Figure S10  Haematoxylin and eosin staining of non-cross-linked biological mesh 
(XCMTM Biologic), without abscess (original magnification × 20) (Word 
document)
Figure S11 Sirius red staining of non-cross-linked biological mesh (XCMTM Biologic), 
without abscess (Word document)
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The Feasibility of Local Anesthesia for
the Surgical Treatment of Umbilical Hernia:
a systematic review of the literature
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ABSTRACT
Background: Yearly approximately 4500 umbilical hernias are repaired in the 
Netherlands, mostly under general anesthesia. The use of local anesthesia has shown 
several advantages in groin hernia surgery. Local anesthesia might be useful in the 
treatment of umbilical hernia as well. However, convincing evidence is lacking. We have 
conducted a systematic review on safety, feasibility, and advantages of local anesthesia 
for umbilical hernia repair. 
Methods: A systematic review was conducted according to the PRISMA guidelines. 
Outcome parameters were duration of surgery, surgical site infection, perioperative 
and postoperative complications, postoperative pain, hernia recurrence, time before 
discharge, and patient satisfaction. 
Results: The systematic review resulted in 9 included articles. Various anesthetic agents 
were used, varying from short acting to longer acting agents. There was no consensus 
regarding the injection technique and no conversions to general anesthesia were 
described. The most common postoperative complication was surgical site infection, 
with an overall percentage of 3.4%. There were no postoperative deaths and no allergic 
reactions described for local anesthesia. The hernia recurrence rate varied from 2% 
to 7.4%. Almost 90% of umbilical hernia patients treated with local anesthesia were 
discharged within 24 hours, compared with 47% of patients treated with general 
anesthesia. The overall patient satisfaction rate varied from 89% to 97%.
Conclusion: Local anesthesia for umbilical hernia seems safe and feasible. However, 
the advantages of local anesthesia are not sufficiently demonstrated, due to the 
heterogeneity of included studies. We therefore propose a randomized controlled trial 
comparing general versus local anesthesia for umbilical hernia repair. 
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INTRODUCTION
Umbilical hernia is a common diagnosis in surgery [1, 2]. Approximately 10% of all 
abdominal wall hernias are defined as umbilical hernia [3], and the prevalence of 
umbilical hernia in the adult population is 2% [4]. The European Hernia Society defines a 
primary umbilical hernia as a ventral hernia present at birth or developed spontaneously 
without trauma to the abdominal wall as the cause of the hernia and with its center at 
the umbilicus [5]. Each year, approximately 4500 umbilical hernias are repaired in the 
Netherlands and most of these patients are operated under general anesthesia.
Worldwide, ever more patients undergo ambulatory hernia surgery performed under 
local anesthesia [6]. Local anesthesia in the treatment for groin hernias has been already 
thoroughly investigated. Studies showed the superiority of local anesthesia for open 
groin hernia repair than general anesthesia or spinal anesthesia [7-13]. However, only 
7% of Dutch surgeons uses local anesthesia in Lichtenstein repair [13]. This is surprising, 
since the use of local anesthesia could prevent complications related to general 
anesthesia. Possible advantages of the use of local anesthesia are less postoperative 
pain and extended postoperative analgesia, less perioperative and postoperative 
complications, early mobilization, and therefore a shorter duration of hospital stay. 
Furthermore, use of local anesthesia could be more cost-effective than general 
anesthesia or spinal anesthesia, since there is no anesthesiologist needed and only less 
expensive local anesthetics are used [7, 13-16]. There is a lack of convincing literature on 
umbilical hernia repaired under local anesthesia [1]. We have conducted a systematic 
review of the literature on the safety, feasibility, and advantages of local anesthesia for 
the repair of umbilical hernia. 
MATERIAL AND METHODS
We conducted a systematic review following the PRISMA guidelines [17]. A systematic 
search was performed in MEDLINE, Embase, Web of Science, Scopus, PubMed Publisher, 
and the Cochrane Library.
The search strategy was prepared by the Biomedical Information Specialist of the 
MedicalVLibrary (Erasmus University Medical Center, Rotterdam, the Netherlands). A 
syntax with search terms was designed, which is available at Appendix 1.
Records identified were independently evaluated by two reviewers. All records were 
screened by title and abstract for eligibility, and the full text of eligible records was 
assessed. Studies were included into the analysis if they met the following inclusion 
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criteria: adult patients with umbilical hernia or paraumbilical hernia, who were operated 
under local anesthesia with or without a control group operated with another type of 
anesthesia. Articles had to be written in Dutch, English or German, and randomized 
controlled trials, cohort studies and case series (with more than 5 patients) were 
included. Exclusion criteria were studies investigating local anesthesia for other types 
of hernia than umbilical hernias, laparoscopic surgery, and animal studies or in vitro 
experiments. 
The following outcome measurements were assessed: postoperative pain, duration of 
surgery, surgical site infection, perioperative and postoperative complications, hernia 
recurrence, time before discharge, and patient satisfaction. We also extracted the 
baseline study characteristics from all included studies: study design, study period, and 
year of publication. The quality of the studies was assessed on the Level of Evidence 
scale of the Oxford Centre for Evidence-based Medicine [18]. 
Both reviewers independently sampled the data in a standardized database. This 
database was set up in Microsoft Office Excel 2010. The data presented in this review were 
directly abstracted from the original articles. No statistical analyses were performed.
RESULTS
A total of 1107 articles were identified after the removal of duplicates. After screening 
of these records 77 articles were found eligible for further assessment. After assessment 
of the full text versions of these 77 articles, 9 articles were suitable for inclusion in this 
review. The reasons for exclusion were as follows: anesthesia or umbilical hernia were 
not well described and not the main subject, research was performed in children or 
animals, the article contained a case report, there was only an abstract available, or the 
article was written in another language than Dutch, English or German. The PRISMA 
flow diagram is shown in Figure 1.
Of the 9 included articles, 6 were prospective cohort studies, and 3 were retrospective 
cohort studies. No randomized study comparing local versus general anesthesia was 
found. All studies contained a Level of Evidence of 2B on the scale of the Oxford Centre 
for Evidence-based Medicine. Table 1 gives an overview of the articles we included for 
this review. 
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In this review, the following outcome parameters will be highlighted: anesthesia 
technique, postoperative pain, duration of surgery, surgical site infection, perioperative 
and postoperative complications, recurrence, time before discharge and patient 
satisfaction. The anesthesia technique was described to outline if there was any 
consensus regarding the injection technique and the type of anesthetics.
Figures and captions 
Figure 1: Flow diagram search 
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Figure 1. PRISMA flow diagram
Surgical technique
There were 2 studies in which a Mayo repair was performed, with the classical ‘vest over 
pants’ technique [19, 20]. Bennett et al. inserted a polypropylene soft mesh plug if the 
defect was < 2 cm. In case the defect was > 2 centimeter, a preperitoneal pocket was 
made and a polypropylene soft mesh was placed, with a 2 centimeter margin [14].  In the 
study of Kurzer et al. a cone polypropylene mesh was used for defects < 3 centimeter,
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and a flat piece mesh for defects > 3 centimeter [2]. Garcia et al. used 1 centimeter 
as a cutoff point for a primary suture, and ‘large’ hernias, as they stated, received a 
polypropylene mesh [4]. Three articles did not mention which cutoff point they used 
to determine the use of primary sutures or a mesh, and in only one study umbilical 
hernia operations with meshes was performed [1, 3, 6, 19].  Dalenbäck et al. were the 
only authors who specified the type of surgical procedure for the type of anesthesia. A 
total of 162 patients underwent an umbilical hernia operation. Of the patients operated 
with a suture repair, 59% were operated under local anesthesia and 41% under general 
anesthesia. Of the patients receiving a mesh repair, 18% were operated under local 
anesthesia and 82% under general anesthesia.
Anesthesia technique 
There are various anesthesia techniques assessed in the studies. Only Acevedo and 
Léon described the use of local anesthesia without addition of a sedative [6]. Four other 
studies combined the use of local anesthesia with sedatives and another 4 studies used 
local anesthesia (without sedatives) or general anesthesia for their patient groups [1-
4, 14, 19-21]. None of the authors randomized between local anesthesia and general 
anesthesia. Table 2 shows the various types of anesthesia (local anesthesia or general 
anesthesia, local anesthesia with our without sedatives) and the different types of 
anesthetic drugs that were used. The anesthetic drugs varied from the short acting 
lidocaine and xylocaine to the longer acting agent bupivacaine. Bennett et al. were the 
only authors who described the injection technique, which was a field block technique: 
infiltration of the skin and rectus sheath around the umbilicus [14]. Kulacoglu et al. 
studied patients with umbilical hernia treated with local anesthesia. They stated there 
were no conversions to general anesthesia; all patients tolerated local anesthesia and 
there were no intraoperative anesthesia-related complications [1].
Postoperative pain
One study made use of the Visual Analogue Scale (VAS) as a measurement scale to 
define ‘postoperative pain’. The authors included patients with different types of hernia 
and concluded that 79% of lean patients (BMI < 30) had a VAS of < 3, compared with 
71.9% of the obese patients (BMI ≥ 30). This difference was statistically significant (p 
= 0.007). In this study, no distinction was made between VAS scores per hernia type. 
It was neither described what VAS score patients had who were operated under local 
anesthesia [6].
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Table 2. Anesthesia techniques: the different types of anesthesia used and types of local 
anesthetics
Author LA LA +  sedation LA or GA
Acevedo and Léon Lidocain 0.5% Not applicable
Bennett et al. Not applicable Not applicable GA: not described
LA: Xylocaine 2%, 
Bupivacain 0.5%
Dalenback et al. Not applicable Not applicable GA: not described
LA: not described
Garcia et al. Not applicable Lidocaine 1% + midazolam Not applicable
Kulacoglu et al. Not applicable Lidocaine, bupivacaine 0.5% 
+ midazolam and fentanyl
Not applicable
Kurzer et al. Not applicable Bupivacaine 0.25% + midazolam Not applicable
Menon and Brown Not applicable Xylocaine 1% + Bupivacaine 
0.5% + midazolam
Not applicable
Sinha and Keith Not applicable Not applicable GA: not described
LA: xylocaine 1%
Stabilini et al. GA: not described
LA: mepivacaine 
Two other studies used terminology like‘ mild, moderate or severe’ and ‘no severe 
postoperative pain’ to report pain [1, 2]. The authors did not mention which questionnaire 
or measurement scale was used for these statements. 
Duration of surgery
Six authors investigated the duration of surgery, which ranged from 24 to 78 minutes 
[1, 4, 6, 14, 20, 21]. Table 3 shows that Bennett et al. were the only authors making 
a distinction between local anesthesia and general anesthesia for this outcome 
parameter. This study showed that the use of local anesthesia for paraumbilical hernia 
could lead to a shorter duration of surgery than the use of general anesthesia (p-value 
< 0.0003). However, patients with a lower BMI were more frequently operated under 
local anesthesia. When BMI was categorized to see if there was any difference between 
patients with a BMI less or more than 25, and less or more than 30 (obese), there was 
no difference found in the length of the procedure [14]. Kulacoglu et al. and Menon and 
Brown all included patients with umbilical hernia treated with local anesthesia alone. 
Kulacoglu et al. showed that the mean operative time was 69 minutes (range: 25-150 
minutes), but in the patient group of Menon and Brown, the duration of surgery was 
significantly shorter with a mean operative time of 30 minutes (range: 22-40 minutes) 
[1, 20].
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Table 3. Duration of surgery
Author N Hernia type Anesthesia
Duration of surgery,
mean (min)
Acevedo and Léon 2031 Inguinofemoral, epigastric, 
umbilical, incisional
LA Lean 62 (± 8.6) min
Obese 78 (±11.7) min, p < 0.001
Bennett et al. 63 Paraumbilical LA + GA LA 24 (17.5-30)
GA 35 (27045), p < 0.0003
Garcia et al. 157 Umbilical, epigastric LA 49.7
Kulacoglu et al. 100 Umbilical LA 69 (25-150)
Menon and Brown 32 Umbilical LA 30 (22-40)
Sinha and Keith 34 Umbilical LA + GA 50 (40-108)
Surgical Site Infection 
Surgical site infection (SSI) is a common postoperative complication and one of the 
most commonly described outcome parameters. The overall percentage of SSI was 3.4% 
(15/431), and  ranged from 1% to 12.9%  [1, 2, 4, 19, 20]. Three studies described that SSI 
responded well to conservative wound care or oral antibiotics, and no further treatment 
was required. Two remaining studies did not describe the treatment for SSI. Besides 
Acevedo and Léon, none of the authors described in which patient group SSI occurred 
[1, 2, 4, 19, 20]. Acevedo and Léon noted that there was a significantly higher rate of SSI 
in obese patients (BMI > 30) than in non-obese patients, respectively 2.1% and 0.7% (p < 
0.023). None of the articles specified the SSI rate per hernia or anesthesia type, nor was it 
described if SSIs were more frequently seen in patients treated with a mesh. 
Other postoperative complications
The most frequent postoperative complications were seromas, with a range of 3% to 
8.9%, and an overall percentage of 4.8%. All seromas either resolved spontaneously 
or were successfully treated with drainage [1, 3, 4, 21]. The second most frequent 
postoperative complication were hematomas (1%) [1, 3, 4]. There was one patient 
who suffered from postoperative bleeding and one other patient who suffered from 
intestinal obstruction. Both patients needed emergency surgery to resolve these 
complications [19]. Postoperatively, there were 2 patients suffering from allergic skin 
changes due to a plaster allergy [1]. Finally, there was one 86-year old patient operated 
under general anesthesia, who experienced episodes of confusion and dizziness 
postoperatively. Therefore, a prolonged hospital stay of 12 days was needed [21]. In 
total, 3 patients passed away after surgery, respectively due to the following causes: 
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liver cirrhosis, cerebral infarction and chronic renal failure. All causes were not related to 
the operation [3]. No perioperative complications were described. None of the articles 
made a comparison between type of anesthesia.   
Recurrence
Seven studies described hernia recurrence rate as an outcome measurement [1-4, 19-
21]. In 3 of these studies, no recurrences occurred [1, 2, 20]. The mean follow-up in these 
studies was 17 months (5-41), 43 months (28-67), and 70 months (27-142). The remaining 
4 articles measured a recurrence rate ranging from 2% to 7.4% [3, 4, 19, 21]. These 4 
studies did not all mention which patients presented with a recurrence. Dalenbäck et 
al. were the only authors who included umbilical hernia patients alone. They made a 
distinction in recurrence rates between patients operated under general anesthesia and 
patients operated under local anesthesia. The authors found 2 recurrences (out of 144 
patients) in the general anesthesia group and 5 recurrences (out of 144 patients) in the 
local anesthesia group. No statistical comparison was made between these two groups 
[19]. The studies did not describe how the recurrence was diagnosed: with physical 
examination only or with the addition of radiological examination. 
Duration of postoperative stay
The mean duration of postoperative stay at the hospital varied from 2 hours to almost 
2 days [1, 3, 4, 20, 21]. Table 4 gives an overview of the mean time before discharge. 
Kulacoglu et al. showed that patients with umbilical hernia, operated under local 
anesthesia, stayed 122±58 min in hospital before discharge [1]. Sinha and Keith 
described that 89% of the patients in the local anesthesia group were discharged in less 
than 24 hours, compared with 47% of the patients in the general anesthesia group [21]. 
The other articles did not specify the duration of stay for the type of anesthesia or type 
of hernia. The longest mean duration of stay was 1.8 days (range: 3 hours – 15 days) and 
was required due to severe associated diseases of the patients, emergency surgery for 
hernia strangulation and wound hematoma [3]. 
Patient satisfaction 
Five studies reported on patient satisfaction, which was reported to be good in 89% 
till 97% of patients. Different methods of measuring this outcome parameter were 
used. Acevedo and Léon defined patient satisfaction as good, if the VAS for patient 
satisfaction was > 7 points on a 10 points scale, in combination with a positive answer to 
the question ‘would you recommend this kind of surgery to others?’ This was measured 
at the 1 week control [6]. Sinha and Keith stated that 97% of their patient population 
was satisfied, according to the definition of Reitter. [21]. The remaining 3 authors did 
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not describe which questionnaire was used to define and measure patient satisfaction 
[1, 14, 19].  Two authors specified the patient satisfaction with regard to the Body Mass 
Index of the patient [6, 14]. None of the articles specified the patient satisfaction per 
hernia type or anesthesia type [1, 19, 21]. 
Table 4. Time to discharge 
Author Type of anesthesia Type of hernia Time to discharge (mean)
Garcia et al. Local anesthesia Umbilical and 
epigastric hernia
7.2 hours
Kulacoglu et al. Local anesthesia Umbilical hernia 122 min ± 58 min (45-420)
Menon and Brown Local anesthesia Umbilical hernia Same day, discharge before 20:00 PM 
Sinha and Keith General or local 
anesthesia
Paraumbilical hernia LA: 89% discharged < 24 hour
GA: 47% discharged < 24 hour
Stabilini et al. General or local 
anesthesia
Umbilical hernia and 
epigastric hernia
1.8 days (3 hours – 15 days)
DISCUSSION
The data from this systematic review reveal that the use of local anesthesia in umbilical 
hernia repair led to a shorter duration of postoperative stay, and that repair of a 
paraumbilical hernia performed under local anesthesia leads to a shorter duration of 
surgery. The use of local anesthesia did not lead to perioperative complications, serious 
postoperative complications, allergic responses or anesthesia-related deaths.
Umbilical hernia is a common surgical problem [1, 2]. At this moment, data on umbilical 
hernia surgery under local anesthesia are only scarcely available. In contrast, groin 
hernias operated under local anesthesia are very well described in literature, and several 
studies have been performed [7, 10-13, 15, 22]. These studies all show the advantages 
of local anesthesia: less postoperative and general anesthesia related complications, a 
shorter duration of surgery, less overnight admissions, less postoperative pain and no 
deaths. Van Veen et al. showed that significantly more urinary retentions occurred in 
patients undergoing Lichtenstein hernia repair under spinal anesthesia [7]. Furthermore, 
the conversion rate to general anesthesia was lower for patients operated under local 
anesthesia (2%) than patients operated under spinal anesthesia (10%) [15]. Nordin et al. 
also showed that local anesthesia has significant cost advantages compared to spinal 
anesthesia and general anesthesia [12]. We therefore performed a review of literature to 
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investigate the safety and feasibility of the use of local anesthesia for umbilical hernia 
and to explore if there are any advantages to the use of local anesthesia for umbilical 
hernia.   
We have performed a literature search and found no randomized controlled trials 
or other significant papers giving solid evidence for the use of local anesthesia as 
being superior in the treatment of umbilical hernias. Only a few small prospective or 
retrospective cohort studies were included in this review. The studies we included do 
not all solely include umbilical hernias, and when the studies did include solely umbilical 
hernias, the authors did not describe their local anesthesia treatment well. 
If we take a closer look at the included studies, a very high heterogeneity can be noticed. 
First of all; there is no consensus regarding the local anesthetic drug, and the technique 
to induce local anesthesia. The used local anesthetic drug varies from shorter acting 
lidocaine to the longer acting ropivacaine. The technique to inject is not discussed in 
most of the articles, one article mentioning the ‘field block’ as a way to induce local 
anesthesia. Some authors diluted their anesthetic with another type of anesthetic, 
others diluted it with saline or adrenaline. Amid et al. described a simple step-by-step 
infiltration technique for inguinal hernia, which is adapted and followed in most of the 
studies using local anesthesia for inguinal hernia [7, 10, 13, 15, 23]. Furthermore, Amid 
et al. used a solution which consisted of 1% lidocaine, 1% bupivacaine and epinephrine, 
which is used by other authors as well [7, 15]. In local anesthesia of umbilical hernia, a 
standardized protocol is missing and should therefore be set up. 
Pain is an important outcome measurement. However, not all studies describe 
perioperative or postoperative  pain as an outcome measurement, and not all authors 
who do describe postoperative  pain use the Visual Analog Scale (VAS) to measure 
pain. Several studies regarding inguinal hernia have shown that postoperative pain 
in patients treated with local anesthesia is (significantly) lower compared to general 
anesthesia or spinal anesthesia [7, 15], but this outcome measurement is, despite of its 
importance, not thoroughly investigated for umbilical hernia.  Due to this inconsistency, 
comparison of the studies is impossible. 
Another essential outcome measurement is represented by postoperative complications. 
Surgical site infections and seromas are the most common complications. In the 
underlying studies, these complications either resolved spontaneously, were treated 
with drainage or antibiotics, and had no serious consequences for the patient. It is 
not clear if complications occurred more frequently among patients treated with local 
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anesthesia, since the authors did not describe which patient developed a postoperative 
complication. There were no perioperative complications, nor any allergies against local 
anesthetics, or deaths described. 
The hernia recurrence rate varied from 2% to 7.4%, with a higher percentage for patients 
who were treated with primary sutures. This is comparable with the available literature, 
which describes a recurrence rate of approximately 2% for mesh repair, rising up to 
8% for suture repair [24, 25]. However, recently the cohort study of Christoffersen et al. 
showed that the total cumulated recurrence rate after primary repair was 10% for mesh 
repair and 21% for sutured repair after 55 months of follow up (p = 0.001) [26], which 
is a surprisingly high percentage.  Dalenbäck et al. showed that the recurrence rate 
among umbilical hernia patients operated under local anesthesia was higher (5/144) 
than in patients operated under general anesthesia (2/144). However, since there was 
no statistical comparison made, no conclusions can be drawn. 
The duration of surgery varied from 24 to 78 minutes, and was for all studies, with one 
exception, not specified per type of hernia or type of anesthesia. Bennett et al. were 
the only authors who did specify the outcomes per anesthesia type and showed that 
patients with a paraumbilical hernia operated under local anesthesia had a shorter 
duration of surgery than patients operated under general anesthesia. However, when 
BMI was categorized (more or less than BMI 25, and more or less than a BMI of 30), there 
were no differences found for duration of surgery. It can be concluded that BMI was a 
confounding factor, and patients who were operated under local anesthesia had more 
frequently a lower BMI.
Almost 90% of the patients operated with local anesthesia were discharged within 24 
hours. This percentage rate is almost twice as high as patients operated under general 
anesthesia: 47% was discharged within 24 hours. This is comparable with the available 
literature for groin hernias. Studies show a significantly shorter in hospital stay as well, 
and significantly less postoperative overnight admissions [7, 15]. There is no study 
comparing the difference in discharge time for local anesthesia and general anesthesia 
in umbilical hernia patients. 
The present review has some limitations. Heterogeneity is the main disadvantage of 
this study. There is no consensus regarding the injection technique or the anesthetic 
drug that should be used. Postoperative pain, an essential outcome parameter, is not 
thoroughly described, and no standardized questionnaires were used to measure this 
outcome parameter. Furthermore, it is not clear if the complications and recurrences 
described in the included articles, occurred in the patient group we aim to investigate. 
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Finally, we cannot conclude if patients with umbilical hernia treated with local 
anesthesia have a shorter duration of operation and a shorter duration of stay, since no 
comparison is made with a control group. Based on our findings, we cannot state that 
local anesthesia for umbilical hernia patients has any advantages. 
CONCLUSION 
Local anesthesia for umbilical hernia patients seems safe and feasible. However, the 
advantages of local anesthesia are not sufficiently demonstrated in the current available 
literature. Almost every outcome parameter is not specified for the patient group we 
aim to investigate: patients with umbilical hernia treated with local anesthesia. We 
still do not know if local anesthesia for umbilical hernia gives excellent results, so we 
cannot implement it in daily practice.  Therefore, we propose to initiate a randomized 
controlled trial, comparing local anesthesia with general anesthesia for patients with 
umbilical hernia. This could reveal if local anesthesia has any advantages. 
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APPENDIX 1
Literature search strategy
Pubmed Publisher 15
In PubMed the following search strategy was performed: ((((umbilic*[tiab] OR "abdominal wall"[tiab] OR ventral[tiab]) AND 
(herni*[tiab] OR defect*[tiab])) OR exomphal*[tiab])) AND ((((local[tiab] OR topical[tiab] OR region*[tiab] OR infiltrat*[tiab] OR 
conduct*[tiab] OR block*[tiab]) AND (anesthe*[tiab] OR anaesthe*[tiab])) OR ((ambula*[tiab] OR day[tiab] OR daycare[tiab] OR 
outpatient*[tiab] OR "short stay"[tiab]) AND (surg*[tiab] OR setting*[tiab] OR operati*[tiab] OR procedure*[tiab] OR treat*[tiab] 
OR therap*[tiab] OR repair*[tiab] OR hernioplast*[tiab] OR herniorrhaph*[tiab])) OR "day case"[tiab]))  AND publisher[sb]
Embase 507
In Embase the following search strategy was performed: ('umbilical hernia'/de OR 'abdominal wall hernia'/de OR (umbilicus/
de AND (hernioplasty/de OR herniorrhaphy/de)) OR (((umbilic* OR 'abdominal wall' OR ventral) NEAR/6 (herni* OR defect*)) 
OR exomphal*):ab,ti) AND ('local anesthetic agent'/exp OR 'local anesthesia'/exp OR 'ambulatory surgery'/de OR 'outpatient 
department'/de OR outpatient/de OR 'ambulatory care'/de OR 'anesthetic needle'/de OR (((local OR topical OR region* OR 
infiltrat* OR conduct* OR block*) NEAR/3 (anesthe* OR anaesthe*)) OR ((ambula* OR day OR daycare OR outpatient* OR 
'short stay') NEAR/3 (surg* OR setting* OR operati* OR procedure* OR treat* OR therap* OR repair* OR hernioplast* OR 
herniorrhaph*)) OR 'day case'):ab,ti) 
Medline 36
In Medline the following search strategy was performed: ("Hernia, Umbilical"/ OR "Hernia, Ventral"/ OR (umbilicus/ AND 
(herniorrhaphy/)) OR (((umbilic* OR "abdominal wall" OR ventral) ADJ6 (herni* OR defect*)) OR exomphal*).ab,ti.) AND 
("Anesthesia, Local"/ OR "Anesthetics, Local"/ OR "Ambulatory Surgical Procedures"/ OR "outpatients"/ OR "Ambulatory Care"/ 
OR (((local OR topical OR region* OR infiltrat* OR conduct* OR block*) ADJ3 (anesthe* OR anaesthe*)) OR ((ambula* OR day OR 
daycare OR outpatient* OR "short stay") ADJ3 (surg* OR setting* OR operati* OR procedure* OR treat* OR therap* OR repair* 
OR hernioplast* OR herniorrhaph*)) OR "day case").ab,ti.)
Cochrane 6
In Cochrane the following search strategy was performed: ((((umbilic* OR 'abdominal wall' OR ventral) NEAR/6 (herni* OR 
defect*)) OR exomphal*):ab,ti) AND ((((local OR topical OR region* OR infiltrat* OR conduct* OR block*) NEAR/3 (anesthe* 
OR anaesthe*)) OR ((ambula* OR day OR daycare OR outpatient* OR 'short stay') NEAR/3 (surg* OR setting* OR operati* OR 
procedure* OR treat* OR therap* OR repair* OR hernioplast* OR herniorrhaph*)) OR 'day case'):ab,ti) 
Web of Science 152
In Web of Science the following search strategy was performed TS=(((((umbilic* OR "abdominal wall" OR ventral) NEAR/6 
(herni* OR defect*)) OR exomphal*)) AND ((((local OR topical OR region* OR infiltrat* OR conduct* OR block*) NEAR/3 
(anesthe* OR anaesthe*)) OR ((ambula* OR day OR daycare OR outpatient* OR "short stay") NEAR/3 (surg* OR setting* OR 
operati* OR procedure* OR treat* OR therap* OR repair* OR hernioplast* OR herniorrhaph*)) OR "day case"))) 
Scopus 230
In Scopus the following search strategy was performed TITLE-ABS-KEY(((((umbilic* OR "abdominal wall" OR ventral) W/6 
(herni* OR defect*)) OR exomphal*)) AND ((((local OR topical OR region* OR infiltrat* OR conduct* OR block*) W/3 (anesthe* 
OR anaesthe*)) OR ((ambula* OR day OR daycare OR outpatient* OR "short stay") W/3 (surg* OR setting* OR operati* OR 
procedure* OR treat* OR therap* OR repair* OR hernioplast* OR herniorrhaph*)) OR "day case"))) 
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ABSTRACT
Background: Most umbilical hernias are repaired under general anesthesia. Nowadays, 
it is becoming more common to undergo inguinal hernia surgery under local anesthesia. 
Local anesthesia has several advantages, such as less postoperative pain and early 
mobilisation of patients, which can lead to a shorter hospital stay. There is a lack of 
evidence regarding local anesthesia for umbilical hernia repair. In this prospective 
cohort study the feasibility and safety of local anesthesia in standardized circumstances 
will be investigated. 
Methods: Patients from four different hospitals in the Netherlands were included. 
Patients could only be enrolled if they were aged ≥18 years and were diagnosed with 
an umbilical hernia. Patients were anesthetized with a local anaesthetic: Ropivacaine 
(0,75% 3 milligram per kilogram body weight), which was injected as a field block. 
Remifentanil (0,5 microgram/kg) was used as a sedative. The main endpoint of this pilot 
study is the feasibility and safety of local anesthesia in umbilical hernia repair. 
Results: 30 patients were included. In 67% of patients, the defect was closed with primary 
sutures. None of the surgical procedures had to be ceased during surgery because 
of excessive pain. The use of local anesthesia did not lead to peri- or postoperative 
complications, allergic responses or postoperative deaths. All patients were discharged 
on the same day they were operated. A mean VAS of 1.8  was identified after surgery. No 
postoperative complications were identified after a follow up of two weeks. 
Conclusion: Both patients and surgeons were positive about the surgical procedure 
with a local anaesthetic. It can be concluded that the use of local anaesthesia, using 
Ropivacaine as a local agent and Remifentanil as a sedative, is safe and feasible in 
umbilical hernia repair. The next step will be conducting a randomized controlled trial, 
in which local anesthesia will be compared with general anesthesia in umbilical hernia 
repair. 
jairam-layout.indd   246 28/05/2018   21:47
247
Umbilical hernia repair under local anesthesia: a prospective cohort
12
INTRODUCTION
Approximately 10% of all abdominal wall hernias are umbilical hernias (1). According to 
the European Hernia Society, an umbilical hernia (UH) is defined as a midline abdominal 
wall defect from three centimetres above up to three centimetres below the umbilicus 
(2). It can be present either at birth, or it can develop spontaneously throughout life, for 
example by increased intra-abdominal pressure, such as in COPD patients or patients 
with liver cirrhosis. The prevalence of UH in adult population is approximately 2% (3). 
Yearly, 4500 UHs are repaired in the Netherlands. Surgical repair can be performed by 
either suture repair or mesh repair. The recurrence rate of mesh repair is low, with a 
percentage of 1% (4). 
Most of UHs are repaired under general anesthesia. Nowadays, it is becoming more 
common to undergo abdominal wall hernia surgery for small hernias under local 
anesthesia. Local anesthesia in the treatment of inguinal hernia has already been 
investigated thoroughly. Several studies have shown the advantages of the use of 
local anesthesia in groin hernia repair over the use of general or spinal anesthesia (5-
11). However, unfortunately the use of local anesthesia is still not commonly applied 
in abdominal wall hernia repair among surgeons (11). Local anesthesia has several 
advantages, such as less postoperative pain, normal micturation and early mobilisation 
of patients, which can lead to a shorter duration of hospital stay. Until now, there is 
a lack of evidence regarding local anesthesia for UH repair. Jairam et al. performed a 
systematic review, in which nine (retrospective and prospective) cohort studies/case-
studies were included (12). It was concluded that the advantages of local anesthesia 
could not be sufficiently demonstrated, due to the heterogeneity amongst included 
studies. In order to conduct an appropriate randomized controlled trial, in which local 
anesthesia will be compared with general anesthesia for UH repair, we aimed to start 
with a prospective cohort study at first. In this study the feasibility and safety of local 
anesthesia will be investigated. 
METHODS
Between January 2015 and December 2017, patients were asked to participate. The 
local ethics committee of the Erasmus University Medical Center Rotterdam approved 
this study. Patients from three different hospitals were included: Havenziekenhuis 
Rotterdam, Maastricht Universitair Medisch Centrum and Spaarne Gasthuis Haarlem. 
Patients could only be enrolled if they were aged ≥18 years and were diagnosed 
with UH. Patients were excluded if they were pregnant, had UH> 3 centimetre in 
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diameter, a recurrence or if they had undergone previous abdominal surgery (either 
midline laparotomy or laparoscopic surgery). Other exclusion criteria were: emergency 
procedure, the presence of an incarcerated hernia, ascites or cirrhosis, an American 
Society of Anaesthesiologists (ASA) score IV and a BMI > 30. All patients gave written 
informed consent. 
The main endpoint of this pilot study is the feasibility and safety of local anesthesia in 
UH repair. There were no secondary endpoints. 
Patients were anesthetized with a local anesthetic: Ropivacaine (0,75% 3 milligram 
per kilogram body weight), which was injected as a field block. Patients also received 
preoperatively Remifentanil (0,5 microgram/kg), to reach a comfortable situation for the 
patient, without losing consciousness. The surgeon was instructed to reserve 5 milliliters 
of Ropivacaine, which could be administered if the patient still experienced severe pain 
(as escape medication). 
Surgical repair was performed by para-umbilical incision, dissection of the hernia sac 
and restoration of the sac together with its contents into the abdominal cavity. The 
defect was primarily closed with absorbable monofilament interrupted sutures (PDS 
2x0) in case the defect was <1 centimeter. In case the defect was ≥ 1 cm, a mesh was 
placed intraperitoneally or in the preperitoneal plane. The achieved overlap had to be at 
least 2 centimeters in each direction of the circular mesh. The mesh that was used in this 
pilot study was the Cabs’Air® mesh (Cousin, France). This mesh is a knitted monofilament 
polypropylene mesh with poly-L-lactic acid (PLLA), having an inflatable expansion 
balloon. For the intraperitoneal defect the Cabs Air Composite® mesh was used, which 
has a monofilament polypropylene side and an ePTFE side. In case the mesh had to be 
placed extraperitoneally, the Cabs Air Semi Resorbable (SR-6)® mesh was used. Closure 
of the subcutaneous tissue and skin was conducted by using a method chosen by the 
individual surgeon. Surgery took place at the operation room. A nurse anesthetist was 
present to monitor vital signs. During surgical repair of UH, the anesthesiologist was 
ready to intervene if necessary. The procedure was ceased if the local anesthetic did not 
adequately reduce the pain. 
Visual Analogue Scale (VAS) evaluated postoperative pain. Patients were followed at the 
outpatient clinic after one week. After 2 weeks, they were asked to fill in the Short Form-
36 questionnaire (SF-36), EuroQol-5D questionnaire (EQ-5D) and the VAS form again.  
Statistical analysis of the VAS, SF-36 and the EQ-5D will be performed with the linear 
model. The measurements of VAS scores will be compared using the Mann-Whitney test.
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RESULTS
In total, 30 patients were included. Table 1 shows the baseline and surgical characteristics. 
Almost 80% of patients were male, mean age being 57 years. In 67% of patients, the 
defect was closed with primary sutures. Patients did not experience excessive pain. 
Therefore, none of the procedures had to be ceased. During operation of all patients, 
vital signs remained stable. All patients were discharged on the same day they were 
operated. Postoperative pain was measured with the Visual Analogue Score (VAS). A 
mean VAS of 1.8 (SE 0.33) was identified.
Table 1. Baseline and surgical characteristics
Baseline characteristics
Male gender, N (%) 24 (80%)
Age, mean (y) 57 y
Surgical characteristics
Defect < 2 centimeters, N (%) 20 (67%)
Complications, N (%)
- hematoma
- seroma
- surgical site infection
0 (0%)
1 (3.3%)
0 (0%)
Ceased surgical procedures, N (%) 0 (0%)
Overnight hospital admission, N (%) 0 (0%)
Two to four weeks after surgery, patients were seen at the outpatient clinic. None of 
the patients developed hematoma or a surgical site infection. One patient developed 
a seroma, which did not deed any surgical intervention. Mean VAS of 1 (SE 0.23) was 
identified during follow up. SF-36 and EQ-5D questionnaires were filled in by all patients. 
Table 2 shows the Quality-of-Life (QoL) scores.
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Table 2. Quality-of-Life scores
Mean (SE)
SF-36 domain
     Pain 79.03 (2.12)
     Physical functioning 79.55 (2.25)
     Physical health 72.42 (3.2)
     Emotional problems 84.36 (3.84)
     Energy or fatigue 72.30 (1.64)
     Emotional wellbeing 74.90 (1.16)
     Social functioning 83.00 (2.52)
     General health 72.90 (2.40)
EQ-5D 0.82 (0.03)
DISCUSSION
This prospective cohort study reveals that the use of local anesthesia for the repair 
of UHs is safe and feasible. UH is a common surgical problem, with a number of 4500 
repairs per year in the Netherlands alone. Currently, most UH repairs take place under 
general anesthesia. This is unfortunate, since local anesthesia might have several 
advantages, such as a shorter duration of hospital stay, cost-effectiveness, better 
immediate postoperative micturition, and less postoperative pain. Literature regarding 
local anesthesia in UH repair is scarce (1, 3, 12-19). This is in contrary to local anesthesia 
in groin hernia repair, which is investigated extensively. Van Veen et al. conducted a 
randomized controlled trial, in which local anesthesia was compared with spinal 
anesthesia in Lichtenstein hernia repair (11). It was found that patients who were 
operated under local anesthesia had significantly less pain after surgery. Duration of 
surgery was shorter in the local anesthesia group. Furthermore, significantly more 
urinary retention and more overnight admissions occurred after spinal anesthesia (11). 
Even though evidence shows that local anesthesia is superior compared to general 
or spinal anesthesia, patients are still more often operated with general or spinal 
anesthesia, for unknown reasons. 
Due to the lack of convincing literature regarding UH and local anesthesia, a 
systematic review was performed by Jairam et al (12). This systematic review showed 
a high heterogeneity, with no consensus regarding injection technique, type of local 
anaesthetic, or conversions to general anesthesia. Only a few small prospective and 
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retrospective cohort studies have been performed until now (3, 13, 14, 16, 18). No 
randomized controlled trial has been conducted so far, providing level-1 evidence in 
showing the superiority of local anesthesia for the treatment of UH. This means that 
no firm conclusions can be made regarding postoperative complications, postoperative 
pain, or mortality. We therefore aimed to perform a well-conducted randomized 
controlled trial. The underlying prospective cohort study was initiated to evaluate the 
safety and feasibility of the performance of local anesthesia, since there was no consensus 
regarding type of anesthesia or the surgical technique. In addition, no information was 
available in literature regarding postoperative complications, postoperative pain, or 
mortality. Last but not least, it was noticed that most surgeons did not feel comfortable 
with local anesthesia for umbilical hernia repair. A learning curve in the following 
randomized controlled trial had to be avoided. 
The inclusion of patients for this study, even in four hospitals of which three large 
teaching hospitals, proved to be difficult as, even after specific training in the local 
anaesthetic technique, surgeons and anaesthesiologists were still reluctant to include 
patients by habit. However, in this cohort the safety and feasibility of local anesthesia 
were demonstrated. None of the surgical procedures had to be ceased during surgery 
because of excessive pain. The use of local anesthesia did not lead to peri- or postoperative 
complications, allergic responses or postoperative deaths. Furthermore, a relatively 
low VAS score was measured directly after surgery, which is comparable with the VAS 
detected in the study of Van Veen et al (11). None of the patients needed overnight 
hospital admission. During visit at the outpatient clinic, no serious complications were 
observed: only one patient developed seroma without any consequence for the patient. 
VAS score was low during follow up (VAS 1, SE 0.23). Hopefully these results will convince 
surgeons of the need of a randomized controlled trial, in which the local anaesthetic of 
this pilot study will be compared with general anesthesia in patients undergoing UH 
repair. 
CONCLUSION
This prospective cohort study is the first study in which the use of a local agent in 
UH surgery is prospectively investigated under standardized circumstances in a 
homogenous group of patients. Both patients and surgeons were positive about the 
surgical procedure with a local anaesthetic. It can be concluded that the use of local 
anaesthesia, using Ropivacaine as a local agent and Remifentanil as a sedative, is safe 
and feasible in UH repair.
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DISCUSSION 
Incisional hernia (IH) is the most frequent complication after abdominal surgery (8, 
43). In the United States alone 200.000 IH repairs are performed each year, with a total 
cost of 3.2 billion dollars. It can be stated that IH has an unnecessary high (economic) 
burden on today’s society (44-46). There are several factors that can contribute to a high 
IH incidence, such as patients’ risk factors (obesity, aneurysm of the abdominal aorta, 
collagen diseases like Ehlers Danlos and Marfan), suture technique and type of incision 
(13-18). In the first part of this thesis it was investigated how incisional hernia could be 
prevented, what the complications are of mesh reinforcement and which costs it may 
bring on society. 
Part I: Prevention of incisional hernia
Treatment of IH should be focussed on prevention of IH, taken into account high 
recurrence rates after mesh repair, mesh-related complications, high costs of IH and 
reduced quality of life. The first step towards prevention of IH is to answer the question 
what the most optimal technique is to close a laparotomy incision. Diener et al. and Van 
‘t Riet et al. concluded that slowly resorbable continuous suturing of the abdominal 
wall leads to a significantly lower IH rate compared to interrupted suture (47, 48). It was 
also concluded that slowly resorbable sutures lead to less pain. Thus, slowly resorbable 
continuous sutures can achieve optimal fascial closure.  Another factor that should be 
taken into account in order to prevent IH is the suture length to wound length ratio, 
first investigated by Jenkins, later by Israelsson et al. (49, 50) and by Deerenberg et al. in 
the STITCH trial. Their findings showed that a small bites suture technique (SL:WL ratio 
of 4:1) is more effective than the large bites technique for the prevention of incisional 
hernia in midline laparotomies (9). 
The PRIMA trial focussed on prophylactic mesh reinforcement (43). The trial confirmed 
the positive results of earlier conducted studies, in which was shown that mesh 
reinforcement leads to a reduction of IH incidence (10, 28-30). In 2015, the European 
Hernia Society published guidelines on the closure of abdominal wall incisions. The 
Bonham Guidelines Group stated that ‘prophylactic mesh augmentation in order 
to reduce the IH incidence after elective midline laparotomy in high-risk patients is 
suggested’. However, it was also stated that the evidence was weak and that larger trials 
were needed, in order to make a strong recommendation (2). These guidelines can be 
found in this thesis (Chapter 2). Recently, well-conducted large randomized controlled 
trials have been published and level-1 evidence has been provided (8, 43). 
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The PRIMA trial is the first large randomized controlled trial, with three randomisation 
arms, in which high-risk patients (AAA, BMI of >27), undergoing midline laparotomy, 
were included. These patients were randomized in either one of the three randomisation 
arms: (1) primary suture (PS), (2) onlay mesh reinforcement (OMR) or (3) sublay mesh 
reinforcement (SMR). The primary endpoint of this RCT was the IH incidence after follow-
up of two years (43). The PRIMAAT trial, of Muysoms et al., included high-risk patients 
(AAA) as well. In this RCT patients were either randomized in a primary suture group or 
sublay mesh reinforcement group (8). 
Both the PRIMA and PRIMAAT trial show results in favour of mesh reinforcement: the 
incidence of IH was significantly lower in the mesh reinforcement group, compared to 
the primary suture group. These findings confirm the outcome of most of the earlier 
conducted studies, both RCTs and prospective cohort studies. Until recently, it was 
unclear which surgical technique; either onlay or sublay mesh reinforcement was 
superior. In the PRIMA trial it was shown that onlay mesh reinforcement, compared 
with sublay mesh reinforcement and primary suture, leads to a statistically significant 
reduction of the IH incidence. Therefore, as this technique is much less challenging and 
time consuming compared to sublay, the onlay mesh reinforcement has the potential to 
become standard treatment in high-risk patients undergoing midline laparotomy. This 
finding is remarkable; since the assumption has always been that with regard to mesh 
infection that sublay mesh reinforcement is superior in comparison with onlay mesh 
reinforcement, even though there was no evidence for this finding. Chapter 4 presents 
the long-term results of the PRIMA trial.
In Chapter 3, the short-term results of the PRIMA trial are being discussed (51). Most 
of the earlier conducted RCTs focussed mainly on IH prevention and the short-term 
complications were often not described. This manuscript focussed on short-term 
results, i.e. the complications that occur in the first month after surgery. There were no 
differences between the three groups (primary suture (PS), onlay polypropylene mesh 
repair (MR), sublay polypropylene mesh repair (PMR)) regarding baseline characteristics 
or intraoperatieve characteristics. Furthermore, there were also no differences in 
intraoperative complications, such as bleeding, duration of surgery, or intestinal lesion. 
Patients receiving prophylactic mesh reinforcement did not attend the intensive care 
more often, nor did they receive more often blood transfusion or ventilation. There 
were no differences in admissions days between the three groups. Seromas occurred 
in 52% of patients. Significantly more seroma’s were observed in the onlay prophylactic 
mesh reinforcement group (34%), compared with the primary suture group (5%) or 
with the sublay prophylactic mesh reinforcement group (13%). However, there were 
no differences between groups regarding surgical site infections (SSI), re-admissions 
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or re-interventions. Thus, the fact that there were more seromas in patients with onlay 
PMR, did not have any consequences for the patient. Other postoperative complications 
that were investigated were hematoma, fascial dehiscence, mesh infection and 
mesh removal, ileus and death. None of these postoperative complications occurred 
(significantly) more frequent in one of the treatment arms. After a follow-up of two 
years, no other complications were found. In total, 15% of the population died, with 
no significant differences in percentages between the three randomisation arms. It 
can be concluded that mesh reinforcement in high-risk patients undergoing midline 
laparotomy is a safe procedure (51).  
A few meta-analyses regarding prevention of IH in patients undergoing PMR have 
been performed so far. After publication of the PRIMA trial, a new meta-analysis was 
conducted, in order to confirm the existing level-1 evidence. In this meta-analysis, 12 
RCTs were included (8, 10, 28-30, 51-57). Studies were divided in high-risk of bias and 
low risk of bias. In general, IH occurred significantly less frequent in patients with PMR 
compared with PS patients. In the low risk of bias group, IH occurred significantly less 
in the PMR group compared with the PS group. No statistical differences were found 
for the high risk of bias group. Both onlay and retromuscular PMR lead to a significant 
reduction of the IH incidence compared with PS. Patients with an onlay PMR had a higher 
risk of developing seroma compared with patients who underwent PS. There was not 
a higher incidence of SSI in onlay PMR compared to PS. This meta-analysis showed that 
onlay prophylactic mesh reinforcement leads to a significantly lower incidence of IH 
with dimensions of the effect larger than with retromuscular mesh reinforcement. The 
findings of the MARIA meta-analysis can be found in Chapter 5. 
It should be taken into account that the findings of the meta-analysis, prospective 
cohorts and RCTs are applicable on a certain patient group, who are operated under 
certain circumstances, using a specific surgical technique and a specific type of mesh. In 
most of the prevention studies, a synthetic non-resorbable mesh is being used, mostly 
polypropylene, in either onlay or sublay position. The mesh that was used in the PRIMA 
trial was a lightweight polypropylene mesh. In the PRIMAAT trial, a large pore, partially 
resorbable light-weight polypropylene mesh was used. The results are therefore only 
applicable for synthetic meshes. Even though it can be concluded that prophylactic mesh 
reinforcement can be safely performed in a clean setting, it is unclear how biological or 
biosynthetic meshes perform, especially on long-term. A systematic review of literature 
regarding prevention of incisional hernia with biological or biosynthetic meshes was 
conducted, in order to reveal the benefits of these meshes (58). Only four studies  (two 
RCTs and two case-control) studies are available for the prevention of IH in midline 
laparotomies with biological or biosynthetic meshes (55, 57, 59, 60). After qualitative 
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assessment, it was concluded that the level of evidence on the efficacy and safety of 
biological meshes is very low (58). Furthermore, PMR can be considered safe in elective 
laparotomies. There is no evidence on how PMR behaves in emergency situations. 
It can be concluded that level-1 evidence is provided for the prevention of IH with 
prophylactic mesh reinforcement in high-risk patients undergoing elective midline 
laparotomy. As a consequence, it should be considered to review and adapt the 
guidelines on the closure of the abdominal wall, based upon the most recently 
published trials.
Part II: New tools, techniques and meshes in ventral hernia surgery
Questionnaires: a new diagnostic tool?
Adequate, reliable long-term follow up is essential in providing high-quality care after 
midline laparotomies. It is known that 80-95% of all incisional hernias occur in the first 
three years after surgery (61). There are several methods of follow up, such as physical 
examination and radiological examination. Until now, physical examination at the 
outpatient clinic is the gold standard for follow up. However, routinely scheduled clinical 
visits are time consuming, costly and demand devotion of both patient and doctor (62). 
Furthermore, it is not always necessary to conduct a three year follow up after abdominal 
surgery and patients will not attend a physician if symptoms are absent. Another method 
of follow-up might be the use of questionnaires. However, there is little evidence on 
their reliability. Van den Heuvel et al. validated questionnaire in order to detect inguinal 
hernia recurrences (21). In this thesis, a questionnaire named PROMID (Patient Reported 
Outcome Measurement In Diagnosing IH), is developed in order to assist in diagnosing 
IH in patients who have undergone abdominal surgery. In a pilot study, the reliability, 
internal consistency and sensitivity of the PROMID questionnaire are being determined. 
The questionnaire regarded patients’ symptoms. It was concluded that the PROMID 
questionnaire is a highly reliable questionnaire, with a test-retest reliability of 1.0. The 
internal consistency is modest. The overall sensitivity of the questionnaire was 95% (63). 
Currently, the PROMID questionnaire is being validated in a prospective cohort study, 
with the aim to use it as a diagnostic tool in order to diagnose IH. 
Biological and biosynthetic meshes: the ideal mesh? 
Until now the question, which mesh is the ‘perfect’ or ‘ideal’ mesh, remains unanswered. 
The difficulty of this question is related to the fact that it should be answered separately 
for each patient and is thus patient-specific. Currently, there are a wide variety of 
synthetic, biological and biosynthetic meshes available. We aimed to investigate 
both biological and synthetic meshes in a peritonitis rat model in order to assess in 
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vivo characteristics, such as shrinkage, incorporation of the mesh, adhesion formation, 
and abscess formation. The feasibility of using the biological mesh in a contaminated 
environment was evaluated. As such, there was also a search for the question: which 
mesh is the ideal mesh to use in this environment? Meshes that were investigated in 
the experimental study in this thesis were as follows: PermacolTM (cross-linked collagen), 
StratticeTM (non-cross-linked collagen), XCMTM Biologic (non-cross-linked collagen), 
Omyra® mesh (condensed polytetrafluoroethylene), and ParieteneTM (polypropylene). 
Our experiment showed that XCMTM Biologic was superior when incorporation, 
macroscopic mesh infection and histological parameters like collagen deposition were 
taken into account. However, XCMTM Biologic did show a high percentage of shrinkage. 
There are no studies yet performed with XCMTM Biologic that assesses the shrinkage 
rates in a rat model. Interestingly, our experiment showed that there was little abscess 
formation for all meshes. This is in contrast with earlier conducted experimental studies 
(64). However, in these studies other meshes were investigated that showed high 
abscess rates, which could be attributed to the fact that the sub strain of Wistar rats was 
more infection resistant. Although biological meshes behave well in a contaminated 
field, the long-term data of outcome and complications are lacking. Furthermore, they 
are expensive. A new mesh that has been introduced on the market is the resorbable 
synthetic mesh. This mesh aims to combine advantages of both synthetic and biological 
meshes. Resorbable synthetic meshes maintain mechanical strength for a certain period, 
will gradually resorb and rebuild connective tissue. However, the actual remodelling 
properties are unclear. Many studies report that there is ‘optimal tissue remodeling’ (33, 
40, 41, 65). However, the definition of this is unclear, not standardized, and furthermore, 
there is not enough evidence yet that these meshes provide sufficient strength on long-
term (41). The synthetic resorbable meshes which are currently available on the market 
are GORE® BIO-A® mesh (Gore), TIGR® Surgical Matrix Mesh (Novus Scientific) and the 
Phasix™ mesh (Bard). Until now, a number of experimental studies with these meshes 
have been conducted (33, 40, 41, 66-69). A review in this thesis was conducted in order 
to give an overview of the characteristics and biomechanical, histological and clinical 
outcome of the use of resorbable synthetic meshes. This review was the first one that was 
published. There is currently no clear experimental evidence available that can support 
the advantages of resorbable synthetic meshes over the use of synthetic or biological 
meshes in human settings. Even though a certain degree of remodelling occurred, it 
remains unclear whether this can lead to strong fascial tissue of good quality on long 
term. This review showed a high heterogeneity: different animal models were used, 
and most of the meshes were placed in a clean environment. Used surgical techniques 
were extremely variable. Furthermore, outcome parameters were not standardized. 
This makes it all difficult to extrapolate to humans. At this moment, several prospective 
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clinical cohort studies for ventral hernia repair and inguinal hernia repair with GORE® 
BIO-A® and TIGR® Matrix Surgical mesh have been published, with good results (70-72). 
GORE® BIO-A® was used for single-staged contaminated ventral hernia repair (CDC class 
II and III) (73). The hernia recurrence rate after 24 months was 17%. TIGR® Matrix Surgical 
mesh was investigated in two clinical studies. One of these was a pilot study (71). Here, 
the mesh was used to prevent wound dehiscence and incisional hernia in 16 patients 
with three or more risk factors for the development of wound dehiscence or incisional 
hernia. After a follow-up of nine months, two complications were found (seroma 
and surgical site infection, both requiring treatment). No complications required re-
operation, and no incisional hernia or wound dehiscence was seen. Another study 
performed with TIGR® Matrix Surgical mesh was done in patients with primary inguinal 
hernias, who were enrolled for Lichtenstein repair (72). No serious adverse events were 
reported after a follow-up of one year. After three-years of follow-up, high recurrence 
rates were seen in patients with medial (44%) and combined inguinal (33%) hernias. 
No recurrences were seen in patients with an isolated lateral inguinal hernia (LIH) (33). 
The first clinical results for the Phasix™ mesh will soon follow. This will be a prospective 
cohort study, in which 85 patients with a Ventral Hernia Working Group (VHWG) Grade 
3 hernia will be treated with Phasix™ mesh. Primary outcome of the study is surgical 
site occurrence (SSO) in the first three months, including hematoma, seroma, infection, 
dehiscence and fistula formation (requiring intervention). Secondary outcomes include 
recurrence, infection and quality of life related outcomes after 24 months. The protocol 
of the Phasix™ mesh study can be found in Chapter 9. 
Umbilical hernia and local anesthesia: a new feasible technique?
Little evidence is available regarding local anesthesia for the repair of umbilical hernias. 
Therefore, a review of literature was conducted. All included articles had a level of 
evidence of 2B, and there was no study conducted that investigated local anesthesia for 
umbilical hernias only. It was concluded that even though the use of local anesthesia 
seemed safe and feasible, the advantages were not sufficiently demonstrated. Therefore, 
a prospective cohort study was conducted. Here it was shown that the use of local 
anaesthesia, using Ropivacaine as a local agent and Remifentanil as a sedative, is safe 
and feasible in UH repair.
FUTURE PERSPECTIVES
Incisional hernia is still one of the most common complications after abdominal surgery, 
especially in high-risk patients. This thesis has focussed on prevention of incisional 
hernia by prophylactic mesh reinforcement. The key of preventing incisional hernia is 
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to avoid midline laparotomies. In an era in which laparoscopic surgery has taken its 
flight and has become standard daily practice, the expectation is that the incidence of 
incisional hernia will decline. However, it should be taken into account that laparoscopic 
surgery is not always possible, such as in specific emergency cases. Furthermore, 
laparoscopic surgery is not always standard daily practice in non-Western countries. 
Last but not least, laparoscopy can lead to trocar hernias. The use of mesh to prevent 
incisional hernia is thus indicated, even in countries in which a mesh is not affordable. 
In this respect the randomized controlled trial of Löfgren et al. showed that the use of a 
low-cost mesh (sterilized mosquito mesh) did not significantly differ in recurrence and 
postoperative complications, compared with a commercial mesh. 
Incisional hernia is a frequent complication after abdominal (midline) surgery. Therefore, 
this topic needs far more attention in the surgical community than it currently gets. 
Education in how to close the abdomen should become structural part of the surgical 
training. Surgeons with a specific field of interest in hernia surgery should educate and 
train surgical residents. Anatomical skills and closing techniques of the abdominal wall 
should become a mandatory part of this training. In this way, the incidence of incisional 
hernia can be reduced.  
With the level-1 evidence that is currently available regarding prophylactic mesh 
reinforcement, guidelines should be set up. This should be started in each individual 
country at their own surgical association or society. Furthermore, the European Hernia 
Society should adapt the guidelines on the closure of abdominal wall incisions. The 
Guidelines Group stated that more evidence was needed in order to make a strong 
recommendation regarding the use of prophylactic mesh augmentation in high-risk 
groups, which is currently the case.
The use of prophylactic mesh reinforcement is not the only option to prevent 
incisional hernias. The small bite suture technique, as investigated by Deerenberg et 
al., demonstrated that this technique is more effective compared with the large bites 
technique in the prevention of incisional hernia. Another prevention method that is 
currently still being investigated is the use of stem cell therapies or growth factors. The 
fundamental mechanism of the formation of incisional hernias is the failure of fascial 
wound healing. The use of stem cells or growth factors have been proposed as a new 
treatment and/or prevention option in abdominal wall repair. Both experimental and 
clinical research regarding this topic is ongoing and should be stimulated. 
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Individual patients’ risk factors should be taken into account to select which patient 
will benefit most from prophylactic mesh reinforcement. Currently, most studies that 
have been performed regarded high-risk patients, such as patients with an aneurysm 
of the abdominal aorta or morbid obese patients. Further research is needed to identify 
other risk factors. Data from large prospective registries might be helpful to explore 
those risk factors.  The Danish Ventral Hernia database is a very good example and other 
countries should follow this example. Collaboration between countries, developing 
one (worldwide) registry would be advantageous in order to analyse many research 
questions. 
Which mesh is the ‘ideal’ mesh? The answer to this question is difficult to formulate, as the 
mesh choice is patient specific. Currently, there are over 200 different meshes available on 
the market, all with a specific indication. Many studies have been performed regarding 
synthetic meshes (prolene or polypropylene), but also on biologic meshes. Slowly 
resorbable synthetic meshes might be interesting, since it can combine ‘best of both 
worlds’. Due to its slowly resorbable capacity, it can provide sufficient strength, which is 
needed to prevent the formation of incisional hernia. However, it might also lead to less 
chronic pain on long term or other mesh related complications. At this moment, clinical 
and experimental data are being published. The most important question is whether 
remodelling occurs and if this can lead to strong fascial tissue of good quality on long 
term. More experimental studies are needed, followed by randomized controlled trials 
and prospective registries.
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SUMMARY
In this thesis there are two parts. Part 1 focuses on the prevention of a major complication 
after abdominal wall surgery: incisional hernia. Part 2 focuses on the search for new 
tools, techniques and meshes in ventral hernia surgery. 
Part I: Prevention of incisional hernia
Chapter 1 describes the subject of this thesis: the prevention of incisional hernia. 
Incisional hernia is one of the most frequently seen complications after abdominal 
surgery. Incidences vary from 10% to 20% in ‘general population’ and can increase up to 
more than 30% in high-risk groups. These incidences are unacceptable. The morbidity 
among patients with an incisional hernia is high. Furthermore, incisional hernia has 
a negative influence on patients’ quality of life and body image. Thus, prevention of 
incisional hernia is of paramount importance. Incisional hernias can be prevented by 
prophylactic mesh reinforcement in patients undergoing midline laparotomy. 
In Chapter 2 the European Hernia Society Guidelines on the closure of abdominal 
wall incisions is presented. It was stated that the evidence regarding prophylactic 
mesh augmentation for an elective midline laparotomy in high-risk patients, in order 
to reduce incisional hernia, is weak. The Guidelines Development Group decided that 
larger trials are needed to make a strong recommendation. 
In Chapter 3 the short-term results of the PRIMA trial are described. High-risk patients, 
undergoing midline laparotomies were randomized in either primary suture of the 
abdomen, onlay mesh reinforcement or sublay mesh reinforcement. Postoperative 
complications after a follow-up of one month were investigated. Significantly more 
seromas were detected after OMR, compared with primary suture and compared 
with SMR. There were no statistically significant differences in other postoperative 
complications, such as surgical site infection (SSI), hematoma, reintervention or 
readmission. 
In Chapter 4 the long-term results of the PRIMA trial are presented. Patients in the onlay 
mesh reinforcement group developed significantly more frequent an incisional hernia, 
compared to patients who were allocated primary suture only (13% vs 30%, OR 0.37, 
95%CI 0.20-0.69, p=0.0016). In the sublay mesh reinforcement group, more incisional 
hernias were identified compared to primary suture, however, this finding was not 
statistically significant (18% vs. 30%, OR 0.55, 0.30-1.00, p=0.05). Seromas were more 
frequent in patients with onlay mesh reinforcement (34/188) than in those assigned 
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primary suture (5/107, p=0.002) or sublay mesh reinforcement (13/185, p=0.002). The 
incidence of wound and surgical site infections, re-admission or re-interventions did 
not significantly differ between treatment groups. 
In Chapter 5 the results of a meta-analysis regarding the prevention of incisional hernias 
after midline laparotomies with prophylactic mesh reinforcement are presented: in 
total, twelve randomized controlled trials were included. The incisional hernia rate was 
significantly lower in patients with prophylactic mesh reinforcement compared with 
sutured closure (RR0.35, 95%CI 0.21-0.57, p<0.0001). Both onlay mesh reinforcement (RR 
0.26, 95%CI 0.11-0.67, p= 0.005) as well as retromuscular mesh reinforcement (RR 0.28 
95%CI 0.10-0.82, p= 0.02) led to a significant reduction of incisional hernias, compared 
with primary suture. In patients undergoing prophylactic mesh reinforcement, a 
higher occurrence of seromas was seen, however, there was no increase of surgical site 
infections. 
In Chapter 6 the results of a systematic review of literature are presented. This systematic 
review was performed to analyse the prevention of incisional hernias in midline 
laparotomies with a biological mesh. The level of evidence on the efficacy and safety 
of biological meshes for the prevention of incisional hernias was low. There were no 
studies comparing biological meshes with synthetic, non-absorbable meshes, for the 
prevention of incisional hernia. There was no evidence that a biological or biosynthetic 
mesh should be preferred to synthetic meshes, in order to prevent incisional hernia in 
patients undergoing midline laparotomy.
Part II: New tools, techniques and meshes in ventral hernia surgery
In Chapter 7 the results of the PROMID pilot study are reported. In this pilot study, 
the reliability of a questionnaire was determined. The PROMID questionnaire is a 
questionnaire with seven questions (regarding syptoms of incisional hernia), and should 
assist in diagnosing incisional hernia, or it can be used in the future as a diagnostic 
tool to detect incisional hernia. It was found that the test-retest reliability was 1.0, 
and the internal consistency 0.56. The least consistent question was whether patients 
experience pain. For conclusion the PROMID questionnaire is highly reliable, but the 
internal consistency is only modest. The questionnaire will be validated in a prospective 
cohort study.
In Chapter 8 a review of literature is given regarding the use of resorbable synthetic 
meshes for non-complex abdominal wall hernias in a preclinical setting. Currently, 
three resorbable synthetic meshes are available: GORE® BIO-A® mesh (Gore), TIGR® Matrix 
Surgical mesh and Phasix™ mesh (Bard). The use of resorbable synthetic meshes seems 
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safe. A certain degree of remodelling occurs, however, it is unclear whether this will lead 
to strong fascial tissue of good quality. At this moment, there is no evidence supporting 
the advantages of resorbable synthetic meshes over the use of synthetic or biological 
meshes. More experimental studies, using standardized parameters, are needed. 
Furthermore, randomized controlled trials and prospective registries with sufficient 
follow-up should be conducted in order to reveal the advantages in a clinical setting.
In Chapter 9 the protocol of a prospective multicentre cohort study of Phasix™ mesh 
is presented. The aim of this clinical study is to include 85 patients with a VHWG grade 
3 hernia, and to collect data on safety and performance of the Phasix™ mesh in this 
patient group. Primary outcome will be surgical site occurrence in the first three months 
after implantation. Secondary outcomes are recurrence, infection and quality of life. 
Follow-up will be up to 24 months. 
In Chapter 10 the characteristics of different mesh types for abdominal wall repair in 
an experimental rat model of peritonitis are reported. Five meshes were investigated: 
Permacol™ (cross-linked collagen), Strattice™ (non-cross-linked collagen), XCM Biologic® 
(non-cross-linked collagen), Omyra® Mesh (condensed polytetrafluoroethylene) and 
Parietene™ (polypropylene). 180 days after implantation, XCM Biologic® and Permacol™ 
had significantly better incorporation than Strattice™ (p=0.003 and p=0.009). Strattice™ 
had significantly fewer adhesions than XCM Biologic® and Permacol™. XCM Biologic® 
showed the most prominent shrinkage. This finding was not statistically significant. 
In this experimental study it was investigated whether there is an ideal mesh. XCM 
Biologic® is a new biological mesh and has shown good results in this study. The use of 
XCM Biologic® may be useful in patients with a contaminated incisional hernia. 
In Chapter 11 a systematic review is presented, in which the feasibility of the use of local 
anesthesia for the surgical treatment of umbilical hernia is described. Various anaesthetic 
agents were used and there was no consensus regarding the injection technique. 
The recurrence rate varied from 2% to 7.4%. Almost 90% of patients were discharged 
within 24 hours, compared with 47% of patients treated with general anesthesia. Local 
anesthesia for the treatment of umbilical hernia seems safe and feasible. However, there 
is a very high heterogeneity among studies, and the advantages are not sufficiently 
demonstrated, due to lack of data. A randomized controlled trial, comparing local versus 
general anesthesia for the treatment of umbilical hernia, should follow. 
In Chapter 12, a prospective cohort study is presented, in which the safety and feasibility 
of local anesthesia are investigated. This is the first study in which the use of a local 
agent in UH surgery is prospectively investigated under standardized circumstances in 
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a homogenous group of patients. Both patients and surgeons were positive about the 
surgical procedure with a local anaesthetic. It can be concluded that the use of local 
anaesthesia, using Ropivacaine as a local agent and Remifentanil as a sedative, is safe 
and feasible in UH repair.
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In Hoofdstuk 1 wordt het onderwerp van dit proefschrift: 'de preventie van littekenbreuken' 
beschreven. Het optreden van een littekenbreuk is de meest frequente postoperatieve 
complicatie na abdominale chirurgie. Tegenwoordig is de incidentie nog steeds hoog, 
variërend van 10 tot 20% in de 'algemene populatie', oplopend tot meer dan 30% in 
hoog-risico groepen. Deze getallen zijn onacceptabel. Het hebben of krijgen van een 
littekenbreuk kent veel gevolgen: het kan leiden tot één of meerdere (her)operatie(s), 
tot complicaties en recidieven. Verder heeft het optreden van een littekenbreuk een 
negatieve invloed op de kwaliteit van leven van patiënten en brengt het hoge kosten 
met zich mee. De preventie van littekenbreuken is derhalve van essentieel belang, niet 
alleen voor de patiënt zelf, maar ook voor de samenleving als geheel. Littekenbreuken 
kunnen worden voorkomen door het plaatsen van een mesh (mat) tijdens het sluiten 
van de mediane laparotomie. Momenteel is het gebruik van een niet-oplosbare 
synthetische mesh als profylaxe de standaard. 
Deel I: Preventie van littekenbreuken
Het eerste deel van dit proefschrift richt zich op de preventie van littekenbreuken. 
In Hoofdstuk 2 worden de resultaten van de European Hernia Society Guidelines 
weergegeven. Deze richtlijn beschrijft de beste methode om de buik te sluiten. Hier 
wordt vastgesteld dat het bewijs omtrent de profylactische mesh plaatsing in hoog 
risico-patiënten, die een mediane laparotomie hebben ondergaan, zwak is. Het besluit 
van de richtlijngroep is dan ook terecht dat er grotere gerandomiseerde trials nodig zijn 
om tot een sterke aanbeveling te komen. 
In Hoofdstuk 3 worden de korte-termijn resultaten van de PRIMA trial beschreven. 
In deze dubbelblinde gerandomiseerde trial werden hoog-risico patiënten, die een 
midline laparotomie ondergingen, gerandomiseerd in drie groepen: primair sluiten 
van de buik, onlay mesh ('onlay mesh reinforcement') of sublay mesh ('sublay mesh 
reinforcement'). Postoperatieve complicaties na follow-up van een maand werden 
onderzocht: er werden significant meer seromen gevonden in de groep, die onlay 
mesh reinforcement onderging, vergeleken met patiënten bij wie de buik primair werd 
gesloten en bij patiënten, die sublay mesh reinforcement ondergingen. Er waren geen 
statistisch significante verschillen in andere postoperatieve complicaties, zoals surgical 
site infections (SSI's), hematomen, re-interventies en heropnames. 
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In Hoofdstuk 4 worden de lange-termijn resultaten van de PRIMA trial besproken. De 
incidentie littekenbreuken was significant hoger bij patiënten in de onlay mesh groep, 
vergeleken met patiënten bij wie de buik primair werd gesloten (13% vs 30%, OR 0.37, 
95%CI 0.20-0.69, p=0.0016). In de sublay mesh groep was de incidentie littekenbreuken 
ook hoger, vergeleken met patiënten bij wie de buik primair werd gesloten. Deze 
bevinding was niet statistisch significant (18% vs. 30%, OR 0.55, 0.30-1.00, p=0.05). 
In Hoofdstuk 5 worden de resultaten van een meta-analyse gepresenteerd. In deze 
meta-analyse werd de preventie van littekenbreuken na mediane laparotomie door 
middel van een profylactische mesh onderzocht. In totaal werden 12 gerandomiseerde 
trials geïncludeerd. Het percentage littekenbreuken was significant lager in de 
patiëntengroep bij wie profylactisch een mesh werd geplaatst, vergeleken met patiënten 
bij wie de buik primair door middel van hechtingen werd gesloten (RR0.35, 95%CI 0.21-
0.57, p<0.0001). Zowel in de onlay als in de sublay mesh groepen werd een significante 
reductie gezien van de littekenbreuk incidentie, vergeleken met de patiëntengroep bij 
wie de buik primair werd gesloten. In patiënten bij wie profylactisch een mesh werd 
geplaatst, werd wel een hogere incidentie van seromen, maar geen hogere incidentie 
van wondinfecties gezien. 
In Hoofdstuk 6 worden de bevindingen van een beschrijvende systematische review 
weergeven. Dit systematische review werd uitgevoerd om de rol van de biologische 
mat als profylaxe in de littekenbreukchirurgie vast te stellen. Geconcludeerd kan 
worden dat de mate van bewijs betreffende de effectiviteit en de veiligheid van 
biologische matten als profylaxe binnen littekenbreukchirurgie laag is. Tot op heden 
zijn er geen preventiestudies uitgevoerd waarin de biologische mat werd vergeleken 
met een synthetische, niet resorbeerbare mat. Er is geen bewijs dat een biologische 
mat de voorkeur heeft boven synthetische matten ter preventie van littekenbreuken bij 
patiënten, die een mediane laparotomie ondergaan. 
Deel II: Nieuwe ontwikkelingen, technieken en meshes bij ventrale 
buikwandhernia’s
Het tweede deel van dit proefschrift richt zich op nieuwe ontwikkelingen en technieken 
binnen het gebied van de chirurgie van ventrale buikwandhernia’s. Tevens worden 
verschillende (nieuwe) meshes op de huidige markt besproken. 
In Hoofdstuk 7 worden de resultaten van de PROMID pilot studie vermeld. In deze pilot 
studie werd de betrouwbaarheid van een vragenlijst bepaald. De PROMID vragenlijst 
bestaat uit zeven vragen en hebben betrekking op symptomen, die kunnen optreden 
bij patiënten met een littekenbreuk. De PROMID vragenlijst zou kunnen helpen bij het 
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diagnosticeren van een littekenbreuk, of deze kan worden gebruikt in de toekomst als 
diagnosticum om een littekenbreuk te detecteren. De pilot studie toonde aan dat de 
vragenlijst een test-retest reliability van 1.0 heeft en dat de interne consistentie 0.56 is. 
De minst consistente vraag betrof de pijnbeleving met betrekking tot de symptomen 
van littekenbreuken. Er kan worden geconcludeerd dat de PROMID vragenlijst 
betrouwbaar is, maar dat de interne consistentie minimaal is. De vragenlijst zal in een 
prospectief cohort worden gevalideerd. 
In Hoofdstuk 8 wordt een review van de literatuur gepresenteerd betreffende het 
gebruik van resorbeerbare synthetische matten voor niet-complexe buikwandhernia’s 
in een experimentele (preklinische) setting. Momenteel zijn er drie resorbeerbare 
synthetische matten verkrijgbaar op de markt: GORE® BIO-A® mesh (Gore), TIGR® Matrix 
Surgical mesh and Phasix™ mesh (Bard). Dit beschrijvende review laat zien dat het 
gebruik van langzaam resorbeerbare synthetische matten veilig lijkt. Er lijkt een zekere 
mate van remodelling op te treden, alhoewel het onduidelijk is of dit tot een sterke 
fascie van goede kwaliteit leidt. Momenteel is er niet genoeg bewijs beschikbaar waarbij 
wordt aangetoond dat het gebruik van resorbeerbare synthetische matten de voorkeur 
heeft boven synthetische of biologische matten. Het opzetten van meer experimentele 
studies (die gestandaardiseerde parameters gebruiken)  en gerandomiseerde trials (met 
langdurige follow-up) zijn essentieel, om zo de voordelen van deze mat te onderzoeken.
In Hoofdstuk 9 wordt het protocol van een prospectieve multicentre cohort studie 
van de Phasix™ mesh (Bard) gepresenteerd. Het doel van deze klinische studie is om 85 
patiënten met een VHWG graad 3 hernia te includeren en data betreffende de veiligheid 
en gebruik van de Phasix™ mesh in deze patiëntengroep te verzamelen. De primaire 
uitkomst is het optreden van surgical site occurences in de eerste drie maanden na 
implantatie. Secundaire uitkomstmaten zijn recidiefpercentage, infectie en kwaliteit 
van leven. De follow-up tijd zal 24 maanden beslaan. 
In Hoofdstuk 10 worden de resultaten van een experimentele studie weergeven. In deze 
studie, uitgevoerd met ratten, worden de karakteristieken van verschillende typen mesh 
(voor de behandeling van buikwandhernia’s) in een peritonitismodel beschreven. Er 
werden 5 meshes onderzocht: Permacol™ (cross-linked collagen), Strattice™ (non-cross-
linked collagen), XCM Biologic® (non-cross-linked collagen), Omyra® Mesh (condensed 
polytetrafluoroethylene) en Parietene™ (polypropylene). 180 Dagen na implantatie 
bleek dat XCM Biologic® en Permacol™ een betere ingroei hadden dan Strattice™ 
(p=0.003 and p=0.009). Strattice™ had significant minder adhesies vergeleken met 
XCM Biologic® en Permacol™. XCM Biologic® toonde de meeste krimp. Deze bevinding 
was niet statistisch significant. In deze experimentele studie werd onderzocht of een 
jairam-layout.indd   281 28/05/2018   21:47
282
Chapter 14
ideale mesh bestaat. Uit deze studie kwam naar voren dat XCM Biologic® een nieuwe 
biologische mat is, welke goede resultaten heeft laten zien in deze studie. Het gebruik 
van deze mesh kan nuttig zijn voor patiënten met een gecontamineerde littekenbreuk. 
In Hoofdstuk 11 wordt een systematische review gepresenteerd, waarin de haalbaarheid 
van het gebruik van lokale anesthesie voor de behandeling van navelbreuken wordt 
onderzocht. In de verschillende studies werden verschillende lokale anesthetica gebruikt 
en er was geen consensus betreft de injectietechniek. Het recidiefpercentage varieerde 
van 2% tot 7.4%. Lokale anesthesie voor de behandeling van navelbreuken lijkt veilig 
en haalbaar. Desondanks is er een grote heterogeniteit tussen de verschillende studies 
en zijn de voordelen van het gebruik van lokale anesthesie onder andere door het 
ontbreken van data niet duidelijk. Een gerandomiseerde trial, waarin lokale anesthesia 
met algemene anesthesia voor de behandeling van navelbreuken vergeleken wordt, 
zou de volgende stap moeten zijn. 
In Hoofdstuk 12 wordt een prospectief cohort gepresenteerd. In deze studie, waarin 30 
patienten zijn geincludeerd, worden de veiligheid en haalbaarheid onderzocht van het 
gebruik van lokale anesthesie in patienten met een navelbreuk. Er werd geconcludeerd 
dat het gebruik van lokale anesthesie (Ropivacaine en Remifentanil), veilig en haalbaar 
is in het corrigeren van een navelbreuk.
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verschillende mensen samengewerkt, die allen een grote bijdrage hebben geleverd aan 
dit proefschrift. Een aantal van hen wil ik in het bijzonder bedanken.
Allereerst; dank aan alle patiënten die hebben deelgenomen aan de verschillende 
studies. Zonder hen zou dit proefschrift nooit tot stand zijn gekomen. 
Professor Lange; mijn promotor. Ik zal onze eerste ontmoeting op een symposium in 
Delft nooit vergeten. U was degene die mij introduceerde in de REPAIR groep en mij een 
kans gaf om wetenschappelijk onderzoek te doen; iets waar ik u erg dankbaar voor ben. 
De wekelijkse REPAIR vergaderingen, inclusief het cultuurmoment (welke heeft geleid 
tot aanschaf van een museum jaarkaart), zal ik nooit vergeten. Dank voor uw input, uw 
eerlijke mening en het enthousiasme gedurende het hele traject. 
Professor Jeekel; mijn co-promotor. Ik ken niemand met zoveel doorzettingsvermogen 
en wetenschappelijke drive als u. Uw enthousiasme werkt aanstekelijk, dit stimuleerde 
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chirurgie, iets wat mij ook heel duidelijk werd op de verscheidene congressen. Dank 
voor uw betrokkenheid en energie (zowel op onderzoeksgebied, als op de dansvloer).
Professor Kleinrensink; zonder u is de REPAIR groep niet compleet. Uw aanstekelijke 
lach op de vrijdagmiddag tijdens de vergadering maakte de week weer compleet. Dank 
voor uw positiviteit en uw adviezen, en uiteraard veel dank dat u plaats neemt in mijn 
commissie. Ik kijk uit naar het optreden na de promotie!
Dr. Menon; (jongste) supervisor van de REPAIR groep. Alhoewel jouw onderzoeksgebied 
meer richting de colorectale chirurgie is, was je altijd zeer betrokken bij de niet-
colorectale onderzoeken, waaronder die van mij. Jouw nuchtere blik en je mening heb 
ik altijd zeer waardevol gevonden.
De commissieleden. Professor Van Eijck, Professor Bouvy en Professor Hovius; hartelijk 
dank voor jullie bereidheid om plaats te nemen in mijn leescommissie. Professor Wijnen 
en Professor Berrevoet; veel dank voor het plaatsnemen in de grote commissie. 
Beste Anneke van Duuren; heel veel dank voor het nauwkeurig invoeren van alle 
data voor de PRIMA trial. Jouw werk is van onschatbare waarde geweest voor onze 
onderzoeksgroep.
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Beste coauteurs; dank voor alle input, kritische blikken en het corrigeren van de 
manuscripten. 
Beste Annelies, dank je wel voor je hulp en begeleiding gedurende het promotie-
traject, met name tijdens de laatste loodjes.
Beste collega’s uit het Fransiscus Gasthuis, het Maasstad Ziekenhuis en het Erasmus 
Medisch Centrum: wat heb ik veel geleerd de afgelopen jaren. Heel veel dank voor de 
samenwerking, maar bovenal: dank voor de gezelligheid! 
Beste mede-onderzoekers uit de Z-flat, het lab en de Daniël. De vele borrels, ski-reizen 
en feestjes maakte iedere dag onderzoek doen een stuk leuker! Voor degenen die nog 
moeten: succes en hou vol, het eind komt op een gegeven moment in zicht.
Lieve roomies; Kirs en Mus. Wat was het gezellig met jullie! Het schrijven van dit boek 
heeft wellicht iets langer geduurd door het eindeloze en ellelange geklets op Z-835, 
maar het was het me dubbel en dwars waard.
Beste REPAIR’ders: Simone, Joost, Eva, Barry, Lucas, Ruth, Joris, Zhouqiao, Michael, 
Leonard, Daniël, Cloë, Floyd, Yağmur, Dimitri en Machteld. Het adagium luidt: eens een 
REPAIR’der, altijd een REPAIR’der. Wat ben ik blij dat ik in deze onderzoeksgroep terecht 
ben gekomen en dat ik met (een deel van) jullie heb mogen samenwerken. Iedere 
vrijdagmiddag om 12:00u samen naar de REPAIR vergadering, gevolgd door 30 à 45 
minuten debatteren over politiek en cultuur (waar mijn museum jaarkaart duidelijk een 
glansrol in had), afgesloten door een gezamenlijke lunch: wat een feest! Ik had me niks 
beters kunnen wensen dan met jullie zo wekelijks het weekend in te luiden.
Joost, mijn congresmaatje. Tegelijkertijd begonnen aan onderzoek, maar niet 
tegelijkertijd gepromoveerd. Je hebt het top gedaan. Ik kon altijd op je advies rekenen 
als het even tegenzat of als ik er niet uit kwam. Eva, ook jij stond altijd klaar als ik advies 
nodig had, zowel op onderzoeksgebied, maar ook daarbuiten. Dat waardeer ik heel erg. 
Lucas, het mooiste project uit mijn boekje komt voort uit jouw ‘onderzoekskindje’. Ik 
heb hier veel geluk mee gehad, besef ik me. We hebben er samen hard aan gewerkt. 
Bedankt voor je hulp.
Lieve vriendinnetjes (inclusief Levent). Door de jaren heen hebben we veel meegemaakt 
met elkaar en zijn we allemaal onze eigen weg ingeslagen. Ik geniet altijd van de borrels, 
etentjes en feestjes met jullie. Op nog heel veel jaren mooie en trouwe vriendschap!
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Lieve Brabantse schoonfamilie. Geïntroduceerd in de wereld van worstenbroodjes 
en carnaval, Bourgondisch leven en heel veel familieweekendjes. Dank voor jullie 
gastvrijheid, jullie interesse in mijn werk en het begrip voor het niet altijd aanwezig 
kunnen zijn op een feestje of partijtje. Ik hoop binnenkort meer tijd te hebben, en ik 
kom dan graag richting het mooie (zeg ik dit nou echt?) Hilvarenbeek.
Lieve familie, binnen en buiten Nederland. Ondanks dat we elkaar niet regelmatig zien, 
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niet wachten om eind dit jaar Suriname te gaan verkennen!
Mijn lieve paranimfen. Lieve Simone, wij ontmoetten elkaar ruim 5 jaar geleden, en wat 
is die tijd snel gegaan. Ik wil je bedanken voor de samenwerking en voor de gezelligheid 
tijdens onze onderzoekstijd de afgelopen jaren, maar ook voor je steun en je advies 
tijdens onze Maasstad tijd. Je bent een betrouwbaar en goed mens Simone, bedankt 
dat je vandaag aan mijn zijde staat. 
Lieve Ran. De keus voor jou als paranimf was snel gemaakt. Behalve dat je mijn zusje 
bent, ben je namelijk ook nog eens mijn allerbeste vriendin. Je begrijpt me als geen 
ander en je weet precies hoe ik in elkaar steek. Ik ben supertrots op je: eerst in je 
eentje naar Maastricht en nu weer terug in het Rotterdamsche, waar je een heerlijk 
appartementje hebt met Enrique. Je bent lief en vaak ook irritant tegelijk, maar ik zou 
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Liefste papa en mama. Wat jullie voor mij betekenen is moeilijk in woorden uit te 
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doorzettingsvermogen. Mam; zo gul, lief en zorgzaam zoals jij bent, daar zijn er maar 
weinig van. Mam en pap; dank jullie wel voor jullie eindeloze steun en liefde. Ik houd 
van jullie.
De laatste woorden zijn voor jou, lieve Dirk. Eindelijk, het boekje is af! Jij hebt mij de 
afgelopen periode veel gesteund, maar ook gestimuleerd wanneer dat nodig was. Je 
bent mijn maatje, en ik kan me geen leven zonder jou meer voorstellen. Ik heb heel veel 
zin in de toekomst, samen met jou! Ik hou van je.
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